var title_f43_45_44752="Anatomy ant segment struct";
var content_f43_45_44752=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F73347&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F73347&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 559px\">",
"   <div class=\"ttl\">",
"    Anterior anatomy of the eye",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 539px; height: 406px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_45_44752=[""].join("\n");
var outline_f43_45_44752=null;
var title_f43_45_44753="Treatment protocols for multiple myeloma";
var content_f43_45_44753=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Treatment protocols for multiple myeloma",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/45/44753/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/45/44753/contributors\">",
"     Tim Brenner, PharmD, BCOP",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/45/44753/contributors\">",
"     Shrina Duggal, PharmD, BCOP",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/45/44753/contributors\">",
"     Jim Natale, PharmD, BCOP",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/45/44753/contributors\">",
"     Scott M Wirth, PharmD, BCOP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/45/44753/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/45/44753/contributors\">",
"     John W Mucenski, PharmD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/45/44753/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/45/44753/contributors\">",
"     Rebecca F Connor, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?43/45/44753/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 13, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H4993546\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following material represents a subset of chemotherapy regimens that are used for the treatment of patients with multiple myeloma.",
"    <strong>",
"     This is",
"    </strong>",
"    <strong>",
"     not an exhaustive list",
"    </strong>",
"    ; it includes regimens that are considered by the authors and editors to be commonly used and important for the care of patients with multiple myeloma. Additional regimens may be added over time, particularly as treatment for multiple myeloma evolves.",
"   </p>",
"   <p>",
"    This topic review is intended to provide only a listing of chemotherapy regimens. It does not address the appropriate context for use of these regimens in the care of patients with multiple myeloma. Clinicians should refer to the individual disease-oriented topic reviews that discuss the use of these protocols in appropriate clinical situations:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?8/29/8666?source=see_link\">",
"       \"Determination of initial therapy in patients with multiple myeloma\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?28/1/28698?source=see_link\">",
"       \"Initial chemotherapy for symptomatic multiple myeloma in patients who are NOT candidates for transplantation\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?17/54/18282?source=see_link\">",
"       \"Initial chemotherapy for symptomatic multiple myeloma in patients who are candidates for transplantation\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?31/52/32584?source=see_link\">",
"       \"Initial chemotherapy for patients with high risk multiple myeloma\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?36/15/37114?source=see_link\">",
"       \"Treatment of relapsed or refractory multiple myeloma\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These tables are provided as examples of how to administer these regimens; there may be other acceptable methods. All chemotherapy regimens must be administered by clinicians who are trained in the use of chemotherapy. The clinician is expected to use his or her independent medical judgment in the context of individual circumstances to make adjustments, as necessary.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4993660\">",
"    <span class=\"h1\">",
"     REGIMENS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H936049102\">",
"    <span class=\"h2\">",
"     Bortezomib (Velcade) plus cyclophosphamide and dexamethasone (VCD or CyBorD)",
"    </span>",
"    &nbsp;&mdash;&nbsp;(",
"    <a class=\"graphic graphic_table graphicRef50061 \" href=\"mobipreview.htm?32/43/33470\">",
"     table 1",
"    </a>",
"    )",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H936049127\">",
"    <span class=\"h2\">",
"     Bortezomib (Velcade) plus melphalan and prednisone (VMP)",
"    </span>",
"    &nbsp;&mdash;&nbsp;(",
"    <a class=\"graphic graphic_table graphicRef55107 \" href=\"mobipreview.htm?27/39/28286\">",
"     table 2",
"    </a>",
"    )",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H936049152\">",
"    <span class=\"h2\">",
"     Lenalidomide (Revlimid) plus dexamethasone (Rd)",
"    </span>",
"    &nbsp;&mdash;&nbsp;(",
"    <a class=\"graphic graphic_table graphicRef56451 \" href=\"mobipreview.htm?25/61/26589\">",
"     table 3",
"    </a>",
"    )",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H936049177\">",
"    <span class=\"h2\">",
"     Melphalan plus prednisone and thalidomide (MPT)",
"    </span>",
"    &nbsp;&mdash;&nbsp;(",
"    <a class=\"graphic graphic_table graphicRef53179 \" href=\"mobipreview.htm?9/17/9502\">",
"     table 4",
"    </a>",
"    )",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H936049202\">",
"    <span class=\"h2\">",
"     Thalidomide plus dexamethasone (Td)",
"    </span>",
"    &nbsp;&mdash;&nbsp;(",
"    <a class=\"graphic graphic_table graphicRef82300 \" href=\"mobipreview.htm?41/56/42893\">",
"     table 5",
"    </a>",
"    )",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 85687 Version 2.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-200.150.3.100-D7E3B57AC3-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_45_44753=[""].join("\n");
var outline_f43_45_44753=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4993546\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4993660\">",
"      REGIMENS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H936049102\">",
"      Bortezomib (Velcade) plus cyclophosphamide and dexamethasone (VCD or CyBorD)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H936049127\">",
"      Bortezomib (Velcade) plus melphalan and prednisone (VMP)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H936049152\">",
"      Lenalidomide (Revlimid) plus dexamethasone (Rd)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H936049177\">",
"      Melphalan plus prednisone and thalidomide (MPT)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H936049202\">",
"      Thalidomide plus dexamethasone (Td)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ONC/85687\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/85687|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?32/43/33470\" title=\"table 1\">",
"      VCd CyBorD for multiple myeloma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?27/39/28286\" title=\"table 2\">",
"      VMP for multiple myeloma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?25/61/26589\" title=\"table 3\">",
"      Rd for multiple myeloma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?9/17/9502\" title=\"table 4\">",
"      MPT for multiple myeloma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?41/56/42893\" title=\"table 5\">",
"      Td for multiple myeloma",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/29/8666?source=related_link\">",
"      Determination of initial therapy in patients with multiple myeloma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/52/32584?source=related_link\">",
"      Initial chemotherapy for patients with high risk multiple myeloma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/1/28698?source=related_link\">",
"      Initial chemotherapy for symptomatic multiple myeloma in patients who are NOT candidates for transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/54/18282?source=related_link\">",
"      Initial chemotherapy for symptomatic multiple myeloma in patients who are candidates for transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/15/37114?source=related_link\">",
"      Treatment of relapsed or refractory multiple myeloma",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f43_45_44754="Gottron papules";
var content_f43_45_44754=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F63383&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F63383&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Gottron's papules in dermatomyositis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiple violaceous, scaly papules are present overlying the joints on the dorsal hand.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_45_44754=[""].join("\n");
var outline_f43_45_44754=null;
var title_f43_45_44755="Sufentanil: Patient drug information";
var content_f43_45_44755=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Sufentanil: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?14/47/15094?source=see_link\">",
"     see \"Sufentanil: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?0/6/96?source=see_link\">",
"     see \"Sufentanil: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F223606\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Sufenta&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F223607\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Sufentanil Citrate Injection, USP;",
"     </li>",
"     <li>",
"      Sufenta&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10013284\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to put you to sleep for surgery.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691611",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to ease pain.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10013283\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702963",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to sufentanil or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10013287\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697693",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may be habit-forming with long-term use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697302",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have lung disease, talk with your doctor. You may be more sensitive to this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4128402",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you drink grapefruit juice or eat grapefruit often, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10013288\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698060",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling lightheaded, sleepy, having blurred eyesight, or a change in thinking clearly. Avoid driving and doing other tasks or actions that call for you to be alert or have clear eyesight until you see how this drug affects you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697978",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hard stools (constipation). Drinking more liquids, working out, or adding fiber to your diet may help. Talk with your doctor about a stool softener or laxative.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698191",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Itching.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10013290\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698973",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Muscle stiffness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699000",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Poor pain control.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699014",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very hard stools (constipation).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10013286\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695991",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a vein.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696019",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given into a vein for a period of time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696029",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given into the spine.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10013292\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11429 Version 33.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-183.1.191.153-6CC31590FA-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_45_44755=[""].join("\n");
var outline_f43_45_44755=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F223606\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F223607\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013284\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013283\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013287\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013288\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013290\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013286\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013292\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?14/47/15094?source=related_link\">",
"      Sufentanil: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?0/6/96?source=related_link\">",
"      Sufentanil: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f43_45_44756="Retroareolar dilated ducts - ultrasound";
var content_f43_45_44756=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RADIOL%2F83705&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RADIOL%2F83705&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 614px\">",
"   <div class=\"ttl\">",
"    Retroareolar dilated ducts - ultrasound",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 594px; height: 282px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The US of the breast is from a 29-year-old lactating woman and shows dilated fluid filled ducts (red arrow) manifesting as branching anechoic structures in the sagittal (A) and transverse planes (B).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Priscilla J Slanetz, MD, MPH, FACR.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_45_44756=[""].join("\n");
var outline_f43_45_44756=null;
var title_f43_45_44757="Levocetirizine: Drug information";
var content_f43_45_44757=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Levocetirizine: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?13/7/13428?source=see_link\">",
"    see \"Levocetirizine: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?8/63/9205?source=see_link\">",
"    see \"Levocetirizine: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F5183881\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Xyzal&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F5183883\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Histamine H;",
"      <sub>",
"       1",
"      </sub>",
"      Antagonist",
"     </li>",
"     <li>",
"      Histamine H;",
"      <sub>",
"       1",
"      </sub>",
"      Antagonist, Second Generation",
"     </li>",
"     <li>",
"      Piperazine Derivative",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F5184440\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Allergic rhinitis, chronic urticaria: Oral: 5 mg once daily (in the evening); some patients may experience relief of symptoms with 2.5 mg once daily",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F5184439\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?8/63/9205?source=see_link\">",
"      see \"Levocetirizine: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Perennial allergic rhinitis, chronic urticaria:",
"     </b>",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Children 6 months to 5 years: 1.25 mg once daily (in the evening); maximum: 1.25 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Children 6-11 years: 2.5 mg once daily (in the evening); maximum: 2.5 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Children &ge;12 years: Refer to adult dosing.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Seasonal allergic rhinitis:",
"     </b>",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Children 2-5 years: 1.25 mg once daily (in the evening); maximum: 1.25 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Children 6-11 years: 2.5 mg once daily (in the evening); maximum: 2.5 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Children &ge;12 years: Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F5184441\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing; dosing should begin at the lower end of the dosing range.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F5184442\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Children 6 months to 11 years with renal impairment: Contraindicated",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Children &ge;12 and Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     50-80 mL/minute: 2.5 mg once daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     30-50 mL/minute: 2.5 mg once every other day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     10-30 mL/minute: 2.5 mg twice weekly (every 3 or 4 days)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;10 mL/minute, hemodialysis patients: Contraindicated",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F5184443\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No adjustment required.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F5027664\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Solution, oral, as dihydrochloride: 0.5 mg/mL (150 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Xyzal&reg;: 0.5 mg/mL (150 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral, as dihydrochloride: 5 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Xyzal&reg;: 5 mg [scored]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F5183882\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F5184446\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Administer in the evening. May be administered without regard to meals.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F5027661\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Relief of symptoms of perennial and seasonal allergic rhinitis; treatment of skin manifestations (uncomplicated) of chronic idiopathic urticaria",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F5183880\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Levocetirizine may be confused with cetirizine",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F5184415\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     &gt;10%: Gastrointestinal: Diarrhea (children 4% to 13%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Central nervous system: Somnolence (2% to 6%), fever (children 4%), fatigue (1% to 4%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Gastrointestinal: Constipation (children 7%), vomiting (children 4%), xerostomia (2% to 3%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Neuromuscular &amp; skeletal: Weakness (2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Otic: Otitis media (children 3%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Respiratory: Nasopharyngitis (4% to 6%), cough (children 3%), epistaxis (children 2%), pharyngitis (1% to 2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     &lt;1% (Limited to important or life-threatening): Aggression, agitation, anaphylaxis, angioedema, bilirubin increased, blurred vision, dizziness, dyspnea, dysuria, fixed-drug eruption, hepatitis, hypersensitivity, myalgia, nausea, palpitation, paresthesia, pruritus, rash, seizure, suicidal ideation, syncope, transaminases increased, urinary retention, urticaria, visual disturbances, weight gain",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;\">",
"     The following potentially-severe adverse reactions have been reported with cetirizine and, therefore, may also occur with levocetirizine: Cholestasis, glomerulonephritis, hallucination, hypotension (severe), orofacial dyskinesia",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F5183891\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to levocetirizine, cetirizine, or any component of the formulation; end-stage renal disease (Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;10 mL/minute); hemodialysis; children 6 months to 11 years of age with renal impairment",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F5184411\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; CNS depression: May cause CNS depression, which may impair physical or mental abilities; patients must be cautioned about performing tasks which require mental alertness (eg, operating machinery or driving).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Prostatic hyperplasia/urinary obstruction: Use with caution in patients with prostatic hyperplasia and/or GU obstruction; discontinue if urinary retention occurs.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Renal impairment: Levocetirizine is excreted primarily by the kidneys; use with caution in adults with mild-to-moderate renal impairment; dosage adjustments may be needed. Use is contraindicated in end-stage renal disease (Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;10 mL/minute), patients undergoing hemodialysis, and in children 6 months to 11 years of age with renal impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Sedatives: Effects may be potentiated when used with other sedative drugs or ethanol.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Elderly: Use with caution in the elderly.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299591\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F5184421\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Acetylcholinesterase Inhibitors (Central): Anticholinergics may diminish the therapeutic effect of Acetylcholinesterase Inhibitors (Central). Acetylcholinesterase Inhibitors (Central) may diminish the therapeutic effect of Anticholinergics. If the anticholinergic action is a side effect of the agent, the result may be beneficial.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aclidinium: May enhance the anticholinergic effect of Anticholinergics.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alcohol (Ethyl): CNS Depressants may enhance the CNS depressant effect of Alcohol (Ethyl).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amphetamines: May diminish the sedative effect of Antihistamines.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anticholinergics: May enhance the adverse/toxic effect of other Anticholinergics.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Azelastine (Nasal): CNS Depressants may enhance the CNS depressant effect of Azelastine (Nasal).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Benzylpenicilloyl Polylysine: Antihistamines may diminish the diagnostic effect of Benzylpenicilloyl Polylysine.  Management: Suspend systemic H1 antagonists for benzylpenicilloyl-polylysine skin testing and delay testing until systemic antihistaminic effects have dissipated. A histamine skin test may be used to assess persistent antihistaminic effects.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Betahistine: Antihistamines may diminish the therapeutic effect of Betahistine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Buprenorphine: CNS Depressants may enhance the CNS depressant effect of Buprenorphine.  Management: Consider reduced doses of CNS depressants used in combination with buprenorphine.  Consider avoiding other CNS depressants in patients thought to be at high risk of buprenorphine overuse or self-injection.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CNS Depressants: May enhance the adverse/toxic effect of other CNS Depressants.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Droperidol: May enhance the CNS depressant effect of CNS Depressants. Management: Consider dose reductions of droperidol or of other CNS agents (e.g., opioids, barbiturates) with concomitant use.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hyaluronidase: Antihistamines may diminish the therapeutic effect of Hyaluronidase.  Management: Patients receiving antihistamines (particularly at larger doses) may not experience the desired clinical response to standard doses of hyaluronidase.  Larger doses of hyaluronidase may be required.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     HydrOXYzine: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ipratropium (Oral Inhalation): May enhance the anticholinergic effect of Anticholinergics.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Magnesium Sulfate: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methotrimeprazine: CNS Depressants may enhance the CNS depressant effect of Methotrimeprazine. Methotrimeprazine may enhance the CNS depressant effect of CNS Depressants.  Management: Reduce adult dose of CNS depressant agents by 50% with initiation of concomitant methotrimeprazine therapy. Further CNS depressant dosage adjustments should be initiated only after clinically effective methotrimeprazine dose is established.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metyrosine: CNS Depressants may enhance the sedative effect of Metyrosine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mirtazapine: CNS Depressants may enhance the CNS depressant effect of Mirtazapine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Paraldehyde: CNS Depressants may enhance the CNS depressant effect of Paraldehyde.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Perampanel: May enhance the CNS depressant effect of CNS Depressants. Management: Patients taking perampanel with any other drug that has CNS depressant activities should avoid complex and high-risk activities, particularly those such as driving that require alertness and coordination, until they have experience using the combination.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pramipexole: CNS Depressants may enhance the sedative effect of Pramipexole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pramlintide: May enhance the anticholinergic effect of Anticholinergics. These effects are specific to the GI tract.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ROPINIRole: CNS Depressants may enhance the sedative effect of ROPINIRole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rotigotine: CNS Depressants may enhance the sedative effect of Rotigotine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Selective Serotonin Reuptake Inhibitors: CNS Depressants may enhance the adverse/toxic effect of Selective Serotonin Reuptake Inhibitors. Specifically, the risk of psychomotor impairment may be enhanced.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Oxybate: May enhance the CNS depressant effect of CNS Depressants. Management: Consider alternatives to combined use. When combined use is needed, consider minimizing doses of one or more drugs. Use of sodium oxybate with alcohol or sedative hypnotics is contraindicated.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tiotropium: Anticholinergics may enhance the anticholinergic effect of Tiotropium.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zolpidem: CNS Depressants may enhance the CNS depressant effect of Zolpidem.  Management: Reduce the Intermezzo brand sublingual zolpidem dose to 1.75 mg for men who are also receiving other CNS depressants.  No such dose change is recommended for women.  Avoid use with other CNS depressants at bedtime; avoid use with alcohol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F5184424\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:0em;margin-left:0em;text-align:justify;display:inline\">",
"     Ethanol: May increase CNS depression; monitor for increased effects with coadministration. Caution patients about effects.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F5183886\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     B (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F5183887\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse events have not been observed in animal reproduction studies; therefore, the manufacturer classifies levocetirizine as pregnancy category B. The use of antihistamines for the treatment of rhinitis during pregnancy is generally considered to be safe at recommended doses. Information related to the use of levocitirizine during pregnancy is limited; therefore, other agents are preferred. Levocetirizine is the active enantiomer of cetirizine; refer to the Cetirizine monograph for additional information.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F5183889\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/not recommended",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F5183890\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     It is not known if levocetirizine is excreted in breast milk. Breast-feeding is not recommended by the manufacturer.",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F5184445\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     May be taken without regard to meals.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F6256223\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Levocetirizine Dihydrochloride Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     2.5 mg/5 mL (148 mL): $92.29",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Xyzal Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     2.5 mg/5 mL (148 mL): $102.55",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Levocetirizine Dihydrochloride Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     5 mg (90): $276.88",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Xyzal Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     5 mg (90): $307.67",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F5184448\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Creatinine clearance (prior to treatment for dosing adjustment)",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F5027658\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Alergocit (PK);",
"     </li>",
"     <li>",
"      Alermax (PY);",
"     </li>",
"     <li>",
"      Antiss (CO);",
"     </li>",
"     <li>",
"      Cenova-L (KP);",
"     </li>",
"     <li>",
"      Cetimer (GT, HN, NI, SV);",
"     </li>",
"     <li>",
"      Cetriler (PE);",
"     </li>",
"     <li>",
"      Cipen (KP);",
"     </li>",
"     <li>",
"      Coalbi (KP);",
"     </li>",
"     <li>",
"      Degraler (CN, EC, PE);",
"     </li>",
"     <li>",
"      Histaplen (UY);",
"     </li>",
"     <li>",
"      L-Zet (PH);",
"     </li>",
"     <li>",
"      Levaler (DO, GT, PA, SV);",
"     </li>",
"     <li>",
"      Levocen (KP);",
"     </li>",
"     <li>",
"      Levocet (EC, IN);",
"     </li>",
"     <li>",
"      Levocezal (KP);",
"     </li>",
"     <li>",
"      Levomine (AR);",
"     </li>",
"     <li>",
"      Levozine (TW);",
"     </li>",
"     <li>",
"      Levrix (NZ);",
"     </li>",
"     <li>",
"      Lezat (CO);",
"     </li>",
"     <li>",
"      Libbera (PE);",
"     </li>",
"     <li>",
"      Locemine (TW);",
"     </li>",
"     <li>",
"      Newzal (KP);",
"     </li>",
"     <li>",
"      Sensitin (PH);",
"     </li>",
"     <li>",
"      Tecovel (PH);",
"     </li>",
"     <li>",
"      Xazal (ES);",
"     </li>",
"     <li>",
"      Xozal (GR);",
"     </li>",
"     <li>",
"      Xusal (DE, MX);",
"     </li>",
"     <li>",
"      Xyzal (AU, BG, CH, CL, CZ, DE, DK, EE, FI, FR, GB, HK, ID, IE, IT, KP, MY, NL, NO, PH, PL, PT, RU, SE, SG, TH, TW);",
"     </li>",
"     <li>",
"      Xyzall (AT, BE);",
"     </li>",
"     <li>",
"      Xyzine (TW);",
"     </li>",
"     <li>",
"      Zyxem (BR, MX)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F5184427\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Levocetirizine is an antihistamine which selectively competes with histamine for H",
"     <sub>",
"      1",
"     </sub>",
"     -receptor sites on effector cells in the gastrointestinal tract, blood vessels, and respiratory tract. Levocetirizine, the active enantiomer of cetirizine, has twice the binding affinity at the H",
"     <sub>",
"      1",
"     </sub>",
"     -receptor compared to cetirizine.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F5184429\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Onset of action: 1 hour",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Duration: 24 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Absorption: Rapid and extensive",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Distribution: 0.4 L/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Protein binding: 91% to 92%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metabolism: Minimal (&lt;14%); via aromatic oxidation, N and O-dealkylation (via CYPA4), and taurine conjugation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Half-life elimination: Children: ~6 hours; Adults: ~8-9 hours; Renal impairment: 11-34 hours; End-stage renal disease: 46 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Time to peak, plasma: Children: 1.2 hours; Adults: Oral solution: 0.5 hours, Tablet: 0.9 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Excretion: Urine (85%); feces (13%)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Nettis E, Colanardi MC, Barra L, et al, &ldquo;Levocetirizine in the Treatment of Chronic Idiopathic Urticaria: A Randomized, Double-Blind, Placebo-Controlled Study,&rdquo;",
"      <i>",
"       Br J Dermatol",
"      </i>",
"      , 2006, 154(3):533-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?43/45/44757/abstract-text/16445787/pubmed\" id=\"16445787\" target=\"_blank\">",
"        16445787",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Simons FE and Simons KJ, &ldquo;Levocetirizine: Pharmacokinetics and Pharmacodynamics in Children Age 6 to 11 Years,&rdquo;",
"      <i>",
"       J Allergy Clin Immunol",
"      </i>",
"      , 2005, 116(2):355-61.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?43/45/44757/abstract-text/16083790/pubmed\" id=\"16083790\" target=\"_blank\">",
"        16083790",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9443 Version 41.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-61.234.146.186-E2D9733EE5-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_45_44757=[""].join("\n");
var outline_f43_45_44757=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5183881\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5183883\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5184440\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5184439\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5184441\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5184442\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5184443\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5027664\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5183882\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5184446\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5027661\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5183880\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5184415\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5183891\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5184411\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299591\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5184421\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5184424\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5183886\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5183887\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5183889\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5183890\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5184445\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6256223\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5184448\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5027658\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5184427\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5184429\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9443\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9443|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?13/7/13428?source=related_link\">",
"      Levocetirizine: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?8/63/9205?source=related_link\">",
"      Levocetirizine: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f43_45_44758="Atenolol and chlorthalidone: Drug information";
var content_f43_45_44758=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Atenolol and chlorthalidone: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?2/24/2438?source=see_link\">",
"    see \"Atenolol and chlorthalidone: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F137732\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Tenoretic&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F137733\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Atenidone&reg;;",
"     </li>",
"     <li>",
"      Novo-Atenolthalidone;",
"     </li>",
"     <li>",
"      Tenoretic&reg;;",
"     </li>",
"     <li>",
"      Teva-Atenolol Chlorthalidone",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F137755\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Beta-Blocker, Beta-1 Selective;",
"     </li>",
"     <li>",
"      Diuretic, Thiazide",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F137734\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     Dose is individualized; combination product may be substituted for individual components in patients currently maintained on both agents separately or in patients not adequately controlled with monotherapy (using one of the agents or an agent within same antihypertensive class).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Hypertension:",
"     </b>",
"     Oral: Initial: Atenolol 50 mg and chlorthalidone 25 mg once daily; if optimal blood pressure response not achieved, may increase dose of atenolol to 100 mg (maximum dose: Atenolol 100 mg/day; chlorthalidone 25 mg/day).",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F137735\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F137736\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &gt;35 mL/minute/1.73 m",
"     <sup>",
"      2",
"     </sup>",
"     : No dosage adjustment necessary.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     15-35 mL/minute/1.73 m",
"     <sup>",
"      2",
"     </sup>",
"     : Maximum dose: Atenolol 50 mg daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;15 mL/minute/1.73 m",
"     <sup>",
"      2",
"     </sup>",
"     : Maximum dose: Atenolol 50 mg every other day; chlorthalidone should be used with caution and is contraindicated in anuria.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F15682660\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling; use with caution.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F137723\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tablet: Atenolol 50 mg and chlorthalidone 25 mg; atenolol 100 mg and chlorthalidone 25 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Tenoretic&reg;: Atenolol 50 mg and chlorthalidone 25 mg; atenolol 100 mg and chlorthalidone 25 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F137712\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F137725\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of hypertension with a cardioselective beta-blocker and a diuretic",
"    </p>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F137753\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     See individual agents.",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F2535537\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to atenolol, chlorthalidone, sulfonamide derived drugs, or any component of the formulation; sinus bradycardia, second- or third-degree heart block (except in patients with a functioning artificial pacemaker); cardiogenic shock, overt cardiac failure; anuria",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F10512381\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse events:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Anaphylactic reactions: Use caution with history of severe anaphylaxis to allergens; patients taking beta-blockers may become more sensitive to repeated challenges. Treatment of anaphylaxis (eg, epinephrine) in patients taking beta-blockers may be ineffective or promote undesirable effects.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Electrolyte disturbances: Hypokalemia, hypochloremic alkalosis, and hyponatremia can occur with chlorthalidone.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Photosensitivity: Photosensitization may occur with chlorthalidone.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Sulfa allergy: Chemical similarities are present among sulfonamides, sulfonylureas, carbonic anhydrase inhibitors, thiazides, and loop diuretics (except ethacrynic acid). Use of chlorthalidone in patients with thiazide or sulfonamide allergy is specifically contraindicated in product labeling, however, a risk of cross-reaction exists in patients with allergy to any of these compounds; avoid use when previous reaction has been severe. Discontinue if signs of hypersensitivity are noted.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Bronchospastic disease: In general, patients with bronchospastic disease should not receive beta-blockers; however, atenolol, with B",
"     <sub>",
"      1",
"     </sub>",
"     selectivity, has been used cautiously with close monitoring.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Conduction abnormality: Consider pre-existing conditions such as sick sinus syndrome before initiating.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Diabetes: Use with caution in patients with prediabetes or diabetes mellitus; may see a change in glucose control or potentiation of hypoglycemia and/or mask signs and symptoms.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Gout: In certain patients with a history of gout, a familial predisposition to gout, or chronic renal failure, gout can be precipitated with chlorthalidone.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Heart failure (HF): Use with caution in patients with compensated heart failure and monitor for a worsening of the condition (efficacy of atenolol in HF has not been demonstrated).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic impairment: Use chlorthalidone with caution in patients with severe hepatic dysfunction; in cirrhosis, avoid electrolyte and acid/base imbalances that might lead to hepatic encephalopathy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hypercalcemia: Thiazide diuretics (eg, chlorthalidone) may decrease renal calcium excretion; consider avoiding use in patients with hypercalcemia.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hypercholesterolemia: Use chlorthalidone with caution in patients with moderate or high cholesterol concentrations.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hypokalemia: Use chlorthalidone with caution in patients with hypokalemia; correct before initiating therapy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Myasthenia gravis: Use atenolol with caution in patients with myasthenia gravis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Peripheral vascular disease (PVD) and Raynaud's disease: Atenolol may precipitate or aggravate symptoms of arterial insufficiency in patients with PVD and Raynaud's disease. Use with caution and monitor for progression of arterial obstruction.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pheochromocytoma (untreated): Adequate alpha-blockade is required prior to use of any beta-blocker.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Psoriasis: Beta-blocker use has been associated with induction or exacerbation of psoriasis, but cause and effect have not been firmly established.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Psychiatric disease: Use atenolol with caution in patients with a history of psychiatric illness; may cause or exacerbate CNS depression.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Use atenolol with caution in patients with renal impairment; dosage adjustment required. Avoid chlorthalidone in patients with severe renal disease (ineffective).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Systemic lupus erythematosus (SLE): Chlorthalidone can cause SLE exacerbation or activation.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Thyroid disease: Atenolol may mask signs of hyperthyroidism (eg, tachycardia). If hyperthyroidism is suspected, carefully manage and monitor; abrupt withdrawal may precipitate thyroid storm. Alterations in thyroid-function tests may be observed.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Calcium channel blockers: Use atenolol with caution in patients on concurrent verapamil or diltiazem; bradycardia or heart block can occur.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cardiac glycosides: Use with caution in patients receiving digoxin; bradycardia or heart block can occur.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Inhaled anesthetic agents: Use with caution in patients receiving inhaled anesthetic agents known to depress myocardial contractility.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Elderly: Bradycardia may be observed more frequently in elderly patients (&gt;65 years of age); dosage reductions may be necessary.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Abrupt withdrawal: Beta-blocker therapy should not be withdrawn abruptly (particularly in patients with CAD), but gradually tapered to avoid acute tachycardia, hypertension, and/or ischemia. Severe exacerbation of angina, ventricular arrhythmias, and myocardial infarction (MI) have been reported following abrupt withdrawal of beta-blocker therapy. Temporary but prompt resumption of beta-blocker therapy may be indicated with worsening of angina or acute coronary insufficiency.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Major surgery: Chronic beta-blocker therapy should not be routinely withdrawn prior to major surgery.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13298791\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F137718\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ACE Inhibitors: Thiazide Diuretics may enhance the hypotensive effect of ACE Inhibitors. Specifically, postural hypotension which can accompany ACE Inhibitor initiation. Thiazide Diuretics may enhance the nephrotoxic effect of ACE Inhibitors.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Acetylcholinesterase Inhibitors: May enhance the bradycardic effect of Beta-Blockers.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alcohol (Ethyl): May enhance the orthostatic hypotensive effect of Thiazide Diuretics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Allopurinol: Thiazide Diuretics may enhance the potential for allergic or hypersensitivity reactions to Allopurinol. Thiazide Diuretics may increase the serum concentration of Allopurinol. Specifically, Thiazide Diuretics may increase the concentration of Oxypurinol, an active metabolite of Allopurinol.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alpha-/Beta-Agonists (Direct-Acting): Beta-Blockers may enhance the vasopressor effect of Alpha-/Beta-Agonists (Direct-Acting). Epinephrine used as a local anesthetic for dental procedures will not likely cause clinically relevant problems.  Management: Cardioselective beta-blockers and lower doses of epinephrine may confer a more limited risk. Patients who may require acute subcutaneous epinephrine (e.g., bee sting kits) should probably avoid beta blockers.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Dipivefrin.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alpha1-Blockers: Beta-Blockers may enhance the orthostatic hypotensive effect of Alpha1-Blockers. The risk associated with ophthalmic products is probably less than systemic products.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alpha2-Agonists: May enhance the AV-blocking effect of Beta-Blockers. Sinus node dysfunction may also be enhanced. Beta-Blockers may enhance the rebound hypertensive effect of Alpha2-Agonists. This effect can occur when the alpha",
"     <sub>",
"      2",
"     </sub>",
"     -agonist is abruptly withdrawn. Management: Closely monitor heart rate during treatment with a beta blocker and clonidine. Withdraw beta blockers several days before clonidine withdrawal when possible, and monitor blood pressure closely. Recommendations for other alpha2-agonists are unavailable.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Apraclonidine; Brimonidine.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amifostine: Antihypertensives may enhance the hypotensive effect of Amifostine.  Management: When amifostine is used at chemotherapy doses, antihypertensive medications should be withheld for 24 hours prior to amifostine administration. If antihypertensive therapy can not be withheld, amifostine should not be administered.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amiodarone: May enhance the bradycardic effect of Beta-Blockers. Possibly to the point of cardiac arrest. Amiodarone may increase the serum concentration of Beta-Blockers.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ampicillin: May decrease the bioavailability of Atenolol.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Analgesics (Opioid): May enhance the orthostatic hypotensive effect of Thiazide Diuretics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anilidopiperidine Opioids: May enhance the bradycardic effect of Beta-Blockers. Anilidopiperidine Opioids may enhance the hypotensive effect of Beta-Blockers.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antidiabetic Agents: Thiazide Diuretics may diminish the therapeutic effect of Antidiabetic Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antihypertensives: May enhance the hypotensive effect of other Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Barbiturates: May enhance the orthostatic hypotensive effect of Thiazide Diuretics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Beta2-Agonists: May enhance the hypokalemic effect of Thiazide Diuretics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Beta2-Agonists: Beta-Blockers (Beta1 Selective) may diminish the bronchodilatory effect of Beta2-Agonists. Of particular concern with nonselective beta-blockers or higher doses of the beta1 selective beta-blockers.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bile Acid Sequestrants: May decrease the absorption of Thiazide Diuretics. The diuretic response is likewise decreased.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bupivacaine: Beta-Blockers may increase the serum concentration of Bupivacaine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Calcium Channel Blockers (Dihydropyridine): May enhance the hypotensive effect of Beta-Blockers. Bradycardia and signs of heart failure have also been reported.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Calcium Channel Blockers (Nondihydropyridine): May enhance the hypotensive effect of Beta-Blockers. Bradycardia and signs of heart failure have also been reported. Calcium Channel Blockers (Nondihydropyridine) may increase the serum concentration of Beta-Blockers.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Bepridil [Off Market].",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Calcium Salts: Thiazide Diuretics may decrease the excretion of Calcium Salts. Continued concomitant use can also result in metabolic alkalosis.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CarBAMazepine: Thiazide Diuretics may enhance the adverse/toxic effect of CarBAMazepine. Specifically, there may be an increased risk for hyponatremia.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cardiac Glycosides: Beta-Blockers may enhance the bradycardic effect of Cardiac Glycosides.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cholinergic Agonists: Beta-Blockers may enhance the adverse/toxic effect of Cholinergic Agonists. Of particular concern are the potential for cardiac conduction abnormalities and bronchoconstriction.  Management: Administer these agents in combination with caution, and monitor for conduction disturbances.  Avoid methacholine with any beta blocker due to the potential for additive bronchoconstriction.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Corticosteroids (Orally Inhaled): May enhance the hypokalemic effect of Thiazide Diuretics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Corticosteroids (Systemic): May enhance the hypokalemic effect of Thiazide Diuretics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dipyridamole: May enhance the bradycardic effect of Beta-Blockers.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Disopyramide: May enhance the bradycardic effect of Beta-Blockers.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dofetilide: Thiazide Diuretics may enhance the QTc-prolonging effect of Dofetilide. Thiazide Diuretics may increase the serum concentration of Dofetilide.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dronedarone: May enhance the bradycardic effect of Beta-Blockers. Dronedarone may increase the serum concentration of Beta-Blockers. This likely applies only to those agents that are metabolized by CYP2D6. Management: Use lower initial beta-blocker doses; adequate tolerance of the combination, based on ECG findings, should be confirmed prior to any increase in beta-blocker dose.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ergot Derivatives: Beta-Blockers may enhance the vasoconstricting effect of Ergot Derivatives.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fingolimod: Beta-Blockers may enhance the bradycardic effect of Fingolimod.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Floctafenine: May enhance the adverse/toxic effect of Beta-Blockers.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Glycopyrrolate: May increase the serum concentration of Atenolol.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herbs (Hypertensive Properties): May diminish the antihypertensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herbs (Hypotensive Properties): May enhance the hypotensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hypotensive Agents: May enhance the adverse/toxic effect of other Hypotensive Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Insulin: Beta-Blockers may enhance the hypoglycemic effect of Insulin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Licorice: May enhance the hypokalemic effect of Thiazide Diuretics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lidocaine (Systemic): Beta-Blockers may increase the serum concentration of Lidocaine (Systemic).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lidocaine (Topical): Beta-Blockers may increase the serum concentration of Lidocaine (Topical).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lithium: Thiazide Diuretics may decrease the excretion of Lithium.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     MAO Inhibitors: May enhance the orthostatic hypotensive effect of Orthostatic Hypotension Producing Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mepivacaine: Beta-Blockers may increase the serum concentration of Mepivacaine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methacholine: Beta-Blockers may enhance the adverse/toxic effect of Methacholine.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methylphenidate: May diminish the antihypertensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Midodrine: Beta-Blockers may enhance the bradycardic effect of Midodrine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Multivitamins/Minerals (with ADEK, Folate, Iron): Thiazide Diuretics may enhance the hypercalcemic effect of Multivitamins/Minerals (with ADEK, Folate, Iron).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Nonsteroidal Anti-Inflammatory Agents: May diminish the antihypertensive effect of Beta-Blockers.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Nonsteroidal Anti-Inflammatory Agents: May diminish the therapeutic effect of Thiazide Diuretics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     OXcarbazepine: Thiazide Diuretics may enhance the adverse/toxic effect of OXcarbazepine. Specifically, there may be an increased risk for hyponatremia.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pentoxifylline: May enhance the hypotensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Phosphodiesterase 5 Inhibitors: May enhance the antihypertensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Porfimer: Photosensitizing Agents may enhance the photosensitizing effect of Porfimer.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Prostacyclin Analogues: May enhance the hypotensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Reserpine: May enhance the hypotensive effect of Beta-Blockers.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     RiTUXimab: Antihypertensives may enhance the hypotensive effect of RiTUXimab.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Phosphates: Diuretics may enhance the nephrotoxic effect of Sodium Phosphates. Specifically, the risk of acute phosphate nephropathy may be enhanced.  Management: Consider avoiding this combination by temporarily suspending treatment with diuretics, or seeking alternatives to oral sodium phosphate bowel preparation. If the combination cannot be avoided, hydrate adequately and monitor fluid and renal status.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sulfonylureas: Beta-Blockers may enhance the hypoglycemic effect of Sulfonylureas. Cardioselective beta-blockers (eg, acebutolol, atenolol, metoprolol, and penbutolol) may be safer than nonselective beta-blockers. All beta-blockers appear to mask tachycardia as an initial symptom of hypoglycemia. Ophthalmic beta-blockers are probably associated with lower risk than systemic agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Theophylline Derivatives: Beta-Blockers (Beta1 Selective) may diminish the bronchodilatory effect of Theophylline Derivatives.  Management: Monitor for reduced theophylline efficacy during concomitant use with any beta-blocker.  Beta-1 selective agents are less likely to antagonize theophylline than nonselective agents, but selectivity may be lost at higher doses.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Topiramate: Thiazide Diuretics may enhance the hypokalemic effect of Topiramate. Thiazide Diuretics may increase the serum concentration of Topiramate.  Management: Monitor for increased topiramate levels/adverse effects (e.g., hypokalemia) with initiation/dose increase of a thiazide diuretic. Closely monitor serum potassium concentrations with concomitant therapy. Topiramate dose reductions may be necessary.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Toremifene: Thiazide Diuretics may enhance the hypercalcemic effect of Toremifene.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin D Analogs: Thiazide Diuretics may enhance the hypercalcemic effect of Vitamin D Analogs.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Yohimbine: May diminish the antihypertensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F137719\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     D (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F13707166\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     See individual agents.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F137738\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/use caution",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F2524337\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Atenolol-Chlorthalidone Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     50-25 mg (100): $92.50",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     100-25 mg (100): $136.49",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Tenoretic 100 Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     100-25 mg (100): $291.10",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Tenoretic 50 Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     50-25 mg (100): $207.40",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F137730\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Ablok Plus (BR);",
"     </li>",
"     <li>",
"      Anola (KP);",
"     </li>",
"     <li>",
"      Atecard-D (IN);",
"     </li>",
"     <li>",
"      Ateclero (KP);",
"     </li>",
"     <li>",
"      Ateclor (DO, GT, NI, SV);",
"     </li>",
"     <li>",
"      Atel (DE);",
"     </li>",
"     <li>",
"      Atemine (KP);",
"     </li>",
"     <li>",
"      Atenigron (IT);",
"     </li>",
"     <li>",
"      Atenogamma (DE);",
"     </li>",
"     <li>",
"      Atenoric (BR);",
"     </li>",
"     <li>",
"      Atensil-D (PY);",
"     </li>",
"     <li>",
"      Blokium-Diu (AE, BF, BH, BJ, CI, CY, EG, ET, GH, GM, GN, IL, IQ, IR, JO, KE, KW, LB, LR, LY, MA, ML, MR, MU, MW, NE, NG, OM, QA, SA, SC, SD, SL, SN, SY, TN, TZ, UG, YE, ZM, ZW);",
"     </li>",
"     <li>",
"      Blokiuret (VE);",
"     </li>",
"     <li>",
"      Prenoretic (PY);",
"     </li>",
"     <li>",
"      Shpyuja (TW);",
"     </li>",
"     <li>",
"      Target (SG);",
"     </li>",
"     <li>",
"      Tenchlor (ZA);",
"     </li>",
"     <li>",
"      Tendiuretic (EC);",
"     </li>",
"     <li>",
"      Teneretic (DE);",
"     </li>",
"     <li>",
"      Tenoret (AE, BF, BH, BJ, CI, CY, EG, ET, GB, GH, GM, GN, IE, IL, IQ, IR, JO, KE, KW, LB, LR, LY, MA, ML, MR, MU, MW, NE, NG, OM, QA, SA, SC, SD, SL, SN, SY, TN, TZ, UG, YE, ZM, ZW);",
"     </li>",
"     <li>",
"      Tenoret 50 (HK, ID, MY, SG, TH);",
"     </li>",
"     <li>",
"      Tenoretic (AE, AT, BB, BE, BF, BH, BJ, BM, BR, BS, BZ, CH, CI, CN, CO, CY, CZ, DE, DK, EG, ES, ET, GB, GH, GM, GN, GR, GY, HK, ID, IE, IL, IQ, IR, IT, JM, JO, KE, KP, KW, LB, LR, LY, MA, ML, MR, MU, MW, MX, MY, NE, NG, NL, OM, PE, PH, PT, QA, SA, SC, SD, SG, SL, SN, SR, SY, TN, TR, TT, TZ, UG, UY, YE, ZM, ZW);",
"     </li>",
"     <li>",
"      Tenoric (IN);",
"     </li>",
"     <li>",
"      Tensolin (TW);",
"     </li>",
"     <li>",
"      Tractocile (FR, HU, SE)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F137727\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     See individual agents.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Foster CA and Aston SJ, &ldquo;Propranolol-Epinephrine Interaction: A Potential Disaster,&rdquo;",
"      <i>",
"       Plast Reconstr Surg",
"      </i>",
"      , 1983, 72(1):74-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?43/45/44758/abstract-text/6867180/pubmed\" id=\"6867180\" target=\"_blank\">",
"        6867180",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Geffner DL and Hershman JM, &ldquo;beta-Adrenergic Blockade for the Treatment of Hyperthyroidism,&rdquo;",
"      <i>",
"       Am J Med",
"      </i>",
"      , 1992, 93(1):61-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?43/45/44758/abstract-text/1352658/pubmed\" id=\"1352658\" target=\"_blank\">",
"        1352658",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Wong DG, Spence JD, Lamki L, et al, &ldquo;Effect of Nonsteroidal Anti-inflammatory Drugs on Control of Hypertension of Beta-Blockers and Diuretics,&rdquo;",
"      <i>",
"       Lancet",
"      </i>",
"      , 1986, 1(8488):997-1001.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?43/45/44758/abstract-text/2871333/pubmed\" id=\"2871333\" target=\"_blank\">",
"        2871333",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Wynn RL, &ldquo;Dental Nonsteroidal Anti-inflammatory Drugs and Prostaglandin-Based Drug Interactions - Part Two,&rdquo;",
"      <i>",
"       Gen Dent",
"      </i>",
"      , 1992, 40(2):104, 106, 108.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?43/45/44758/abstract-text/1354194/pubmed\" id=\"1354194\" target=\"_blank\">",
"        1354194",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Wynn RL, &ldquo;Epinephrine Interactions With Beta-Blockers,&rdquo;",
"      <i>",
"       Gen Dent",
"      </i>",
"      , 1994, 42(1):16, 18.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?43/45/44758/abstract-text/7911769/pubmed\" id=\"7911769\" target=\"_blank\">",
"        7911769",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8645 Version 39.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-61.234.146.186-FBD0C7583D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_45_44758=[""].join("\n");
var outline_f43_45_44758=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F137732\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F137733\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F137755\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F137734\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F137735\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F137736\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15682660\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F137723\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F137712\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F137725\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F137753\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2535537\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10512381\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13298791\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F137718\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F137719\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13707166\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F137738\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2524337\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F137730\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F137727\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8645\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8645|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?2/24/2438?source=related_link\">",
"      Atenolol and chlorthalidone: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f43_45_44759="FNH MRI T1 weighted";
var content_f43_45_44759=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F51338&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F51338&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 577px\">",
"   <div class=\"ttl\">",
"    Focal nodular hyperplasia of the liver seen on MRI",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 557px; height: 423px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    T1-weighted MRI pre-gadolinium shows a hypointense lesion in the left lobe of the liver (top left). Immediately after gadolinium infusion, the arterial phase reveals a hyperintense mass with a hypodense central scar, characteristic of FNH (top right). After two minutes, the mass appears nearly isodense with the normal liver, and the central scar is difficult to distinguish (bottom left). After three minutes, the central scar is hyperdense&nbsp;due to delayed accumulation of gadolinium (bottom right).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Douglas R LaBrecque, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_45_44759=[""].join("\n");
var outline_f43_45_44759=null;
var title_f43_45_44760="Pharmacotherapy for schizophrenia: Side effect management";
var content_f43_45_44760=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pharmacotherapy for schizophrenia: Side effect management",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/45/44760/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/45/44760/contributors\">",
"     Stephen Marder, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/45/44760/contributors\">",
"     T. Scott Stroup, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/45/44760/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/45/44760/contributors\">",
"     Murray B Stein, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/45/44760/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/45/44760/contributors\">",
"     Richard Hermann, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?43/45/44760/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 22, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H893410703\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Schizophrenia is a severe disorder involving chronic or recurrent psychosis and long-term deterioration in functioning [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/45/44760/abstract/1\">",
"     1",
"    </a>",
"    ]. It is among the most disabling and economically catastrophic disorders, ranked by the World Health Organization as one of the top 10 illnesses contributing to the global burden of disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/45/44760/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Antipsychotic medications are first-line medication treatment for schizophrenia. They have been shown in clinical trials to be effective in treating symptoms and behaviors associated with the disorder. The optimal medication, dose, and route of administration vary according to stage of illness, individual patient characteristics, and the clinical situation.",
"   </p>",
"   <p>",
"    Antipsychotic medications have significant side effects, which influence selection among them. A table shows the side effect profiles of individual antipsychotics (",
"    <a class=\"graphic graphic_table graphicRef82533 \" href=\"mobipreview.htm?32/57/33694\">",
"     table 1",
"    </a>",
"    ). Assessment for these side effects and management of them are essential parts of schizophrenia treatment.",
"   </p>",
"   <p>",
"    This topic addresses the management of side effects during pharmacotherapy for schizophrenia. Pharmacotherapy for schizophrenia during acute and maintenance phase treatment is discussed separately. The clinical presentation, epidemiology, clinical manifestations, and diagnosis of schizophrenia are discussed separately. Common comorbid presentations of schizophrenia and an overview other psychotic disorders are also discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/35/29241?source=see_link\">",
"     \"Pharmacotherapy for schizophrenia: Acute and maintenance phase treatment\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/47/34552?source=see_link\">",
"     \"Schizophrenia: Clinical manifestations, course, assessment, and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/58/28583?source=see_link\">",
"     \"Overview of psychosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/3/2105?source=see_link\">",
"     \"Anxiety in schizophrenia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/21/25944?source=see_link\">",
"     \"Depression in schizophrenia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/42/36521?source=see_link\">",
"     \"Dual diagnosis: Severe mental illness and substance use disorders\"",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28219024\">",
"    <span class=\"h1\">",
"     EXTRAPYRAMIDAL SYMPTOMS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients receiving an antipsychotic should receive routine monitoring for manifestations of extrapyramidal symptoms (EPS), including akathisia, parkinsonism, and dystonias. All of the antipsychotic medications have the potential for causing EPS. They are common with some antipsychotics (eg,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/50/32553?source=see_link\">",
"     haloperidol",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/10/38055?source=see_link\">",
"     fluphenazine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?40/35/41526?source=see_link\">",
"     thiothixene",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/2/19495?source=see_link\">",
"     trifluoperazine",
"    </a>",
"    ), and uncommon with others (",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/56/20361?source=see_link\">",
"     quetiapine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/21/35161?source=see_link\">",
"     clozapine",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/59/35767?source=see_link\">",
"     iloperidone",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28219031\">",
"    <span class=\"h2\">",
"     Akathisia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Akathisia is the most common form of EPS. It usually presents as motor restlessness with a compelling urge to move and an inability to sit still. Individuals with milder akathisia may describe a subjective feeling of restlessness but not show restless motor behavior. If patients do not demonstrate restless behaviors, the examiner should inquire if they pace frequently or if they have difficulty sitting still.",
"   </p>",
"   <p>",
"    Treatment options for akathisia include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A cautious antipsychotic dose reduction, if feasible, should be attempted first, with close monitoring of the patient for exacerbation of psychotic symptoms.",
"     </li>",
"     <li>",
"      If decreasing the antipsychotic drug dose is unfeasible or inadequate, we suggest treatment with a benzodiazepine. Two small randomized trials of 26 patients with schizophrenia found benzodiazepine treatment to reduce symptoms of akathisia compared to placebo (NNT=1.2) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/45/44760/abstract/3\">",
"       3",
"      </a>",
"      ].",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?8/8/8329?source=see_link\">",
"       Lorazepam",
"      </a>",
"      can be started at 0.5 mg orally twice daily. If the symptoms do not resolve and the patient has not experienced side effects such as ataxia and sedation, the medication can be incrementally raised up to 6 to 10",
"      <span class=\"nowrap\">",
"       mg/day.",
"      </span>",
"      Since benzodiazepines such as lorazepam are associated with sedation, withdrawal seizures, a potential for addiction, and tolerance, patients should receive the lowest dose that reduces akathisia.",
"     </li>",
"     <li>",
"      In our clinical experience, a beta blocker such as",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?8/49/8986?source=see_link\">",
"       propranolol",
"      </a>",
"      or an anticholinergic drug such as",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?3/55/3958?source=see_link\">",
"       benztropine",
"      </a>",
"      can be used to effectively treat akathisia if a benzodiazepine is not effective.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Three small trials, two of them randomized, showed mixed results for a beta blocker in akathisia compared to placebo [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/45/44760/abstract/4-6\">",
"       4-6",
"      </a>",
"      ].",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?8/49/8986?source=see_link\">",
"       Propranolol",
"      </a>",
"      is started at 10 mg orally twice daily and can be gradually increased up to 20 mg three times daily. Blood pressure should be monitored with the use of a beta blocker. Beta blockers are contraindicated in patients with airway diseases such as bronchial asthma and COPD as well as patients with heart failure. Common side effects include fatigue, syncope, and light headedness.",
"     </li>",
"     <li>",
"      A small randomized trial found",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?3/55/3958?source=see_link\">",
"       benztropine",
"      </a>",
"      to be effective in akathisia compared to placebo [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/45/44760/abstract/7\">",
"       7",
"      </a>",
"      ]. Benztropine can be started at 1 mg twice daily and increased up to 2 mg twice daily. Patients receiving benztropine should be monitored for anticholinergic effects including dry mouth, constipation, urinary retention, and memory impairment.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28219038\">",
"    <span class=\"h2\">",
"     Parkinsonian syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Secondary parkinsonism consists of mask-like facies, resting tremor, cogwheel rigidity, shuffling gait, and psychomotor retardation (bradykinesia). Moderate or severe parkinsonism is usually obvious to an examiner. Milder parkinsonism can usually be diagnosed by examining for cog wheel rigidity or observing for a diminished arm swing when the patient walks. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/13/14554?source=see_link&amp;anchor=H2#H2\">",
"     \"Clinical manifestations of Parkinson disease\", section on 'Cardinal manifestations'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Parkinsonism secondary to antipsychotics can be treated with an anticholinergic antiparkinsonian medication.",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?3/55/3958?source=see_link\">",
"     Benztropine",
"    </a>",
"    may be started at 1 to 2",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    in divided doses. Doses of 1 to 2",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    are often effective in treating antipsychotic-induced parkinsonism, but if necessary the dose can be increased gradually every three to four days to 6 or 8",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    if tolerated. Anticholinergic medications such as benztropine can lead to dry mouth, constipation, urinary retention, and memory impairment. Anticholinergics should be used cautiously in patients with glaucoma and in those with cognitive impairments.",
"   </p>",
"   <p>",
"    If the patient is on an anticholinergic antipsychotic or does not tolerate",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?3/55/3958?source=see_link\">",
"     benztropine",
"    </a>",
"    , a non-anticholinergic antiparkinsonian medication may be used, such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?12/46/13031?source=see_link\">",
"     amantadine",
"    </a>",
"    , 100 mg orally two to three times daily. Amantadine can cause hypotension and mild agitation. &nbsp;",
"   </p>",
"   <p>",
"    Prophylactic use of antiparkinsonian agents is not generally recommended to prevent antipsychotic-induced parkinsonism, though it may be useful in patients treated with high-potency, first-generation antipsychotics who have a known history of sensitivity to EPS or are treated with relatively high doses (eg, greater than",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/50/32553?source=see_link\">",
"     haloperidol",
"    </a>",
"    10",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    or the equivalent dose of other antipsychotics) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/45/44760/abstract/8,9\">",
"     8,9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28219045\">",
"    <span class=\"h2\">",
"     Dystonias",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute dystonias are involuntary contractions of major muscle groups, and are characterized by symptoms such as torticollis, retrocollis, oculogyric crisis, and opisthotonos. These are usually rapid in onset and highly disturbing to patients. An extremely rare dystonia, laryngospasm, can be life threatening. Risk factors for dystonia include young age, male sex, use of cocaine, and a history of acute dystonic reaction.",
"   </p>",
"   <p>",
"    Dystonias that are very disturbing can be treated with 1 to 2 mg of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?3/55/3958?source=see_link\">",
"     benztropine",
"    </a>",
"    or 50 mg of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?33/2/33824?source=see_link\">",
"     diphenhydramine",
"    </a>",
"    daily, administered intravenously or intramuscularly. Milder dystonias can be treated with oral benztropine 1 to 2 mg once or twice daily. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/60/970?source=see_link\">",
"     \"Classification and evaluation of dystonia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The emergence of a dystonia should lead to a reevaluation of the patient's antipsychotic regimen. After acute treatment of the dystonia, the preferred intervention is changing to an antipsychotic with a lower liability for EPS (",
"    <a class=\"graphic graphic_table graphicRef82533 \" href=\"mobipreview.htm?32/57/33694\">",
"     table 1",
"    </a>",
"    ). If changing the antipsychotic is not an option, adding an anticholinergic antiparkinson medication such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?3/55/3958?source=see_link\">",
"     benztropine",
"    </a>",
"    1 to 2 mg by mouth twice daily may be effective.",
"   </p>",
"   <p>",
"    Prophylactic treatment with an anticholinergic agent (",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?3/55/3958?source=see_link\">",
"     benztropine",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?33/2/33824?source=see_link\">",
"     diphenhydramine",
"    </a>",
"    ) is recommended to prevent an acute dystonic reaction in patients who receive intramuscular",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/50/32553?source=see_link\">",
"     haloperidol",
"    </a>",
"    (eg, in the treatment of acute agitation or psychosis). Prophylactic treatment is particularly important in individuals with little prior exposure to antipsychotics. As an example, intramuscular haloperidol 5 or 10 mg can be accompanied by intramuscular benztropine 1 or 2 mg.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H893411288\">",
"    <span class=\"h2\">",
"     Monitoring",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients starting an antipsychotic medication should be evaluated for EPS weekly until the medication dose has been stable for at least two weeks. Two weekly assessments should also follow any significant dose increase [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/45/44760/abstract/10\">",
"     10",
"    </a>",
"    ]. Once the patient&rsquo;s dosage has been stabilized, the frequency of EPS assessment should depend on the patient&rsquo;s sensitivity to EPS and the EPS liability of their antipsychotic. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/24/7562?source=see_link\">",
"     \"First-generation antipsychotic medications: Pharmacology, administration, and comparative side effects\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/10/15530?source=see_link\">",
"     \"Second-generation antipsychotic medications: Pharmacology, administration, and comparative side effects\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28219052\">",
"    <span class=\"h1\">",
"     TARDIVE DYSKINESIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tardive dyskinesia (TD) is reviewed here briefly and discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/26/36264?source=see_link\">",
"     \"Tardive dyskinesia: Etiology and epidemiology\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/40/27269?source=see_link\">",
"     \"Tardive dyskinesia: Clinical features and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/8/34952?source=see_link\">",
"     \"Tardive dyskinesia: Prevention and treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    TD is a syndrome consisting of characteristic involuntary movements that occur after chronic use of antipsychotic medications. These movements seldom occur after less than six months of treatment and usually occur after years of treatment. The movements that characterize TD are as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Sucking, smacking of lips",
"     </li>",
"     <li>",
"      Choreoathetoid movements of the tongue",
"     </li>",
"     <li>",
"      Facial grimacing",
"     </li>",
"     <li>",
"      Lateral jaw movements",
"     </li>",
"     <li>",
"      Choreiform or athetoid movements of the extremities",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      truncal areas",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Patients who experience EPS during acute treatment appear to be at a greater risk for developing TD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/45/44760/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. Other risk factors for TD among patients taking antipsychotic drugs include older age, longer duration of antipsychotic drug exposure and use of anticholinergic-antiparkinson drugs. Most of these associations are based on prevalence rather than incidence studies; thus, their role as risk factors for TD is not firmly established. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/26/36264?source=see_link&amp;anchor=H14#H14\">",
"     \"Tardive dyskinesia: Etiology and epidemiology\", section on 'Risk factors for TD'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients on an antipsychotic medication should be evaluated for TD regularly, at least annually. Patients taking drugs known to have a high risk of EPS or TD should be evaluated every six months (",
"    <a class=\"graphic graphic_table graphicRef82533 \" href=\"mobipreview.htm?32/57/33694\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/45/44760/abstract/10\">",
"     10",
"    </a>",
"    ]. Elderly patients are at a higher risk for TD and should be evaluated more frequently. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/26/36264?source=see_link&amp;anchor=H14#H14\">",
"     \"Tardive dyskinesia: Etiology and epidemiology\", section on 'Risk factors for TD'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/8/34952?source=see_link&amp;anchor=H2#H2\">",
"     \"Tardive dyskinesia: Prevention and treatment\", section on 'Prevention'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The evaluation for TD can occur at the same time that the patient is being observed for acute EPS. While the patient is sitting, the clinician observes whether there are abnormal movements in the face, mouth, jaw, and the extremities. The tongue is observed with the mouth open. While standing, the patient is observed for abnormal movements of the trunk. Clinicians may choose to use the Abnormal Involuntary Movement Scale (AIMS) for documenting the results of the examination (",
"    <a class=\"graphic graphic_form graphicRef51103 \" href=\"mobipreview.htm?43/13/44243\">",
"     form 1",
"    </a>",
"    ). The AIMS includes both a standardized examination and a system for rating abnormal movements.",
"   </p>",
"   <p>",
"    When patients develop TD, clinicians should re-evaluate the current treatment strategy. Changing patients to an antipsychotic with a low risk for TD such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/56/20361?source=see_link\">",
"     quetiapine",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/21/35161?source=see_link\">",
"     clozapine",
"    </a>",
"    may be a useful strategy for some individuals. There are currently no pharmacological agents that are effective for treating TD. These issues are discussed in greater detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/8/34952?source=see_link&amp;anchor=H5#H5\">",
"     \"Tardive dyskinesia: Prevention and treatment\", section on 'Pharmacologic treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28219059\">",
"    <span class=\"h1\">",
"     METABOLIC SIDE EFFECTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of the antipsychotic medications are known to cause weight gain, hyperlipidemia, hyperglycemia, and hypertension including",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?36/36/37449?source=see_link\">",
"     olanzapine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/56/20361?source=see_link\">",
"     quetiapine",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?11/33/11802?source=see_link\">",
"     risperidone",
"    </a>",
"    .",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/50/32553?source=see_link\">",
"     Haloperidol",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?42/11/43193?source=see_link\">",
"     aripiprazole",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?4/39/4728?source=see_link\">",
"     ziprasidone",
"    </a>",
"    seldom cause these side effects (",
"    <a class=\"graphic graphic_table graphicRef82533 \" href=\"mobipreview.htm?32/57/33694\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    As an example of weight gain, the CATIE study found that adult patients taking",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?36/36/37449?source=see_link\">",
"     olanzapine",
"    </a>",
"    gained an average of two pounds per month over 18 months; 30 percent gained 7 percent or more of their initial body weight [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/45/44760/abstract/13\">",
"     13",
"    </a>",
"    ]. These side effects raise particular concern due to the early mortality experienced, on average, by patients with schizophrenia secondary to cardiovascular disease and other causes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/45/44760/abstract/14\">",
"     14",
"    </a>",
"    ]. Elevated blood glucose can occur secondary to weight gain or independently. Serum lipid levels rise in association with body weight.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H956391806\">",
"    <span class=\"h2\">",
"     Monitoring",
"    </span>",
"    &nbsp;&mdash;&nbsp;A table provides a recommended schedule for monitoring the metabolic effects of first and second-generation antipsychotics (",
"    <a class=\"graphic graphic_table graphicRef74435 \" href=\"mobipreview.htm?25/17/25884\">",
"     table 2",
"    </a>",
"    ). More frequent measurements may be necessary for individual patients (eg, more frequent assessment of lipids and glucose in the patient who has a significant weight gain) or for patients on specific antipsychotics (eg,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?36/36/37449?source=see_link\">",
"     olanzapine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/56/20361?source=see_link\">",
"     quetiapine",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/21/35161?source=see_link\">",
"     clozapine",
"    </a>",
"    , where there is clear evidence of an increased risk of insulin resistance) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/45/44760/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although assessment for metabolic side effects was initially recommended for people taking what are commonly described as second-generation antipsychotics, we recommend this schedule for individuals taking any antipsychotic medication. The rationale for this recommendation is the increased risk for cardiovascular disease and diabetes associated with schizophrenia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28219066\">",
"    <span class=\"h2\">",
"     Clinical management",
"    </span>",
"    &nbsp;&mdash;&nbsp;The selection of a strategy for managing weight gain and other metabolic problems depends on a number of factors including the history of responsiveness to different antipsychotics, the severity of the metabolic disturbance, and the willingness of the patient to make lifestyle changes. Options include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Treating developing problems symptomatically, eg, antihypertensives for hypertension or statins for dyslipidemia. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?25/32/26122?source=see_link\">",
"       \"Treatment of lipids (including hypercholesterolemia) in secondary prevention\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?31/36/32330?source=see_link\">",
"       \"Overview of hypertension in adults\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Persons with new-onset diabetes (FBS &ge; 126",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      or random glucose &ge; 200",
"      <span class=\"nowrap\">",
"       mg/dL)",
"      </span>",
"      should receive an evaluation by a general medical physician.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Diet management and exercise, which can be helpful for some patients with mild or moderate dyslipidemias and weight gain, although evidence of effectiveness is limited in patients with schizophrenia [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/45/44760/abstract/14,16\">",
"       14,16",
"      </a>",
"      ]. The existing trials used different approaches to encourage patients to make changes in their diets and to increase their physical activity. Although the trials tended to be small and to include carefully selected subjects, most demonstrated benefits in short term weight loss.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?7/48/7944?source=see_link\">",
"       Metformin",
"      </a>",
"      . Evidence from randomized trials has shown metformin 1000 to 2000",
"      <span class=\"nowrap\">",
"       mg/day",
"      </span>",
"      well-tolerated and effective in helping persons with schizophrenia lose weight, whether new onset [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/45/44760/abstract/17\">",
"       17",
"      </a>",
"      ] or not [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/45/44760/abstract/18\">",
"       18",
"      </a>",
"      ]. Most trials of recent weight gain found 12 to 16 weeks of metformin to lead to loss of approximately 50 percent of the weight gain induced by antipsychotic treatment [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/45/44760/abstract/17-20\">",
"       17-20",
"      </a>",
"      ]. These studies did not select patients with demonstrated diabetes or prediabetes. The doses used in these studies were commonly 750 mg daily or higher. Metformin was well tolerated in these studies but common side effects of metformin include diarrhea, nausea, and flatulence. Metformin should not be prescribed for individuals with impaired creatinine clearance. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?37/26/38312?source=see_link&amp;anchor=H6#H6\">",
"       \"Metformin in the treatment of diabetes mellitus\", section on 'Side effects'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Switching to an antipsychotic that has a lower liability for weight gain or dyslipidemia. Studies have shown that switching from drugs with relatively high risk of weight gain and dyslipidemia (eg,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?36/36/37449?source=see_link\">",
"       olanzapine",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?19/56/20361?source=see_link\">",
"       quetiapine",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?11/33/11802?source=see_link\">",
"       risperidone",
"      </a>",
"      ) to medications with lower risk (eg,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?42/11/43193?source=see_link\">",
"       aripiprazole",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?4/39/4728?source=see_link\">",
"       ziprasidone",
"      </a>",
"      ) is often (but not always) effective in promoting weight loss and improving lipid profiles [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/45/44760/abstract/13\">",
"       13",
"      </a>",
"      ]. Careful monitoring of clinical status is recommended when attempting such a switch to help avoid exacerbation of symptoms of schizophrenia. A gradual cross titration from the current to the newer drug over one to three weeks will usually protect patients against an exacerbation of psychosis.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28219073\">",
"    <span class=\"h1\">",
"     PROLACTIN ELEVATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;First-generation antipsychotics,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?11/33/11802?source=see_link\">",
"     risperidone",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?43/43/44728?source=see_link\">",
"     paliperidone",
"    </a>",
"    can elevate plasma prolactin. This elevation can lead to galactorrhea and menstrual disturbances in women as well as sexual dysfunction and gynecomastia in men. Individuals who are receiving medications that can cause elevated prolactin levels should be asked whether they are having symptoms such as amenorrhea or galactorrhea for women, enlarged breasts for men, and sexual dysfunction for both men and women. If the answers are positive, a prolactin level can be used to clarify the diagnosis and plan treatment. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/41/22167?source=see_link&amp;anchor=H10#H10\">",
"     \"Causes of hyperprolactinemia\", section on 'Drug use'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/51/19254?source=see_link&amp;anchor=H2#H2\">",
"     \"Clinical manifestations and diagnosis of hyperprolactinemia\", section on 'Clinical presentation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In most cases, elevated prolactin can be managed by changing the patient to an antipsychotic with a lower likelihood of causing prolactin elevation. In women with antipsychotic-induced amenorrhea where a change in antipsychotic is undesirable, a small randomized trial suggested that",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?7/48/7944?source=see_link\">",
"     metformin",
"    </a>",
"    may be an effective treatment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/45/44760/abstract/21\">",
"     21",
"    </a>",
"    ]. Metformin 1000",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    was compared to placebo in 84 women with first-episode schizophrenia and antipsychotic-induced amenorrhea and weight gain. After six months of treatment, significantly more patients in the metformin group resumed menstruation compared to the placebo group (66.7 versus 4.8 percent); the mean body mass index (BMI) decreased among patients receiving metformin, while BMI increased in patients on placebo. A longer trial demonstrating that metformin leads to the return of ovulatory cycles is needed before metformin should be a standard recommendation for antipsychotic-induced amenorrhea.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28219080\">",
"    <span class=\"h1\">",
"     OTHER SIDE EFFECTS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H956391487\">",
"    <span class=\"h2\">",
"     Seizures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most antipsychotics cause a dose-related reduction in the seizure threshold. As a result, patients with seizure disorders should be carefully monitored in conjunction with their neurologist; when medications are added to an existing antiepileptic drug regimen, increased drug level monitoring may be indicated. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/39/40570?source=see_link&amp;anchor=H10#H10\">",
"     \"Overview of the management of epilepsy in adults\", section on 'Maximizing the likelihood of a successful outcome'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If a patient experiences new onset seizures, antipsychotic drugs should not be assumed to be the etiology, as these rarely cause seizures in a patient not otherwise prone to epilepsy. Usual procedures for evaluation of new-onset seizures should be followed. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/9/25753?source=see_link\">",
"     \"Evaluation of the first seizure in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H956391578\">",
"    <span class=\"h2\">",
"     Orthostatic hypotension",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antipsychotics with &alpha;-adrenergic blocking effects (eg,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/21/35161?source=see_link\">",
"     clozapine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?11/33/11802?source=see_link\">",
"     risperidone",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?43/43/44728?source=see_link\">",
"     paliperidone",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/59/35767?source=see_link\">",
"     iloperidone",
"    </a>",
"    ) can produce a dose-related orthostatic hypotension and associated tachycardia. These effects are most pronounced during the first days of treatment. To prevent the otherwise common occurrence of orthostatic hypotension with some agents, particularly clozapine and iloperidone, the dose should be started low (eg, 12.5 to 25 mg of clozapine or 1 mg twice daily of iloperidone) and increased gradually to allow the patient to develop tolerance. For iloperidone, the dose can be increased by 2 mg daily until the patient reaches a therapeutic dose of 12 to 24 mg. The dose of clozapine can be increased by 25 to 50 mg daily until a therapeutic dose of 300 to 500 mg is reached. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H956391585\">",
"    <span class=\"h2\">",
"     Neuroleptic malignant syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neuroleptic malignant syndrome (NMS), a tetrad of clinical features (fever, rigidity, mental status changes, and autonomic instability), is associated with medications that block dopamine transmission. NMS is a rare but potentially life-threatening event that can be seen with all antipsychotic drugs with a reported incidence rate of less than one to three percent of patients taking these medications [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/45/44760/abstract/22\">",
"     22",
"    </a>",
"    ]. Treatment involves withdrawal of medication, and intensive management for cardiovascular support, control of hyperthermia, and fluid and electrolyte balance. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/4/20553?source=see_link\">",
"     \"Neuroleptic malignant syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H956391592\">",
"    <span class=\"h2\">",
"     QT prolongation",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/21/35161?source=see_link\">",
"     Clozapine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/35/32311?source=see_link\">",
"     thioridazine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/59/35767?source=see_link\">",
"     iloperidone",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?4/39/4728?source=see_link\">",
"     ziprasidone",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?6/20/6472?source=see_link\">",
"     pimozide",
"    </a>",
"    and intravenous",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/50/32553?source=see_link\">",
"     haloperidol",
"    </a>",
"    prolong the QT interval, particularly at higher doses. These medications should be avoided in patients with cardiac disease, elderly patients, and in conjunction with other medications that prolong the QT interval such as antiarrhythmics and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/29/36304?source=see_link\">",
"     erythromycin",
"    </a>",
"    . In other patients, an ECG should be performed prior to starting the medication and periodically (eg, yearly) during treatment. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/55/23418?source=see_link\">",
"     \"Acquired long QT syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H956391599\">",
"    <span class=\"h2\">",
"     Sudden death",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antipsychotics are associated with increased risk for sudden death [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/45/44760/abstract/23\">",
"     23",
"    </a>",
"    ]. Risk increases with higher medication dose. A case-controlled study of 90,000 Medicaid recipients (mean age 45.7; not limited to patients with schizophrenia) found that, compared to nonuse, current use of antipsychotics doubled the risk of sudden death (incidence rate ratios 1.99, 95% CI 1.68-2.34, and 2.26, 1.88-2.72, for first and second-generation antipsychotics respectively). The rate of sudden death with antipsychotics (1.8 per 1,000 person years) is almost ten-fold the rate of death related to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/21/35161?source=see_link\">",
"     clozapine",
"    </a>",
"    -associated agranulocytosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/45/44760/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The mechanism underlying sudden death was not determined, but is presumed related to the known effect of antipsychotics on cardiac repolarization and QTc prolongation. Patients with known cardiac disease should have an ECG before starting an antipsychotic medication. However, it is unclear whether ECG monitoring will identify patients at increased risk for sudden death. Medications that prolong the QTc interval, such as antiarrhythmics and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/29/36304?source=see_link\">",
"     erythromycin",
"    </a>",
"    , should be avoided when possible in patients who are treated with antipsychotics. (See",
"    <a class=\"local\" href=\"#H956391592\">",
"     'QT prolongation'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H956391047\">",
"    <span class=\"h2\">",
"     Anticholinergic effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anticholinergic side effects of antipsychotic drugs include dry mouth, urinary hesitancy, constipation, visual disturbance, and cognitive impairment. These effects tend to be worse in older patients. Anticholinergic effects are seen with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/21/35161?source=see_link\">",
"     clozapine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?29/38/30312?source=see_link\">",
"     chlorpromazine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?36/36/37449?source=see_link\">",
"     olanzapine",
"    </a>",
"    , and, to a lesser extent, with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/56/20361?source=see_link\">",
"     quetiapine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/59/35767?source=see_link\">",
"     iloperidone",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/2/27687?source=see_link\">",
"     loxapine",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28219095\">",
"    <span class=\"h2\">",
"     Sedation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although any antipsychotic can cause sedation in some patients, severe sedation is most common with low potency medications such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?29/38/30312?source=see_link\">",
"     chlorpromazine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/21/35161?source=see_link\">",
"     clozapine",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/56/20361?source=see_link\">",
"     quetiapine",
"    </a>",
"    . These side effects are usually most severe during the first weeks of treatment and often require gradual titration of the antipsychotic. Sedating medications may be best tolerated at bed time.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?43/37/44625?source=see_link\">",
"       \"Patient information: Schizophrenia (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H893411222\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antipsychotic drugs are first-line treatment for schizophrenia; however, they have significant side effects. Antipsychotics differ widely in their side effect profiles, influencing drug selection. A table describes the side effect profiles of individual antipsychotics (",
"    <a class=\"graphic graphic_table graphicRef82533 \" href=\"mobipreview.htm?32/57/33694\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Extrapyramidal symptoms (EPS) of antipsychotic drugs include akathisia, parkinsonism, and dystonias. EPS are common with some antipsychotics (eg,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/50/32553?source=see_link\">",
"       haloperidol",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?37/10/38055?source=see_link\">",
"       fluphenazine",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?40/35/41526?source=see_link\">",
"       thiothixene",
"      </a>",
"      , and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?19/2/19495?source=see_link\">",
"       trifluoperazine",
"      </a>",
"      ) and uncommon with others (",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?19/56/20361?source=see_link\">",
"       quetiapine",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?34/21/35161?source=see_link\">",
"       clozapine",
"      </a>",
"      , and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?34/59/35767?source=see_link\">",
"       iloperidone",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H28219024\">",
"       'Extrapyramidal symptoms'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Akathisia presents with a subjective feeling of restlessness accompanied in more severe presentations with motor movements such as fidgeting, pacing, or difficulty sitting still. Akathisia can be treated with a benzodiazepine or a beta blocker. (See",
"      <a class=\"local\" href=\"#H28219031\">",
"       'Akathisia'",
"      </a>",
"      above.)",
"      <br/>",
"      <br/>",
"      We suggest treatment with a benzodiazepine for akathisia (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). Two small randomized trials found benzodiazepine treatment to reduce akathisia compared to placebo [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/45/44760/abstract/3\">",
"       3",
"      </a>",
"      ].",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?8/8/8329?source=see_link\">",
"       Lorazepam",
"      </a>",
"      can be started at 0.5 mg orally twice daily and increased incrementally up to 6 to 10",
"      <span class=\"nowrap\">",
"       mg/day.",
"      </span>",
"     </li>",
"     <li>",
"      Secondary parkinsonism consists of mask-like facies, resting tremor, cogwheel rigidity, shuffling gait, and psychomotor retardation.",
"      <br/>",
"      <br/>",
"      If parkinsonism is uncomfortable or disabling, we suggest treatment with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?3/55/3958?source=see_link\">",
"       benztropine",
"      </a>",
"      (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Benztropine may be started at 1 to 2",
"      <span class=\"nowrap\">",
"       mg/day",
"      </span>",
"      in divided doses. Doses of 1 to 2",
"      <span class=\"nowrap\">",
"       mg/day",
"      </span>",
"      are often effective in treating antipsychotic-induced parkinsonism but if necessary, the dose can be increased gradually every three to four days to 6 or 8",
"      <span class=\"nowrap\">",
"       mg/day",
"      </span>",
"      if tolerated. If the patient is on an antipsychotic with significant anticholinergic effects or does not tolerate benztropine, a non-anticholinergic antiparkinsonian medication can be used, such as",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?12/46/13031?source=see_link\">",
"       amantadine",
"      </a>",
"      , 100 mg orally two to three times daily. (See",
"      <a class=\"local\" href=\"#H28219038\">",
"       'Parkinsonian syndrome'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Acute dystonias are involuntary contractions of major muscle groups and are characterized by symptoms such as torticollis, retrocollis, oculogyric crisis, and opisthotonos. Severe dystonias can be treated with 1 to 2 mg of IM or IV",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?3/55/3958?source=see_link\">",
"       benztropine",
"      </a>",
"      or 25 mg of IM or IV",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?33/2/33824?source=see_link\">",
"       diphenhydramine",
"      </a>",
"      . Milder dystonias can be treated with 1 or 2 mg of benztropine once or twice daily. (See",
"      <a class=\"local\" href=\"#H28219045\">",
"       'Dystonias'",
"      </a>",
"      above.)",
"      <br/>",
"      <br/>",
"      Patients starting an antipsychotic medication or receiving an increased dose should be evaluated for EPS weekly until the medication dose has been stable for at least two weeks. Once the patient&rsquo;s dosage has been stabilized, the patient should be assessed for EPS at least every six months. (See",
"      <a class=\"local\" href=\"#H893411288\">",
"       'Monitoring'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Tardive dyskinesia (TD) is a syndrome consisting of characteristic involuntary movements of the lips, tongue, face, jaw, extremities, or trunk that occur after chronic use of antipsychotic medications. These movements seldom occur after less than three months of treatment and usually occur after years of treatment. TD appears to be more common with first-generation antipsychotics than second-generation antipsychotics, and the risk of TD may be particularly low with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?19/56/20361?source=see_link\">",
"       quetiapine",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?34/21/35161?source=see_link\">",
"       clozapine",
"      </a>",
"      , and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?34/59/35767?source=see_link\">",
"       iloperidone",
"      </a>",
"      . (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?26/40/27269?source=see_link\">",
"       \"Tardive dyskinesia: Clinical features and diagnosis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?34/8/34952?source=see_link\">",
"       \"Tardive dyskinesia: Prevention and treatment\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?7/24/7562?source=see_link\">",
"       \"First-generation antipsychotic medications: Pharmacology, administration, and comparative side effects\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?15/10/15530?source=see_link\">",
"       \"Second-generation antipsychotic medications: Pharmacology, administration, and comparative side effects\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Patients on an antipsychotic medication should be evaluated for TD regularly, at least annually. Patients taking drugs known to have a high risk of EPS or TD should be evaluated every six months (",
"      <a class=\"graphic graphic_table graphicRef82533 \" href=\"mobipreview.htm?32/57/33694\">",
"       table 1",
"      </a>",
"      ). Many antipsychotic medications cause weight gain, hyperlipidemia, hyperglycemia, and hypertension, collectively known as metabolic syndrome (an indicator or risk for cardiovascular disease). These side effects are more commonly seen with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?36/36/37449?source=see_link\">",
"       olanzapine",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?19/56/20361?source=see_link\">",
"       quetiapine",
"      </a>",
"      , and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?11/33/11802?source=see_link\">",
"       risperidone",
"      </a>",
"      , and less commonly with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?42/11/43193?source=see_link\">",
"       aripiprazole",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?4/39/4728?source=see_link\">",
"       ziprasidone",
"      </a>",
"      . (See",
"      <a class=\"local\" href=\"#H28219059\">",
"       'Metabolic side effects'",
"      </a>",
"      above.)",
"      <br/>",
"      <br/>",
"      All patients receiving antipsychotic medication should receive regular measurements of body mass index, waist circumference, serum lipids, and either fasting blood glucose (FBG) or hemoglobin A1c. These assessments should be performed when starting a new medication and regular intervals (",
"      <a class=\"graphic graphic_table graphicRef74435 \" href=\"mobipreview.htm?25/17/25884\">",
"       table 2",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Strategies for managing weight gain and other metabolic problems include changing antipsychotics, diet and exercise counseling, symptomatic treatment (eg, with statins or antihypertensives), or use of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?7/48/7944?source=see_link\">",
"       metformin",
"      </a>",
"      for weight gain. (See",
"      <a class=\"local\" href=\"#H28219066\">",
"       'Clinical management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      First-generation antipsychotics,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?11/33/11802?source=see_link\">",
"       risperidone",
"      </a>",
"      , and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?43/43/44728?source=see_link\">",
"       paliperidone",
"      </a>",
"      can elevate plasma prolactin. This elevation can lead to galactorrhea and menstrual disturbances in women as well as sexual dysfunction and gynecomastia in men. This side effect can usually be managed by changing to a medication that is less likely to elevate prolactin. (See",
"      <a class=\"local\" href=\"#H28219073\">",
"       'Prolactin elevation'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?21/41/22167?source=see_link&amp;anchor=H10#H10\">",
"       \"Causes of hyperprolactinemia\", section on 'Drug use'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Other, less common side effects of antipsychotic drugs include seizures, orthostatic hypotension, neuroleptic malignant syndrome, QT prolongation, and sudden death. Some antipsychotics cause sedation and anticholinergic effects. (See",
"      <a class=\"local\" href=\"#H28219080\">",
"       'Other side effects'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?22/55/23418?source=see_link\">",
"       \"Acquired long QT syndrome\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?20/4/20553?source=see_link\">",
"       \"Neuroleptic malignant syndrome\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision, American Psychiatric Association, Washington, DC, 2000.",
"    </li>",
"    <li>",
"     Murray CJL, Lopez AD. The Global Burden of Disease, Harvard University Press, Cambridge, MA 1996. p.21.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44760/abstract/3\">",
"      Lima AR, Soares-Weiser K, Bacaltchuk J, Barnes TR. Benzodiazepines for neuroleptic-induced acute akathisia. Cochrane Database Syst Rev 2002; :CD001950.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44760/abstract/4\">",
"      Irwin M, Sullivan G, Van Putten T. Propranolol as a primary treatment of neuroleptic-induced akathisia. Hillside J Clin Psychiatry 1988; 10:244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44760/abstract/5\">",
"      Adler L, Duncan E, Angrist B, et al. Effects of a specific beta 2-receptor blocker in neuroleptic-induced akathisia. Psychiatry Res 1989; 27:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44760/abstract/6\">",
"      Kramer MS, Gorkin R, DiJohnson C. Treatment of neuroleptic-induced akathisia with propranolol: a controlled replication study. Hillside J Clin Psychiatry 1989; 11:107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44760/abstract/7\">",
"      Adler LA, Peselow E, Rosenthal M, Angrist B. A controlled comparison of the effects of propranolol, benztropine, and placebo on akathisia: an interim analysis. Psychopharmacol Bull 1993; 29:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44760/abstract/8\">",
"      Rifkin A, Quitkin F, Kane J, et al. Are prophylactic antiparkinson drugs necessary? A controlled study of procyclidine withdrawal. Arch Gen Psychiatry 1978; 35:483.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44760/abstract/9\">",
"      Buchanan RW, Kreyenbuhl J, Kelly DL, et al. The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements. Schizophr Bull 2010; 36:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44760/abstract/10\">",
"      Marder SR, Essock SM, Miller AL, et al. Physical health monitoring of patients with schizophrenia. Am J Psychiatry 2004; 161:1334.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44760/abstract/11\">",
"      Tenback DE, van Harten PN, van Os J. Non-therapeutic risk factors for onset of tardive dyskinesia in schizophrenia: a meta-analysis. Mov Disord 2009; 24:2309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44760/abstract/12\">",
"      Sachdev P. Early extrapyramidal side-effects as risk factors for later tardive dyskinesia: a prospective study. Aust N Z J Psychiatry 2004; 38:445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44760/abstract/13\">",
"      Lieberman JA, Stroup TS, McEvoy JP, et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 2005; 353:1209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44760/abstract/14\">",
"      Brown S, Inskip H, Barraclough B. Causes of the excess mortality of schizophrenia. Br J Psychiatry 2000; 177:212.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44760/abstract/15\">",
"      Baptista T, Kin NM, Beaulieu S, de Baptista EA. Obesity and related metabolic abnormalities during antipsychotic drug administration: mechanisms, management and research perspectives. Pharmacopsychiatry 2002; 35:205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44760/abstract/16\">",
"      Ganguli R. Behavioral therapy for weight loss in patients with schizophrenia. J Clin Psychiatry 2007; 68 Suppl 4:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44760/abstract/17\">",
"      Wu RR, Zhao JP, Guo XF, et al. Metformin addition attenuates olanzapine-induced weight gain in drug-naive first-episode schizophrenia patients: a double-blind, placebo-controlled study. Am J Psychiatry 2008; 165:352.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44760/abstract/18\">",
"      Wu RR, Zhao JP, Jin H, et al. Lifestyle intervention and metformin for treatment of antipsychotic-induced weight gain: a randomized controlled trial. JAMA 2008; 299:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44760/abstract/19\">",
"      Baptista T, Rangel N, Fern&aacute;ndez V, et al. Metformin as an adjunctive treatment to control body weight and metabolic dysfunction during olanzapine administration: a multicentric, double-blind, placebo-controlled trial. Schizophr Res 2007; 93:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44760/abstract/20\">",
"      Baptista T, Mart&iacute;nez J, Lacruz A, et al. Metformin for prevention of weight gain and insulin resistance with olanzapine: a double-blind placebo-controlled trial. Can J Psychiatry 2006; 51:192.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44760/abstract/21\">",
"      Wu RR, Jin H, Gao K, et al. Metformin for treatment of antipsychotic-induced amenorrhea and weight gain in women with first-episode schizophrenia: a double-blind, randomized, placebo-controlled study. Am J Psychiatry 2012; 169:813.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44760/abstract/22\">",
"      Caroff SN, Mann SC. Neuroleptic malignant syndrome. Med Clin North Am 1993; 77:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44760/abstract/23\">",
"      Ray WA, Chung CP, Murray KT, et al. Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med 2009; 360:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44760/abstract/24\">",
"      Schneeweiss S, Avorn J. Antipsychotic agents and sudden cardiac death--how should we manage the risk? N Engl J Med 2009; 360:294.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 15766 Version 11.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-122.72.76.133-7BCA055868-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_45_44760=[""].join("\n");
var outline_f43_45_44760=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H893411222\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H893410703\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28219024\">",
"      EXTRAPYRAMIDAL SYMPTOMS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28219031\">",
"      Akathisia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28219038\">",
"      Parkinsonian syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28219045\">",
"      Dystonias",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H893411288\">",
"      Monitoring",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28219052\">",
"      TARDIVE DYSKINESIA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28219059\">",
"      METABOLIC SIDE EFFECTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H956391806\">",
"      Monitoring",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28219066\">",
"      Clinical management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28219073\">",
"      PROLACTIN ELEVATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28219080\">",
"      OTHER SIDE EFFECTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H956391487\">",
"      Seizures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H956391578\">",
"      Orthostatic hypotension",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H956391585\">",
"      Neuroleptic malignant syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H956391592\">",
"      QT prolongation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H956391599\">",
"      Sudden death",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H956391047\">",
"      Anticholinergic effects",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28219095\">",
"      Sedation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H893411222\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PSYCH/15766\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PSYCH/15766|Form\">",
"      <a href=\"#\" title=\"FORMS\">",
"       FORMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_form\" href=\"mobipreview.htm?43/13/44243\" title=\"form 1\">",
"      Abnormal involuntary movement scale",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PSYCH/15766|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?32/57/33694\" title=\"table 1\">",
"      Adverse effects for antipsychotic meds",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?25/17/25884\" title=\"table 2\">",
"      Monitoring for metabolic side effects of antipsychotic drugs",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/55/23418?source=related_link\">",
"      Acquired long QT syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/3/2105?source=related_link\">",
"      Anxiety in schizophrenia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/41/22167?source=related_link\">",
"      Causes of hyperprolactinemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/60/970?source=related_link\">",
"      Classification and evaluation of dystonia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/51/19254?source=related_link\">",
"      Clinical manifestations and diagnosis of hyperprolactinemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/13/14554?source=related_link\">",
"      Clinical manifestations of Parkinson disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/21/25944?source=related_link\">",
"      Depression in schizophrenia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/42/36521?source=related_link\">",
"      Dual diagnosis: Severe mental illness and substance use disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/9/25753?source=related_link\">",
"      Evaluation of the first seizure in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/24/7562?source=related_link\">",
"      First-generation antipsychotic medications: Pharmacology, administration, and comparative side effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/26/38312?source=related_link\">",
"      Metformin in the treatment of diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/4/20553?source=related_link\">",
"      Neuroleptic malignant syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/36/32330?source=related_link\">",
"      Overview of hypertension in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/58/28583?source=related_link\">",
"      Overview of psychosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/39/40570?source=related_link\">",
"      Overview of the management of epilepsy in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?43/37/44625?source=related_link\">",
"      Patient information: Schizophrenia (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/35/29241?source=related_link\">",
"      Pharmacotherapy for schizophrenia: Acute and maintenance phase treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/47/34552?source=related_link\">",
"      Schizophrenia: Clinical manifestations, course, assessment, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/10/15530?source=related_link\">",
"      Second-generation antipsychotic medications: Pharmacology, administration, and comparative side effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/40/27269?source=related_link\">",
"      Tardive dyskinesia: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/26/36264?source=related_link\">",
"      Tardive dyskinesia: Etiology and epidemiology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/8/34952?source=related_link\">",
"      Tardive dyskinesia: Prevention and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/32/26122?source=related_link\">",
"      Treatment of lipids (including hypercholesterolemia) in secondary prevention",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f43_45_44761="Clinical manifestations and diagnosis of menopause";
var content_f43_45_44761=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"0\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Clinical manifestations and diagnosis of menopause",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/45/44761/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/45/44761/contributors\">",
"     Robert F Casper, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/45/44761/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/45/44761/contributors\">",
"     Robert L Barbieri, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/45/44761/contributors\">",
"     William F Crowley, Jr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/45/44761/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/45/44761/contributors\">",
"     Kathryn A Martin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?43/45/44761/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 24, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Natural menopause is defined as the permanent cessation of menstrual periods, determined retrospectively after a woman has experienced 12 months of amenorrhea without any other obvious pathological or physiological cause. It occurs at a median age of 51.4 years in normal women, and is a reflection of complete, or near complete, ovarian follicular depletion, with resulting hypoestrogenemia and high FSH concentrations (",
"    <a class=\"graphic graphic_figure graphicRef72948 \" href=\"mobipreview.htm?15/43/16062\">",
"     figure 1",
"    </a>",
"    ). Menopause before age 40 is considered to be abnormal and is referred to as primary ovarian insufficiency (premature ovarian failure). The menopausal transition, or perimenopause, occurs after the reproductive years, but before menopause, and is characterized by irregular menstrual cycles, endocrine changes, and symptoms such as hot flashes.",
"   </p>",
"   <p>",
"    This topic will review the clinical features and diagnosis of the menopausal transition and menopause. The physiology and epidemiology of menopause, postmenopausal hormone therapy, and primary ovarian insufficiency are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/22/15720?source=see_link\">",
"     \"Ovarian development and failure (menopause) in normal women\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/23/32122?source=see_link\">",
"     \"Postmenopausal hormone therapy: Benefits and risks\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/40/7817?source=see_link\">",
"     \"Pathogenesis and causes of spontaneous primary ovarian insufficiency (premature ovarian failure)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H171785533\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The menopausal transition, or perimenopause, begins on average four years before the final menstrual period, and includes a number of physiologic changes that may affect a woman&rsquo;s quality of life. It is characterized by irregular menstrual cycles and marked hormonal fluctuations, often accompanied by hot flashes, sleep disturbances, mood symptoms, and vaginal dryness [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/45/44761/abstract/1-6\">",
"     1-6",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H952677165\">",
"     'Symptoms'",
"    </a>",
"    below.) In addition, changes in lipids and bone loss begin to occur, both of which have implications for long-term health.",
"   </p>",
"   <p>",
"    Virtually all women experience the menstrual irregularity and hormonal fluctuations prior to clinical menopause, up to 80 percent develop hot flashes (the most common menopausal symptom), but only 20 to 30 percent seek medical attention for treatment. (See",
"    <a class=\"local\" href=\"#H172096462\">",
"     'Hot flashes'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Much of the available information about the endocrine and clinical manifestations of the menopausal transition comes from a number of longitudinal cohort studies of midlife women [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/45/44761/abstract/7-19\">",
"     7-19",
"    </a>",
"    ], the largest of which, the Study of Women&rsquo;s Health Across the Nation (SWAN), has followed a multiethnic, community-based cohort of over 3000 women ages 42 to 52 years for 15 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/45/44761/abstract/7,12-14,16,17,20-29\">",
"     7,12-14,16,17,20-29",
"    </a>",
"    ]. Based upon data from the cohort studies, a staging system was developed that is now considered to be the gold standard for characterizing reproductive aging from the reproductive years through menopause. The STRAW staging system (Stages of Reproductive Aging Workshop) includes definitions for the late reproductive years, the menopausal transition, perimenopause, menopause, and postmenopause (",
"    <a class=\"graphic graphic_figure graphicRef82933 \" href=\"mobipreview.htm?34/59/35760\">",
"     figure 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/45/44761/abstract/3\">",
"     3",
"    </a>",
"    ]. Although the STRAW system has been used primarily for women&rsquo;s health research, it is helpful in the clinical setting for patients and clinicians for assessing fertility potential, contraceptive needs, and potential need for hormone therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H171787387\">",
"    <span class=\"h2\">",
"     Menstrual cycle and endocrine changes",
"    </span>",
"    &nbsp;&mdash;&nbsp;The typical menstrual cycle and hormonal changes that women experience as they traverse from the premenopausal or reproductive years through the postmenopausal years include the following (",
"    <a class=\"graphic graphic_figure graphicRef82933 \" href=\"mobipreview.htm?34/59/35760\">",
"     figure 2",
"    </a>",
"    ):",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H172092802\">",
"    <span class=\"h3\">",
"     Late reproductive years",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the late reproductive years before the onset of the menopausal transition, serum inhibin B begins to decrease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/45/44761/abstract/30\">",
"     30",
"    </a>",
"    ], serum FSH increases slightly, estradiol levels are preserved, but luteal phase progesterone levels decrease as fertility potential begins to decline (",
"    <a class=\"graphic graphic_figure graphicRef77945 \" href=\"mobipreview.htm?30/53/31583\">",
"     figure 3",
"    </a>",
"    ). Menstrual cycles are ovulatory, but the follicular phase (the first half of the menstrual cycle before ovulation occurs) begins to shorten (eg, 10 versus 14 days) (",
"    <a class=\"graphic graphic_figure graphicRef79769 \" href=\"mobipreview.htm?35/16/36111\">",
"     figure 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/45/44761/abstract/31\">",
"     31",
"    </a>",
"    ]. Women who are having difficulty conceiving often seek advice about their menopausal status during this stage. Although there is variability in age at any given stage of reproductive aging, women are typically in their 40s when cycles begin to shorten. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/61/40921?source=see_link&amp;anchor=H9#H9\">",
"     \"Evaluation of female infertility\", section on 'Assessment of ovarian reserve'",
"    </a>",
"    .)",
"    <br/>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H172092809\">",
"    <span class=\"h3\">",
"     Menopausal transition/perimenopause",
"    </span>",
"    &nbsp;&mdash;&nbsp;As the process of ovarian follicular depletion continues in midlife (",
"    <a class=\"graphic graphic_figure graphicRef72948 \" href=\"mobipreview.htm?15/43/16062\">",
"     figure 1",
"    </a>",
"    ), women eventually experience a change in intermenstrual interval. The change in bleeding pattern, which is accompanied by hormonal fluctuations and a variety of symptoms, is referred to as the menopausal transition (MT), or perimenopause, and occurs on average at age 47 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/45/44761/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Women typically first notice a lengthening in the intermenstrual interval (in contrast to the shortening that occurs in the late reproductive years). Normal intermenstrual interval during the reproductive years is 25 to 35 days; during the menopausal transition, this may increase to 40 to 50 days. Early follicular phase FSH levels are high but variable (",
"    <a class=\"graphic graphic_figure graphicRef82324 \" href=\"mobipreview.htm?23/42/24239\">",
"     figure 5",
"    </a>",
"    ). The initial stage of the MT is referred to as the &ldquo;early transition&rdquo; in the STRAW staging system, which is described below (",
"    <a class=\"graphic graphic_figure graphicRef82933 \" href=\"mobipreview.htm?34/59/35760\">",
"     figure 2",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H172091386\">",
"     'The STRAW staging system'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    <br/>",
"    After the initial lengthening of intermenstrual interval, women then develop more dramatic menstrual cycle changes with skipped cycles, episodes of amenorrhea, and an increasing frequency of anovulatory cycles (",
"    <a class=\"graphic graphic_figure graphicRef82324 \" href=\"mobipreview.htm?23/42/24239\">",
"     figure 5",
"    </a>",
"    ). This stage is referred to as the &ldquo;late transition&rdquo; in the STRAW staging system, and typically lasts for one to three years before the final menstrual period (FMP) (",
"    <a class=\"graphic graphic_figure graphicRef82933 \" href=\"mobipreview.htm?34/59/35760\">",
"     figure 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/45/44761/abstract/3\">",
"     3",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H172091386\">",
"     'The STRAW staging system'",
"    </a>",
"    below.) Of note, not all women follow a &ldquo;typical&rdquo; bleeding pattern. Some will have episodes of amenorrhea interspersed with short ovulatory cycles that resemble those of the late reproductive stage.",
"   </p>",
"   <p>",
"    The more irregular cycles are accompanied by more dramatic fluctuations in serum FSH and estradiol concentrations (",
"    <a class=\"graphic graphic_figure graphicRef82324 \" href=\"mobipreview.htm?23/42/24239\">",
"     figure 5",
"    </a>",
"    ). A random serum sample may demonstrate high FSH and low estradiol concentrations consistent with menopause, but soon thereafter FSH and estradiol may return to the normal premenopausal range (",
"    <a class=\"graphic graphic_figure graphicRef82324 \" href=\"mobipreview.htm?23/42/24239\">",
"     figure 5",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/45/44761/abstract/33\">",
"     33",
"    </a>",
"    ]. One study reported that a random serum FSH &gt;25",
"    <span class=\"nowrap\">",
"     IU/L",
"    </span>",
"    is characteristic of the late menopausal transition [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/45/44761/abstract/4\">",
"     4",
"    </a>",
"    ], but measurements of serum FSH during the late MT are not routinely recommended because of their variability. (See",
"    <a class=\"local\" href=\"#H171787807\">",
"     'Evaluation'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Other endocrine changes across the menopausal transition include a progressive decrease in serum inhibin B, as well as a decrease in antim&uuml;llerian hormone (AMH), another product of the granulosa cell. In addition, ovarian antral follicle count (AFC), defined as follicles measuring 2 to 10 mm in diameter on transvaginal ultrasound, declines steadily from the reproductive years though postmenopause. Inhibin B, AMH, and AFC have all been used to assess ovarian reserve in the setting of assisted reproductive techniques, but none are validated for the evaluation of menopausal status [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/45/44761/abstract/3\">",
"     3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/61/40921?source=see_link&amp;anchor=H9#H9\">",
"     \"Evaluation of female infertility\", section on 'Assessment of ovarian reserve'",
"    </a>",
"    .)",
"    <br/>",
"    <br/>",
"    In general, the transition is characterized by a gradual decrease in menstrual bleeding [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/45/44761/abstract/20\">",
"     20",
"    </a>",
"    ]. However, some women do experience heavy or prolonged bleeding, which has always been assumed to be due to anovulatory cycles and prolonged exposure to unopposed estrogen. However, in one report, the heaviest bleeding occurred in women in the late transition during ovulatory cycles, which were more likely than anovulatory cycles to be associated with high serum estradiol concentrations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/45/44761/abstract/34\">",
"     34",
"    </a>",
"    ]. Women with obesity and uterine fibroids are also more likely to experience heavy bleeding [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/45/44761/abstract/20\">",
"     20",
"    </a>",
"    ]. The evaluation and management of heavy (&gt;80 mL) and prolonged bleeding (&gt;7 days) is reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/41/20122?source=see_link&amp;anchor=H6#H6\">",
"     \"Chronic menorrhagia or anovulatory uterine bleeding\", section on 'Menopausal transition'",
"    </a>",
"    .)",
"    <br/>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H172092817\">",
"    <span class=\"h3\">",
"     Menopause",
"    </span>",
"    &nbsp;&mdash;&nbsp;After the years of menstrual irregularity, women eventually experience permanent cessation of menses. Twelve months of amenorrhea is considered to represent clinical menopause and is termed &ldquo;postmenopause&rdquo; in the STRAW system. The final menstrual period (FMP) is determined retrospectively. Although the median age at natural menopause is 51.4 years, the timing of menopause is affected by a number of factors including genetics and smoking, which are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/22/15720?source=see_link&amp;anchor=H179689159#H179689159\">",
"     \"Ovarian development and failure (menopause) in normal women\", section on 'Epidemiology'",
"    </a>",
"    .)",
"    <br/>",
"    <br/>",
"    The increase in serum FSH becomes sustained near the final menstrual period, then increases over several years to levels in the 70 to 100",
"    <span class=\"nowrap\">",
"     IU/L",
"    </span>",
"    range, followed by a decline with increasing age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/45/44761/abstract/35,36\">",
"     35,36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <br/>",
"    There are no validated predictors of the final menstrual period. Women who have experienced at least three months of amenorrhea are highly likely (about 95 percent) to become postmenopausal within the next four years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/45/44761/abstract/12\">",
"     12",
"    </a>",
"    ]. Other factors associated with a shorter time to FMP included older age, current smoking, higher serum FSH concentration, and more variable menstrual cycles [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/45/44761/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H952677165\">",
"    <span class=\"h2\">",
"     Symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;The hallmark symptom of the menopausal",
"    <span class=\"nowrap\">",
"     transition/perimenopause",
"    </span>",
"    and early postmenopausal years is the hot flash. Women may experience a number of other symptoms whose association with the menopausal transition is well established, including vaginal dryness, sleep disturbances, and new-onset depression [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/45/44761/abstract/37\">",
"     37",
"    </a>",
"    ]. For other symptoms such as joint pain and memory loss, the association with menopause is less clear.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H172096462\">",
"    <span class=\"h3\">",
"     Hot flashes",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common symptom during the menopausal transition and menopause are hot flashes (also referred to as vasomotor symptoms or hot flushes), which occur in up to 80 percent of women in some cultures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/45/44761/abstract/21,37-39\">",
"     21,37-39",
"    </a>",
"    ]. However, only about 20 to 30 percent of women seek medical attention for treatment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/45/44761/abstract/22,40,41\">",
"     22,40,41",
"    </a>",
"    ]. Some women first develop hot flashes that cluster around menses during their late reproductive years, but symptoms are typically mild and do not require treatment. Symptoms become far more common during the menopausal transition, with a frequency of approximately 40 percent in the early transition, increasing to 60 to 80 percent in the late menopausal transition and early postmenopausal periods (",
"    <a class=\"graphic graphic_figure graphicRef82933 \" href=\"mobipreview.htm?34/59/35760\">",
"     figure 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/45/44761/abstract/22,23,32,38,42\">",
"     22,23,32,38,42",
"    </a>",
"    ]. When hot flashes occur at night, women typically describe them as &ldquo;night sweats.&rdquo;",
"   </p>",
"   <p>",
"    Hot flashes typically begin as the sudden sensation of heat centered on the upper chest and face that rapidly becomes generalized. The sensation of heat lasts from two to four minutes, is often associated with profuse perspiration and occasionally palpitations, and is sometimes followed by chills and shivering, and a feeling of anxiety. Hot flashes usually occur several times per day, although the range may be from only one or two each day to as many as one per hour during the day and night. Hot flashes are particularly common at night. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/53/25434?source=see_link\">",
"     \"Menopausal hot flashes\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    More than 80 percent of women who have hot flashes will continue to have them for more than one year. Untreated, hot flashes stop spontaneously within four to five years of onset in most women. However, some women have hot flashes that persist for many years, with 9 percent reporting persistent symptoms after age 70 years.",
"   </p>",
"   <p>",
"    A more detailed discussion of the pathophysiology, risk factors for, and treatment of hot flashes is found elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/53/25434?source=see_link\">",
"     \"Menopausal hot flashes\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Sleep disturbance",
"    </span>",
"    &nbsp;&mdash;&nbsp;A distressing feature of hot flashes is that they are more common at night than during the day and are associated with arousal from sleep. However, women experience sleep disturbances even in the absence of hot flashes. The estimated prevalence of difficulty sleeping based upon two longitudinal cohort studies was 32 to 40 percent in the early menopausal transition, increasing to 38 to 46 percent in the late transition [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/45/44761/abstract/39,43\">",
"     39,43",
"    </a>",
"    ]. Menopausal sleep disturbances are discussed in more detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/53/25434?source=see_link\">",
"     \"Menopausal hot flashes\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H952676297\">",
"    <span class=\"h3\">",
"     Depression",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of reports indicate that there is a significant increased risk of new onset depression in women during the menopausal transition compared with their premenopausal years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/45/44761/abstract/24,44-50\">",
"     24,44-50",
"    </a>",
"    ]. The risk then decreases in the early postmenopause. In a within-woman eight-year longitudinal study to determine risk factors for depressive disorders, a diagnosis of depression was 2.5 times more likely to occur in the menopausal transition compared with when the woman was premenopausal (OR 2.50; 95% CI 1.25-5.02) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/45/44761/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The role of estrogen in the treatment of depression in perimenopausal women is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/8/40074?source=see_link\">",
"     \"Initial treatment of depression in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/42/40615?source=see_link\">",
"     \"Treatment of menopausal symptoms with hormone therapy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Vaginal dryness",
"    </span>",
"    &nbsp;&mdash;&nbsp;The epithelial lining of the vagina and urethra are estrogen-dependent tissues, and estrogen deficiency leads to thinning of the vaginal epithelium. This results in vaginal atrophy (atrophic vaginitis), causing symptoms of vaginal dryness, itching, and often dyspareunia. The prevalence of vaginal dryness in one longitudinal study was 3, 4, 21, and 47 percent of women in the reproductive, early menopausal transition, late menopausal transition, and three years postmenopausal stages, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/45/44761/abstract/37,39\">",
"     37,39",
"    </a>",
"    ]. Symptoms of vaginal atrophy are usually progressive and worsen as time passes and hypoestrogenism continues.",
"   </p>",
"   <p>",
"    Early in the menopause transition, women may notice a slight decrease in vaginal lubrication upon sexual arousal, which is often one of the first signs of estrogen insufficiency. As the hypoestrogenic state becomes chronic, additional symptoms may be reported by the woman, including a sensation of vaginal dryness during daily activities, not necessarily during sexual activity. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/54/8039?source=see_link&amp;anchor=H719871#H719871\">",
"     \"Clinical manifestations and diagnosis of vaginal atrophy\", section on 'Epidemiology'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    On exam, the vagina typically appears pale, with lack of the normal rugae. The external genitalia may show scarce pubic hair, diminished elasticity and turgor of the vulvar skin, introital narrowing or decreased moisture, and fusion or resorption of the labia minora. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/54/8039?source=see_link\">",
"     \"Clinical manifestations and diagnosis of vaginal atrophy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Sexual function",
"    </span>",
"    &nbsp;&mdash;&nbsp;Estrogen deficiency leads to a decrease in blood flow to the vagina and vulva. This decrease is a major cause of decreased vaginal lubrication and sexual dysfunction in menopausal women [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/45/44761/abstract/51\">",
"     51",
"    </a>",
"    ]. Vaginal dryness and dyspareunia, as described above, may also contribute to reduced sexual function. The cervix also can atrophy and become flush with the top of the vaginal vault. The elasticity of the vaginal wall may decrease and the entire vagina can become shorter or narrower. Continuing sexual activity may prevent these changes in size and shape of the vagina, even in the absence of estrogen therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/45/44761/abstract/52\">",
"     52",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/1/43032?source=see_link\">",
"     \"Approach to the woman with sexual pain\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/42/25258?source=see_link\">",
"     \"Sexual dysfunction in women: Epidemiology, risk factors, and evaluation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Symptoms related to genitourinary atrophy are exquisitely responsive to estrogen therapy, in particular, vaginal estrogen therapy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/53/16218?source=see_link&amp;anchor=H533431292#H533431292\">",
"     \"Preparations for postmenopausal hormone therapy\", section on 'Vaginal estrogen for vaginal atrophy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H159313567\">",
"    <span class=\"h3\">",
"     Cognitive changes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women often describe problems with memory loss and difficulty concentrating during the menopausal transition and menopause, and substantial biologic evidence supports the importance of estrogen to cognitive function. A decline in cognitive function was not observed in the SWAN study, but increases in anxiety and depression had independent, unfavorable effects on cognitive performance [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/45/44761/abstract/25\">",
"     25",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/63/41975?source=see_link\">",
"     \"Estrogen and cognitive function\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H159313632\">",
"    <span class=\"h3\">",
"     Joint pain",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although the prevalence is not known, some women experience diffuse joint pain during the menopausal transition and postmenopausal period [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/45/44761/abstract/53,54\">",
"     53,54",
"    </a>",
"    ]. It is unclear if this is related to estrogen deficiency or a rheumatologic disorder, but in the Women's Health Initiative, women with joint pain or stiffness at baseline were more likely to get relief with combined estrogen-progestin therapy than with placebo [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/45/44761/abstract/55\">",
"     55",
"    </a>",
"    ]. However, another study reported that neuromuscular symptoms",
"    <span class=\"nowrap\">",
"     (backache/joint",
"    </span>",
"    pain) were stable across the menopausal transition, suggesting that an underlying medical condition was the cause of the symptoms, not the hormonal changes associated with the menopausal transition [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/45/44761/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Other",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Breast pain",
"      </strong>",
"      &ndash; Breast pain and tenderness are common in the early menopausal transition, but begin to diminish in the late menopausal transition [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/45/44761/abstract/39\">",
"       39",
"      </a>",
"      ]. This is probably due to the fluctuations in serum estradiol concentrations. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?8/33/8728?source=see_link\">",
"       \"Breast pain\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Menstrual migraines",
"      </strong>",
"      &ndash; Menstrual migraines are migraine headaches that cluster around the onset of each menstrual period. In many women, these headaches worsen in frequency and intensity during the menopausal transition [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/45/44761/abstract/57\">",
"       57",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?34/38/35433?source=see_link\">",
"       \"Estrogen-associated migraine\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Long-term consequences of estrogen deficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ovarian estradiol production and secretion decreases and stops altogether after menopause as a result of ovarian follicular depletion. However, the ovary continues to secrete testosterone. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/45/20184?source=see_link&amp;anchor=H4#H4\">",
"     \"Androgen production and therapy in women\", section on 'Effect of age and menopause'",
"    </a>",
"    .) There are a number of long-term effects of estrogen deficiency, including osteoporosis, cardiovascular disease, and dementia. Each of these is discussed in detail separately.",
"   </p>",
"   <p>",
"    <strong>",
"     Bone loss",
"    </strong>",
"    &mdash; Bone loss begins during the menopausal transition. The annual rates of bone mineral density loss appear to be highest during the one year before through two years after the final menstrual period. This issue and postmenopausal osteoporosis are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/25/6553?source=see_link&amp;anchor=H8#H8\">",
"     \"Epidemiology and etiology of premenopausal osteoporosis\", section on 'Perimenopausal bone loss'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/52/39754?source=see_link\">",
"     \"Overview of the management of osteoporosis in postmenopausal women\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <strong>",
"     Cardiovascular disease",
"    </strong>",
"    &mdash; The risk of cardiovascular disease increases after menopause, thought to be at least in part due to estrogen deficiency. This may be mediated in part by changes in lipid profiles during perimenopause, as illustrated by longitudinal data from over 2500 subjects in the Study of Women&rsquo;s Health Across the Nation (SWAN) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/45/44761/abstract/26\">",
"     26",
"    </a>",
"    ]. After adjusting for subject age, there was a small increase in serum LDL during the menopausal transition (a 6 percent increase in mean LDL from 116",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    in the premenopausal years to 123",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    in the early postmenopausal years). There was no change in serum HDL, but data from a later SWAN ancillary study suggested that the protective effect of HDL may decrease as women transition to menopause [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/45/44761/abstract/27\">",
"     27",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/57/28570?source=see_link&amp;anchor=H15#H15\">",
"     \"Determinants and management of cardiovascular risk in women\", section on 'Menopause'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <strong>",
"     Dementia",
"    </strong>",
"    &mdash; There is limited epidemiologic support for the hypothesis that estrogen preserves overall cognitive function in non-demented women. However, in the Women&rsquo;s Health Initiative, both unopposed estrogen and combined estrogen-progestin therapy had no global cognitive benefits in older, non-demented postmenopausal women. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/63/41975?source=see_link&amp;anchor=H4#H4\">",
"     \"Estrogen and cognitive function\", section on 'Epidemiologic evidence'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <strong>",
"     Degenerative arthritis",
"    </strong>",
"    &mdash; Estrogen deficiency after menopause may contribute to the development of osteoarthritis, but data are limited. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/42/19114?source=see_link&amp;anchor=H26#H26\">",
"     \"Pathogenesis of osteoarthritis\", section on 'Sex hormones'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <strong>",
"     Body composition",
"    </strong>",
"    &mdash; In the early postmenopausal years, women who do not take estrogen therapy typically gain fat mass and lose lean mass. Some, but not all, studies, suggest that postmenopausal hormone therapy is associated with a decrease in central fat distribution. Although women typically gain weight during midlife, it does not appear to be due to menopausal status or stage [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/45/44761/abstract/28\">",
"     28",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/23/32122?source=see_link&amp;anchor=H822282019#H822282019\">",
"     \"Postmenopausal hormone therapy: Benefits and risks\", section on 'Weight'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <strong>",
"     Skin changes",
"    </strong>",
"    &mdash; The collagen content of the skin and bones is reduced by estrogen deficiency. Decreased cutaneous collagen may lead to increased aging and wrinkling of the skin. Limited data suggest that collagen changes may be minimized with estrogen. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/23/32122?source=see_link&amp;anchor=H33#H33\">",
"     \"Postmenopausal hormone therapy: Benefits and risks\", section on 'Skin'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <strong>",
"     Balance",
"    </strong>",
"    &mdash; Impaired balance in postmenopausal women may be a central effect of estrogen deficiency. Problems with balance may play a role in the incidence of forearm fractures in women. The role of estrogen therapy on falls is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/23/32122?source=see_link&amp;anchor=H32#H32\">",
"     \"Postmenopausal hormone therapy: Benefits and risks\", section on 'Falls'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H171787807\">",
"    <span class=\"h1\">",
"     EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;In our experience, among women who present at midlife for evaluation of possible menopausal transition or menopause, many are interested in postmenopausal hormone therapy, while others simply want to know what to expect in the coming years: bleeding patterns, symptoms, or potential long-term consequences of estrogen deficiency (eg, osteoporosis, coronary heart disease, or dementia).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H172091386\">",
"    <span class=\"h2\">",
"     The STRAW staging system",
"    </span>",
"    &nbsp;&mdash;&nbsp;As noted above, the STRAW staging system was developed based upon data from multiple longitudinal cohort studies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/45/44761/abstract/3\">",
"     3",
"    </a>",
"    ]. It is considered the gold standard for characterizing reproductive aging from the reproductive years through menopause and includes criteria for the reproductive years, the menopausal transition, perimenopause, final menstrual period (FMP), and postmenopause based upon bleeding patterns, endocrine findings, and symptoms (",
"    <a class=\"graphic graphic_figure graphicRef82933 \" href=\"mobipreview.htm?34/59/35760\">",
"     figure 2",
"    </a>",
"    ). The menopausal transition (MT) and postmenopause are further subdivided into &ldquo;early&rdquo; and &ldquo;late&rdquo; stages.",
"   </p>",
"   <p>",
"    Although the STRAW system has been used primarily for women&rsquo;s health research, it may be helpful in the clinical setting for patients and clinicians to assess fertility potential, contraceptive needs, and potential need for hormone therapy. We find the bleeding and symptom criteria of STRAW to be useful when counseling patients about what to anticipate in the coming years (",
"    <a class=\"graphic graphic_figure graphicRef82933 \" href=\"mobipreview.htm?34/59/35760\">",
"     figure 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Of note, the STRAW staging criteria are not considered to represent diagnostic criteria for the MT or menopause, primarily because they include endocrine data (FSH, inhibin B, antim&uuml;llerian hormone) and pelvic ultrasound (antral follicle count) as supportive criteria when determining reproductive stage. All four criteria have been used to assess ovarian reserve in the setting of assisted reproductive technologies, but none have been validated for use in the evaluation of menopausal status. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/61/40921?source=see_link&amp;anchor=H9#H9\">",
"     \"Evaluation of female infertility\", section on 'Assessment of ovarian reserve'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/56/37770?source=see_link&amp;anchor=H6#H6\">",
"     \"In vitro fertilization\", section on 'Adequate ovarian reserve'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H172092122\">",
"    <span class=\"h2\">",
"     General approach",
"    </span>",
"    &nbsp;&mdash;&nbsp;The evaluation for women of all ages should start with an assessment of the woman&rsquo;s menstrual cycle history (ideally with a menstrual calendar), and a detailed history of any menopausal symptoms (hot flashes, sleep disturbances, depression, vaginal dryness). All women with symptoms of vaginal dryness, dyspareunia, or sexual dysfunction should have a pelvic exam to evaluate for vaginal atrophy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H172086724\">",
"    <span class=\"h3\">",
"     Women over age 45",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although the menopausal transition (MT) begins on average at age 47 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/45/44761/abstract/32\">",
"     32",
"    </a>",
"    ], the age at onset of MT is variable, and women over age 45 who present with characteristic menopausal signs and symptoms are more likely to be in the menopausal transition than to have a new endocrine disorder. Therefore, for women over age 45 years who present with irregular menstrual cycles with menopausal symptoms such as hot flashes, mood changes, or sleep disturbance, we suggest no further diagnostic evaluation, as they are highly likely to be in the menopausal transition.",
"   </p>",
"   <p>",
"    Although serum FSH is often measured, it is not necessary to make the diagnosis and, if normal, may be misleading. In the SWAN longitudinal cohort study described above, changes in menstrual bleeding patterns were a better predictor of menopausal stage or final menstrual period than serum FSH concentrations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/45/44761/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The possibility of pregnancy must always be considered and a serum hCG should be drawn in sexually active women who are not using reliable contraception.",
"    <br/>",
"    <br/>",
"    We recommend additional endocrine testing (eg, prolactin and TSH) in this group if there are any suggestive features of hyperprolactinemia or thyroid disease (galactorrhea, goiter, tachycardia, proptosis, etc). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/51/19254?source=see_link\">",
"     \"Clinical manifestations and diagnosis of hyperprolactinemia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/60/14279?source=see_link\">",
"     \"Overview of the clinical manifestations of hyperthyroidism in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/10/14503?source=see_link\">",
"     \"Clinical manifestations of hypothyroidism\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For the occasional woman with irregular cycles and no other symptoms suggestive of the menopausal transition, we suggest the same approach. However, for asymptomatic women who want reassurance that their irregular periods are due to the menopausal transition, if they are having intervals of amenorrhea of &ge;60 days (eg, in the &ldquo;late transition&rdquo;), a serum FSH &gt;25",
"    <span class=\"nowrap\">",
"     IU/L",
"    </span>",
"    would be reassuring in this instance that this is simply the MT and nothing else [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/45/44761/abstract/4\">",
"     4",
"    </a>",
"    ]. Of note, serum FSH concentrations vary widely during the transition, so a value in the normal premenopausal range does not rule out perimenopause as the cause of her symptoms. (See",
"    <a class=\"local\" href=\"#H172092809\">",
"     'Menopausal transition/perimenopause'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H172086734\">",
"    <span class=\"h3\">",
"     Ages 40 to 45",
"    </span>",
"    &nbsp;&mdash;&nbsp;For women between 40 and 45 years who present with irregular menstrual cycles, with or without menopausal symptoms, we suggest the same endocrine evaluation as for any woman with",
"    <span class=\"nowrap\">",
"     oligo/amenorrhea.",
"    </span>",
"    This would include lab testing to exclude the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pregnancy &ndash; Serum hCG",
"     </li>",
"     <li>",
"      Hyperprolactinemia &ndash; Serum prolactin",
"     </li>",
"     <li>",
"      Hyperthyroidism &ndash; Serum TSH",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Although the presence of hot flashes with irregular menses strongly suggests the menopausal transition, we prefer to err on the side of caution and look for other possible causes of",
"    <span class=\"nowrap\">",
"     oligo/amenorrhea.",
"    </span>",
"    (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/56/34697?source=see_link&amp;anchor=H16#H16\">",
"     \"Etiology, diagnosis, and treatment of secondary amenorrhea\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H172086747\">",
"    <span class=\"h3\">",
"     Under age 40",
"    </span>",
"    &nbsp;&mdash;&nbsp;For women under age 40 with irregular menses and menopausal symptoms, we suggest a complete evaluation for irregular menses. If primary ovarian insufficiency (premature ovarian failure) is confirmed, further evaluation for this disorder should be performed. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/56/34697?source=see_link&amp;anchor=H16#H16\">",
"     \"Etiology, diagnosis, and treatment of secondary amenorrhea\", section on 'Diagnosis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/2/36903?source=see_link\">",
"     \"Clinical manifestations and evaluation of spontaneous primary ovarian insufficiency (premature ovarian failure)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H172097880\">",
"    <span class=\"h2\">",
"     Atypical hot flashes",
"    </span>",
"    &nbsp;&mdash;&nbsp;For women of any age with atypical hot flashes or night sweats, evaluation for other disorders such as carcinoid, pheochromocytoma, or underlying malignancy is indicated. This issue is discussed in detail elsewhere. (See",
"    <a class=\"local\" href=\"#H172096462\">",
"     'Hot flashes'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/14/17641?source=see_link\">",
"     \"Approach to the patient with night sweats\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H172086754\">",
"    <span class=\"h2\">",
"     Heavy bleeding",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women with heavy (&gt;80 mL) or prolonged (&gt;7 days) bleeding should undergo the same evaluation as any premenopausal woman, eg, a pregnancy test, determine if the bleeding is ovulatory or anovulatory, rule out structural abnormalities with pelvic ultrasound, and perform an endometrial biopsy if indicated. This issue is reviewed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/41/20122?source=see_link&amp;anchor=H6#H6\">",
"     \"Chronic menorrhagia or anovulatory uterine bleeding\", section on 'Menopausal transition'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H93667232\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H98254765\">",
"    <span class=\"h2\">",
"     Normal women",
"    </span>",
"   </p>",
"   <p>",
"    In normal, healthy women over age 45 years:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      We make the diagnosis of the menopausal transition or &ldquo;perimenopause&rdquo; based upon a change in intermenstrual interval with or without menopausal symptoms (hot flashes, sleep disturbance, depression, vaginal dryness or sexual dysfunction) (",
"      <a class=\"graphic graphic_figure graphicRef82933 \" href=\"mobipreview.htm?34/59/35760\">",
"       figure 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H171787387\">",
"       'Menstrual cycle and endocrine changes'",
"      </a>",
"      above.) A high serum FSH concentration is",
"      <strong>",
"       not",
"      </strong>",
"      required to make the diagnosis.",
"      <br/>",
"      <br/>",
"      There is currently no reliable method for predicting the final menstrual period for women in the menopausal transition. However, women in the &ldquo;late transition,&rdquo; as defined by the STRAW criteria, are likely to be closer to the FMP than women in the &ldquo;early transition&rdquo; (",
"      <a class=\"graphic graphic_figure graphicRef82933 \" href=\"mobipreview.htm?34/59/35760\">",
"       figure 2",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/45/44761/abstract/3\">",
"       3",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      We diagnose menopause as 12 months of amenorrhea in the absence of other biological or physiological causes. A high serum FSH is not required to make the diagnosis.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In women between the ages of 40 and 45 years:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The diagnosis of the menopausal transition and menopause is the same as that for women over 45 years, except that other causes of menstrual cycle dysfunction must first be ruled out (eg, endocrine evaluation for non-menopausal causes of",
"      <span class=\"nowrap\">",
"       oligo/amenorrhea",
"      </span>",
"      must be normal including serum hCG, prolactin, and TSH).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    For women under age 40 years:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Women in this age group with a change in intermenstrual interval and menopausal symptoms should not be diagnosed with either the menopausal transition or menopause. They have primary ovarian insufficiency (premature ovarian failure). The biology and natural history are different and are reviewed separately. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?36/2/36903?source=see_link\">",
"       \"Clinical manifestations and evaluation of spontaneous primary ovarian insufficiency (premature ovarian failure)\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H74734210\">",
"    <span class=\"h2\">",
"     Special situations",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H83165950\">",
"    <span class=\"h3\">",
"     Women with underlying menstrual cycle disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of menopausal transition is more difficult, and the STRAW staging system does not apply to women with underlying menstrual disorders such as polycystic ovary syndrome (PCOS) or hypothalamic amenorrhea. Little information is available about menstrual cycle and endocrine changes in either disorder, but some data suggest that women with PCOS may develop more regular cycles in their later reproductive years, for reasons that are unclear [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/45/44761/abstract/58,59\">",
"     58,59",
"    </a>",
"    ]. For women with either diagnosis who develop menopausal symptoms, we suggest measuring FSH concentration for diagnostic purposes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H83165966\">",
"    <span class=\"h3\">",
"     Women taking oral contraceptives",
"    </span>",
"    &nbsp;&mdash;&nbsp;Oral estrogen-progestin contraceptives are considered to be safe in nonsmokers up to the age of menopause (average age 50 to 51 years) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/45/44761/abstract/60\">",
"     60",
"    </a>",
"    ]. Women taking them want reassurance that they are postmenopausal before stopping. However, it is difficult to determine if menopause has occurred because these women do not develop the irregular bleeding or vasomotor symptoms that are typical of the menopausal transition. In addition, because their hypothalamic-pituitary axis is suppressed by the high dose of exogenous estrogen, measurement of the serum FSH level is unreliable. Some clinicians measure serum FSH concentration on the 7",
"    <sup>",
"     th",
"    </sup>",
"    day of the pill-free interval, but we do not suggest this approach, because FSH is typically still suppressed and in the premenopausal range.",
"   </p>",
"   <p>",
"    We suggest stopping the pill and measuring serum FSH two to four weeks later. A level &ge;25",
"    <span class=\"nowrap\">",
"     IU/L",
"    </span>",
"    indicates that the patient has likely entered the menopausal transition. However, there is no FSH value that would provide absolute reassurance that she is postmenopausal. We typically stop the pill by age 50 to 51 years, when the chance of conceiving is extremely low. If menopausal symptoms occur, the possibility of short-term menopausal hormone therapy for symptom relief can be discussed. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/24/39306?source=see_link\">",
"     \"Overview of contraception\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/42/40615?source=see_link\">",
"     \"Treatment of menopausal symptoms with hormone therapy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H83165980\">",
"    <span class=\"h3\">",
"     Post-hysterectomy or endometrial ablation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Menopause in women who have undergone hysterectomy or endometrial ablation cannot be determined using menstrual bleeding criteria. Therefore, supportive criteria, including assessment of menopausal symptoms and biochemical data are needed. In this setting, we suggest measurement of FSH concentrations (",
"    <a class=\"graphic graphic_figure graphicRef82324 \" href=\"mobipreview.htm?23/42/24239\">",
"     figure 5",
"    </a>",
"    ). A serum FSH &gt;25",
"    <span class=\"nowrap\">",
"     IU/L,",
"    </span>",
"    particularly in the setting of hot flashes, is suggestive of the late menopausal transition [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/45/44761/abstract/4\">",
"     4",
"    </a>",
"    ]. For a postmenopausal woman, FSH would be considerably higher (in the 70 to 100",
"    <span class=\"nowrap\">",
"     IU/L",
"    </span>",
"    range) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/45/44761/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hyperthyroidism should always be considered in the differential diagnosis, as irregular menses, sweats (although different from typical hot flashes), and mood changes are all potential clinical manifestations of hyperthyroidism [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/45/44761/abstract/61\">",
"     61",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/60/14279?source=see_link\">",
"     \"Overview of the clinical manifestations of hyperthyroidism in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other etiologies for menstrual cycle changes that should be considered include pregnancy, hyperprolactinemia, and thyroid disease. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/56/34697?source=see_link&amp;anchor=H16#H16\">",
"     \"Etiology, diagnosis, and treatment of secondary amenorrhea\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Atypical hot flashes and night sweats may be due to other disorders, such as medications, carcinoid, pheochromocytoma, or underlying malignancy. These are discussed in detail elsewhere. (See",
"    <a class=\"local\" href=\"#H172096462\">",
"     'Hot flashes'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/14/17641?source=see_link\">",
"     \"Approach to the patient with night sweats\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?39/27/40370?source=see_link\">",
"       \"Patient information: Menopause (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?25/59/26546?source=see_link\">",
"       \"Patient information: Menopause (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H36\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The menopausal transition, or perimenopause, begins on average four years before the final menstrual period, and is marked by irregular menstrual cycles, intense hormonal fluctuations, often accompanied by vasomotor complaints, sleep disturbances, and changes in sexual function. (See",
"      <a class=\"local\" href=\"#H171785533\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The early menopausal transition is characterized by a change in intermenstrual interval, an increase in serum FSH, and normal or high estradiol. The late transition is characterized by more dramatic menstrual cycle changes, and greater FSH, and estradiol variability. Hot flashes are the most common symptom in perimenopausal women. They are most common in the late menopausal transition and early postmenopausal stage. Hot flashes are often associated with sleep disturbances. (See",
"      <a class=\"local\" href=\"#H172096462\">",
"       'Hot flashes'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Genitourinary atrophy symptoms, including vaginal dryness, dyspareunia, and sometimes sexual dysfunction, are most prevalent during the late menopausal transition and postmenopausal years. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Vaginal dryness'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H20\">",
"       'Sexual function'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?24/42/25258?source=see_link\">",
"       \"Sexual dysfunction in women: Epidemiology, risk factors, and evaluation\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Women during the menopausal transition appear to have a higher rate of mood symptoms than pre- or postmenopausal women. (See",
"      <a class=\"local\" href=\"#H952676297\">",
"       'Depression'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The STRAW staging system was developed based upon data from multiple longitudinal cohort studies. It is considered the gold standard for characterizing reproductive aging from the reproductive years through menopause and includes criteria for the reproductive years, the menopausal transition, perimenopause, final menstrual period (FMP), and postmenopause based upon bleeding patterns, endocrine findings, and symptoms (",
"      <a class=\"graphic graphic_figure graphicRef82933 \" href=\"mobipreview.htm?34/59/35760\">",
"       figure 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H172091386\">",
"       'The STRAW staging system'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of the menopausal transition (MT) is made in women over 45 years based upon irregular menstrual cycles and menopausal symptoms such as hot flashes, mood changes, or sleep disturbance. We suggest no further diagnostic evaluation. Although serum FSH is often measured, it offers no additional information, and may be misleading. (See",
"      <a class=\"local\" href=\"#H171787807\">",
"       'Evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Menopause may be diagnosed clinically as 12 months of amenorrhea in a woman over age 45 in the absence of other biological or physiological causes. We do not recommend further diagnostic evaluation for women in this group. (See",
"      <a class=\"local\" href=\"#H93667232\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend a serum TSH in women over age 45 with",
"      <strong>",
"       any",
"      </strong>",
"      symptoms suggestive of hyperthyroidism. (See",
"      <a class=\"local\" href=\"#H171787807\">",
"       'Evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Women between the ages of 40 and 45 years who present with irregular menstrual cycles and menopausal symptoms may be in the menopausal transition. However, for women in this age group, with or without menopausal symptoms, we recommend the same endocrine evaluation as for any woman with",
"      <span class=\"nowrap\">",
"       oligo/amenorrhea:",
"      </span>",
"      serum hCG, prolactin, TSH, FSH. (See",
"      <a class=\"local\" href=\"#H172086734\">",
"       'Ages 40 to 45'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For women under age 40 with irregular menses and menopausal symptoms, we recommend a complete evaluation for premature ovarian failure. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?36/2/36903?source=see_link\">",
"       \"Clinical manifestations and evaluation of spontaneous primary ovarian insufficiency (premature ovarian failure)\"",
"      </a>",
"      and",
"      <a class=\"local\" href=\"#H172086747\">",
"       'Under age 40'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44761/abstract/1\">",
"      Taffe JR, Dennerstein L. Menstrual patterns leading to the final menstrual period. Menopause 2002; 9:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44761/abstract/2\">",
"      Miro F, Parker SW, Aspinall LJ, et al. Origins and consequences of the elongation of the human menstrual cycle during the menopausal transition: the FREEDOM Study. J Clin Endocrinol Metab 2004; 89:4910.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44761/abstract/3\">",
"      Harlow SD, Gass M, Hall JE, et al. Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. J Clin Endocrinol Metab 2012; 97:1159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44761/abstract/4\">",
"      Freeman EW, Sammel MD, Gracia CR, et al. Follicular phase hormone levels and menstrual bleeding status in the approach to menopause. Fertil Steril 2005; 83:383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44761/abstract/5\">",
"      Burger HG, Hale GE, Dennerstein L, Robertson DM. Cycle and hormone changes during perimenopause: the key role of ovarian function. Menopause 2008; 15:603.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44761/abstract/6\">",
"      Burger HG. Unpredictable endocrinology of the menopause transition: clinical, diagnostic and management implications. Menopause Int 2011; 17:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44761/abstract/7\">",
"      Bromberger JT, Schott LL, Kravitz HM, et al. Longitudinal change in reproductive hormones and depressive symptoms across the menopausal transition: results from the Study of Women's Health Across the Nation (SWAN). Arch Gen Psychiatry 2010; 67:598.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44761/abstract/8\">",
"      Freeman EW, Grisso JA, Berlin J, et al. Symptom reports from a cohort of African American and white women in the late reproductive years. Menopause 2001; 8:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44761/abstract/9\">",
"      Hollander LE, Freeman EW, Sammel MD, et al. Sleep quality, estradiol levels, and behavioral factors in late reproductive age women. Obstet Gynecol 2001; 98:391.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44761/abstract/10\">",
"      Lee CG, Carr MC, Murdoch SJ, et al. Adipokines, inflammation, and visceral adiposity across the menopausal transition: a prospective study. J Clin Endocrinol Metab 2009; 94:1104.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44761/abstract/11\">",
"      Maki PM, Freeman EW, Greendale GA, et al. Summary of the National Institute on Aging-sponsored conference on depressive symptoms and cognitive complaints in the menopausal transition. Menopause 2010; 17:815.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44761/abstract/12\">",
"      Santoro N, Brockwell S, Johnston J, et al. Helping midlife women predict the onset of the final menses: SWAN, the Study of Women's Health Across the Nation. Menopause 2007; 14:415.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44761/abstract/13\">",
"      Matthews KA, Crawford SL, Chae CU, et al. Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition? J Am Coll Cardiol 2009; 54:2366.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44761/abstract/14\">",
"      Neer RM, SWAN Investigators. Bone loss across the menopausal transition. Ann N Y Acad Sci 2010; 1192:66.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44761/abstract/15\">",
"      Woods NF, Mitchell ES. Sleep symptoms during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women's Health Study. Sleep 2010; 33:539.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44761/abstract/16\">",
"      Randolph JF Jr, Zheng H, Sowers MR, et al. Change in follicle-stimulating hormone and estradiol across the menopausal transition: effect of age at the final menstrual period. J Clin Endocrinol Metab 2011; 96:746.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44761/abstract/17\">",
"      Randolph JF Jr, Sowers M, Gold EB, et al. Reproductive hormones in the early menopausal transition: relationship to ethnicity, body size, and menopausal status. J Clin Endocrinol Metab 2003; 88:1516.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44761/abstract/18\">",
"      Manson JM, Sammel MD, Freeman EW, Grisso JA. Racial differences in sex hormone levels in women approaching the transition to menopause. Fertil Steril 2001; 75:297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44761/abstract/19\">",
"      Su HI, Sammel MD, Freeman EW, et al. Body size affects measures of ovarian reserve in late reproductive age women. Menopause 2008; 15:857.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44761/abstract/20\">",
"      Van Voorhis BJ, Santoro N, Harlow S, et al. The relationship of bleeding patterns to daily reproductive hormones in women approaching menopause. Obstet Gynecol 2008; 112:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44761/abstract/21\">",
"      Gold EB, Colvin A, Avis N, et al. Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: study of women's health across the nation. Am J Public Health 2006; 96:1226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44761/abstract/22\">",
"      Randolph JF Jr, Sowers M, Bondarenko I, et al. The relationship of longitudinal change in reproductive hormones and vasomotor symptoms during the menopausal transition. J Clin Endocrinol Metab 2005; 90:6106.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44761/abstract/23\">",
"      Thurston RC, Joffe H. Vasomotor symptoms and menopause: findings from the Study of Women's Health across the Nation. Obstet Gynecol Clin North Am 2011; 38:489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44761/abstract/24\">",
"      Bromberger JT, Assmann SF, Avis NE, et al. Persistent mood symptoms in a multiethnic community cohort of pre- and perimenopausal women. Am J Epidemiol 2003; 158:347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44761/abstract/25\">",
"      Greendale GA, Derby CA, Maki PM. Perimenopause and cognition. Obstet Gynecol Clin North Am 2011; 38:519.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44761/abstract/26\">",
"      Derby CA, Crawford SL, Pasternak RC, et al. Lipid changes during the menopause transition in relation to age and weight: the Study of Women's Health Across the Nation. Am J Epidemiol 2009; 169:1352.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44761/abstract/27\">",
"      Woodard GA, Brooks MM, Barinas-Mitchell E, et al. Lipids, menopause, and early atherosclerosis in Study of Women's Health Across the Nation Heart women. Menopause 2011; 18:376.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44761/abstract/28\">",
"      Sternfeld B, Wang H, Quesenberry CP Jr, et al. Physical activity and changes in weight and waist circumference in midlife women: findings from the Study of Women's Health Across the Nation. Am J Epidemiol 2004; 160:912.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44761/abstract/29\">",
"      Randolph JF Jr, Crawford S, Dennerstein L, et al. The value of follicle-stimulating hormone concentration and clinical findings as markers of the late menopausal transition. J Clin Endocrinol Metab 2006; 91:3034.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44761/abstract/30\">",
"      Welt CK, McNicholl DJ, Taylor AE, Hall JE. Female reproductive aging is marked by decreased secretion of dimeric inhibin. J Clin Endocrinol Metab 1999; 84:105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44761/abstract/31\">",
"      Sherman BM, Korenman SG. Hormonal characteristics of the human menstrual cycle throughout reproductive life. J Clin Invest 1975; 55:699.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44761/abstract/32\">",
"      McKinlay SM, Brambilla DJ, Posner JG. The normal menopause transition. Maturitas 1992; 14:103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44761/abstract/33\">",
"      Hee J, MacNaughton J, Bangah M, Burger HG. Perimenopausal patterns of gonadotrophins, immunoreactive inhibin, oestradiol and progesterone. Maturitas 1993; 18:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44761/abstract/34\">",
"      Hale GE, Manconi F, Luscombe G, Fraser IS. Quantitative measurements of menstrual blood loss in ovulatory and anovulatory cycles in middle- and late-reproductive age and the menopausal transition. Obstet Gynecol 2010; 115:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44761/abstract/35\">",
"      van Disseldorp J, Faddy MJ, Themmen AP, et al. Relationship of serum antim&uuml;llerian hormone concentration to age at menopause. J Clin Endocrinol Metab 2008; 93:2129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44761/abstract/36\">",
"      Hall JE. Neuroendocrine physiology of the early and late menopause. Endocrinol Metab Clin North Am 2004; 33:637.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44761/abstract/37\">",
"      Woods NF, Mitchell ES. Symptoms during the perimenopause: prevalence, severity, trajectory, and significance in women's lives. Am J Med 2005; 118 Suppl 12B:14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44761/abstract/38\">",
"      National Institutes of Health. National Institutes of Health State-of-the-Science Conference statement: management of menopause-related symptoms. Ann Intern Med 2005; 142:1003.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44761/abstract/39\">",
"      Dennerstein L, Dudley EC, Hopper JL, et al. A prospective population-based study of menopausal symptoms. Obstet Gynecol 2000; 96:351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44761/abstract/40\">",
"      Soules MR, Sherman S, Parrott E, et al. Executive summary: Stages of Reproductive Aging Workshop (STRAW). Fertil Steril 2001; 76:874.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44761/abstract/41\">",
"      Kronenberg F. Hot flashes: epidemiology and physiology. Ann N Y Acad Sci 1990; 592:52.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44761/abstract/42\">",
"      McKinlay SM. The normal menopause transition: an overview. Maturitas 1996; 23:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44761/abstract/43\">",
"      Kravitz HM, Ganz PA, Bromberger J, et al. Sleep difficulty in women at midlife: a community survey of sleep and the menopausal transition. Menopause 2003; 10:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44761/abstract/44\">",
"      Bromberger JT, Meyer PM, Kravitz HM, et al. Psychologic distress and natural menopause: a multiethnic community study. Am J Public Health 2001; 91:1435.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44761/abstract/45\">",
"      Avis NE, Brambilla D, McKinlay SM, Vass K. A longitudinal analysis of the association between menopause and depression. Results from the Massachusetts Women's Health Study. Ann Epidemiol 1994; 4:214.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44761/abstract/46\">",
"      Schmidt PJ, Haq N, Rubinow DR. A longitudinal evaluation of the relationship between reproductive status and mood in perimenopausal women. Am J Psychiatry 2004; 161:2238.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44761/abstract/47\">",
"      Cohen LS, Soares CN, Vitonis AF, et al. Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles. Arch Gen Psychiatry 2006; 63:385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44761/abstract/48\">",
"      Freeman EW, Sammel MD, Lin H, Nelson DB. Associations of hormones and menopausal status with depressed mood in women with no history of depression. Arch Gen Psychiatry 2006; 63:375.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44761/abstract/49\">",
"      Freeman EW, Sammel MD, Liu L, et al. Hormones and menopausal status as predictors of depression in women in transition to menopause. Arch Gen Psychiatry 2004; 61:62.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44761/abstract/50\">",
"      Cohen LS, Soares CN, Joffe H. Diagnosis and management of mood disorders during the menopausal transition. Am J Med 2005; 118 Suppl 12B:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44761/abstract/51\">",
"      Sarrel PM. Ovarian hormones and vaginal blood flow: using laser Doppler velocimetry to measure effects in a clinical trial of post-menopausal women. Int J Impot Res 1998; 10 Suppl 2:S91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44761/abstract/52\">",
"      Cutler WB, Garcia CR, McCoy N. Perimenopausal sexuality. Arch Sex Behav 1987; 16:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44761/abstract/53\">",
"      Szoeke CE, Cicuttini F, Guthrie J, Dennerstein L. Self-reported arthritis and the menopause. Climacteric 2005; 8:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44761/abstract/54\">",
"      Matthews KA, Wing RR, Kuller LH, et al. Influence of the perimenopause on cardiovascular risk factors and symptoms of middle-aged healthy women. Arch Intern Med 1994; 154:2349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44761/abstract/55\">",
"      Barnabei VM, Cochrane BB, Aragaki AK, et al. Menopausal symptoms and treatment-related effects of estrogen and progestin in the Women's Health Initiative. Obstet Gynecol 2005; 105:1063.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44761/abstract/56\">",
"      Mitchell ES, Woods NF. Symptom experiences of midlife women: observations from the Seattle Midlife Women's Health Study. Maturitas 1996; 25:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44761/abstract/57\">",
"      MacGregor EA. Menstruation, sex hormones, and migraine. Neurol Clin 1997; 15:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44761/abstract/58\">",
"      Elting MW, Korsen TJ, Rekers-Mombarg LT, Schoemaker J. Women with polycystic ovary syndrome gain regular menstrual cycles when ageing. Hum Reprod 2000; 15:24.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44761/abstract/59\">",
"      Elting MW, Kwee J, Korsen TJ, et al. Aging women with polycystic ovary syndrome who achieve regular menstrual cycles have a smaller follicle cohort than those who continue to have irregular cycles. Fertil Steril 2003; 79:1154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44761/abstract/60\">",
"      Black A, Francoeur D, Rowe T, et al. SOGC clinical practice guidelines: Canadian contraception consensus. J Obstet Gynaecol Can 2004; 26:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/45/44761/abstract/61\">",
"      Mohyi D, Tabassi K, Simon J. Differential diagnosis of hot flashes. Maturitas 1997; 27:203.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7395 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-200.215.4.194-8300F9CC1D-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_45_44761=[""].join("\n");
var outline_f43_45_44761=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H36\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H171785533\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H171787387\">",
"      Menstrual cycle and endocrine changes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H172092802\">",
"      - Late reproductive years",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H172092809\">",
"      - Menopausal transition/perimenopause",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H172092817\">",
"      - Menopause",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H952677165\">",
"      Symptoms",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H172096462\">",
"      - Hot flashes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Sleep disturbance",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H952676297\">",
"      - Depression",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Vaginal dryness",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Sexual function",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H159313567\">",
"      - Cognitive changes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H159313632\">",
"      - Joint pain",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Other",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Long-term consequences of estrogen deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H171787807\">",
"      EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H172091386\">",
"      The STRAW staging system",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H172092122\">",
"      General approach",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H172086724\">",
"      - Women over age 45",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H172086734\">",
"      - Ages 40 to 45",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H172086747\">",
"      - Under age 40",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H172097880\">",
"      Atypical hot flashes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H172086754\">",
"      Heavy bleeding",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H93667232\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H98254765\">",
"      Normal women",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H74734210\">",
"      Special situations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H83165950\">",
"      - Women with underlying menstrual cycle disorders",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H83165966\">",
"      - Women taking oral contraceptives",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H83165980\">",
"      - Post-hysterectomy or endometrial ablation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H36\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ENDO/7395\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ENDO/7395|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?15/43/16062\" title=\"figure 1\">",
"      Follicle number and age",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?34/59/35760\" title=\"figure 2\">",
"      STRAW staging system for reproductive aging women",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?30/53/31583\" title=\"figure 3\">",
"      Hormone levels reproductive age",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?35/16/36111\" title=\"figure 4\">",
"      Early transition hormone",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?23/42/24239\" title=\"figure 5\">",
"      Onset menopausal transition",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/45/20184?source=related_link\">",
"      Androgen production and therapy in women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/14/17641?source=related_link\">",
"      Approach to the patient with night sweats",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/1/43032?source=related_link\">",
"      Approach to the woman with sexual pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/33/8728?source=related_link\">",
"      Breast pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/41/20122?source=related_link\">",
"      Chronic menorrhagia or anovulatory uterine bleeding",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/51/19254?source=related_link\">",
"      Clinical manifestations and diagnosis of hyperprolactinemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/54/8039?source=related_link\">",
"      Clinical manifestations and diagnosis of vaginal atrophy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/2/36903?source=related_link\">",
"      Clinical manifestations and evaluation of spontaneous primary ovarian insufficiency (premature ovarian failure)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/10/14503?source=related_link\">",
"      Clinical manifestations of hypothyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/57/28570?source=related_link\">",
"      Determinants and management of cardiovascular risk in women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/25/6553?source=related_link\">",
"      Epidemiology and etiology of premenopausal osteoporosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/63/41975?source=related_link\">",
"      Estrogen and cognitive function",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/38/35433?source=related_link\">",
"      Estrogen-associated migraine",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/56/34697?source=related_link\">",
"      Etiology, diagnosis, and treatment of secondary amenorrhea",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/61/40921?source=related_link\">",
"      Evaluation of female infertility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/56/37770?source=related_link\">",
"      In vitro fertilization",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/8/40074?source=related_link\">",
"      Initial treatment of depression in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/53/25434?source=related_link\">",
"      Menopausal hot flashes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/22/15720?source=related_link\">",
"      Ovarian development and failure (menopause) in normal women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/24/39306?source=related_link\">",
"      Overview of contraception",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/60/14279?source=related_link\">",
"      Overview of the clinical manifestations of hyperthyroidism in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/52/39754?source=related_link\">",
"      Overview of the management of osteoporosis in postmenopausal women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/40/7817?source=related_link\">",
"      Pathogenesis and causes of spontaneous primary ovarian insufficiency (premature ovarian failure)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/42/19114?source=related_link\">",
"      Pathogenesis of osteoarthritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?25/59/26546?source=related_link\">",
"      Patient information: Menopause (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?39/27/40370?source=related_link\">",
"      Patient information: Menopause (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/23/32122?source=related_link\">",
"      Postmenopausal hormone therapy: Benefits and risks",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/53/16218?source=related_link\">",
"      Preparations for postmenopausal hormone therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/42/25258?source=related_link\">",
"      Sexual dysfunction in women: Epidemiology, risk factors, and evaluation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/42/40615?source=related_link\">",
"      Treatment of menopausal symptoms with hormone therapy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f43_45_44762="AIP infiltrate Light LP";
var content_f43_45_44762=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F53366%7EGAST%2F74906%7EGAST%2F63135%7EGAST%2F63668%7EGAST%2F55993%7EGAST%2F74906%7EGAST%2F63135%7EGAST%2F71710&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F53366%7EGAST%2F74906%7EGAST%2F63135%7EGAST%2F63668%7EGAST%2F55993%7EGAST%2F74906%7EGAST%2F63135%7EGAST%2F71710&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Autoimmune pancreatitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 270px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Low power view of a pancreas biopsy in a patient with autoimmune pancreatitis. The acinar parenchyma is atrophic and fibrotic and contains a lymphoplasmacytic infiltrate.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Russell Dorer, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Autoimmune pancreatitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 270px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Low power view of a pancreas biopsy in a patient with autoimmune pancreatitis. Obliterative phlebitis is present focally (arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Russell Dorer, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Autoimmune pancreatitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 270px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    High power view of a pancreas biopsy in a patient with autoimmune pancreatitis. Obliterative phlebitis is present focally (arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Russell Dorer, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Autoimmune pancreatitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 270px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAEOAWgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDfkUtcXLJG2DNIBuwTkMe/vnipIrCCYTBLh43RAy7gCrkH7ue1WPKjSeSNy+55HYA8/wARz7VHmKOGQ+VuU5bCjG4ev/1661qelZW0FSGLBV1RvMUEIV5Hrz3HQio4wTfTkrEgj4VCOCPXPapg4kKsiLIpX5mBIIGO3rT1Tz8gL5QA2qWwQc+vP86aQ2k2JJFB5yO6pHISQgPQn1p80EcWQcB2K4VACcj+lOlfZGomiVyufmLADA6fTNZ0pSeSTfLM8p3qkSfIIvRmPQjHP4VcYpmMtBXWa8u3tooFIjcZZl2g8dB71BJIvlxWrJFmIsGlwFdj2yfrViW7hhtEKSyeWMbmGcluh+naoHYXCecfLnAPyMrfMcnG05HBrTl8iepcigiuLeYxkxP5akOy5VTn1/rSQRt9n23QicLkLsBU564Df0NTWTtbWU8VrMVimyktuwABI9z74qpJGT5f2krDGjMVCglWPoecenWkooOpH5MQeJzGSxX19RnA/nU9stlFYSlbdjcq6v5h/DcmOhHNVEu2idoY1k8vJZhC2CnuM9RV25hBaWSffGQwLgsBliM4Ppn1FNxWzKWpNA1tLb798bFXA8tF6KeBz3Oe1X0iVrdjFFCccDBDf/qx6Vh2sdzb6ddyIAjrzKAO3H8RosQllerPGrRI/OWwoYHOeD70nBPYafc6I2yxlQIo3jzgHjOfx60820ATb5akHoQop0LhYvmczY5DKvH/AOupkwoYvu3sNwB5zgelY2NtLaFJrWFoYyscZAwSdvLc8cVymqW0a6tcAKQi4VQcjkjt+ZrsI1kNwuNgBUOR9ARiuV1C3ljeaMI7ruDMockhcnj8MitKaVyJbEcEakLPKyttQbgpwCO/brUl5iAwx20KCLldzZb8f1qOwlUwTxGMpvxIpxwuM5JPSrFtukWWBjv4y+V6cjBHpnkVryozYRJaJFE27ZxgxFd/OecH3zmp4bSK7Lz4JiiYHEYOcZ9e1QGyeCCPyEG9jnrkkd+vfAq79m8oeRa3EpSVdzFTwuDzuApWQ7DL77I7xKqqom+8w6rg5HT15pyxxNZlA0SuyB2kHQjnGD2/rTZmjup3MSRqqcMq9MgYPHpREFSNltkU3U3yhPL4JVcHGT79+lCSE2JcW9mqTylGeGUBVycAAe/b1/Cn28ts0avboJmlBjCgcj0OcYFRqPMUWk4QojjdxtGPT9T+dWryYQlPIRGIG5Y14AHr+uafKhNETRQQLule2Q7SXAOWJHA6dDweKy57eOe7jkVnAcHdhcBAOMnNTosaqpK5D4ygHzA55onK/Km5SCRluoCnkn8yKaSC1iW2EUksAMasFU5djg+hz7dTzViS2t3uPLAkldWXd5a4woAAB+vrWVIipcz28O5YyvVWzvHU5p6vLCNnm5crtzj5gvYH1IpcqY9ixeQm4udtrHt28NyMYAxmqpiET4B5Y5OR6Y5/E5FXZYVilSNixUgghhyD9R9aguIo40bEzeUeSu7JB7DmmkhFeWPeWIQqoZmVCOAP6n/69Vybf7OmEIcZBct15x+daFrPM0IhGxXDAgFdox9e/wD9eoJILiK5RYkjVtxLIQCGxyCM+oJ4p2WzBaFQ+WwJfJUEBfVvw6/nVzT7GS7YuVEccTZcMSM/j6U/+zP35+2bLVFUExHg5Pb1zUmo3LecNOs5PMtVQBiozuOMnPpjpSaT2BLuUrwrPeyugbygcR8bVCjt+maqO22N1ZTsIwCG+YfT61YQSRFPkDyHK4BOGB/wqQNbrIwffleDGRkMPY/iaaikJ9hi20S2/miZn2ckBPTt9Sae028BGVUzz1zkd88dcdKinSKRzHGUCq+G3MW3fT2HSo4mMcwxGjN1Dlj6YHFFkJol8lZI12MSVHLE5yc9DTNiqgaUgYHVW7+h9O1T220rKskhBjBY4yWx9PrTbeeOFmEaERMDwVA3cUWQE32F1AZmjJk5UMSCas29jsmUPOgblpARnHHT6e9W7QwxoqiGMh1AypAK/XP1qHVpiq4AwMANuwxI7Lj1/GotrYRVuHeJ7iRTEUBULnseBgYoqPfA0MZ+zjDj5iT0+Y459aK2ppJaozqPU2Z/LF3NyQEZsL25Y1SWR41kdJESFDjc+SOe3FWrpHkvJUG0x7yDmPcG+Y8fhVdoY55hugxyU3lsgeh2jrXEkrHYmya2glkliaJo5Jk52xggye57cce/FTrMHAaeSMyEbTtGFLdDmo59IiMYT7bJOxUNiIEAEHnJPOfpUErMsEsDkMIWXDLxuz29jSWuxV+pE4SKIxMPlkbB3nOOTz9OKuokaW7qwLxsfugcMenH4mo1gjhhjaUEQDc4aQcZPqOtTw/JHGAiqpB42k9PT09q0RlN3MO5mlFktsRHlcZQjrj+9TIkMUL+VH8zMDICcgccYH9a07m3Yi6kuEDrIcp3OMZAOOh6VVgjdY4lWRkYMN0bqMD/ABrS5C1JVklu1BuZVKBjgMeQQOgx1z+YqF2ZMNuA6l1V+rZOQR9KtTlbm2ZSoXD4kfGcZPT3qFrIxRSttk3qN27PXrzz7f0ouCRFbO4CGMKDnOMcDrkbu/WrQS4nuWQQKd7EsF4+UDggn8KbHa3SxLDbTKqXSiQxMN2CDkZx0PXn1q06xyOizXix7EKPhiT16A9cZxTY1oPghWW6lUyRyQQfIHb5NwPZl71q6eY4ZxcSxQT2aKNyMmdy88j0I7VmW8xmndZV2xiMEGNfvYOMlj+VZ3lyyXc95ZsYbdMkMwKgED7pHfj+dS1fcrlRpaXdySsYAWiYnKMQRlemD78A1rFHbZhQ+BzuOG+o7VlC4hgjS9WBpJWiBDJ6nrx+NTWepbXjTDSxBCZZGfcy45yPUVEo31RrGVtDSkw4MThJFI5DnGQOenr9KwtcsirG6diocKCrZxIOPm/SughYunOA4yVBwwYVn6xNHHpeGjEsG3aFHKrk9Pp1NRBtPQuUU0YGnukswhjMah1JUrkGPHJz6+v41LJKI42aKW5UoQvmADnv9ce1QLtMpe1j2qQERWPzZx7f19alhjS1VJpB5kqqSQpJTJ6DHrXQYW7kwtszkmWJVK8SE7i3qPrx0osoblJWiebEhIYsueCOmT6dRiqPmmPKklQzkord27kY/wA81aeN5njU4LxgnaxySSf6e/amJaENrGPtjw3DTJcM/mMuMDOc5z/SpNTkSe8coxQRoGEYGBzjPTvxkVfsZElQHURGyKcRy4yVGeVz6elV9QjjefzLmJjGRtV0bblexJ9f0qb6luPUgjZUj8iQMNoGSo5GenJ706d90yRriQvH8yBc/Q/XA5qzpYkUywyAkvk7iv3hjI68fjWfI4F0zzSCMhNrfL0I4GeeuO9URdvQYt27zSTxgo+MAgYJ5A5U/wD6qmtoGZ1McCtGifMTgfTv6ZpLdd0xZZM8kAyDlmx6d+e1WLGOW4uRbygqgGAFwDnI6YouOw1IW0+UjKom8M37wMcU3cjX4cHrn+EZORjA981Nc2iWs7iFPNbmJ9yjk9SevToKq7EGDHLCqO3yEE5I6gD0GaFqIszRqPPnfJaHEbLnoOeoH5fWoJoj5j4XcCTtOM9OPy6VNZo8EsbTLIInG4gnpz0wOeRz+NS6fFHdXU0lwgCbS2QcYPTHPHensSzJdQ0YKAB9m3Hbdnrn8Kv2Jg81TdESH7qt2Q9j9cd+1aV3/wAS1/LtVQSSY2LIR8h+n4ZrGmCebL9pLSSKgDLwCxJ6/Si/Mg20LWv/AGi9mtrqM+WwGCrY+8O5x1yKzoybGSNvLZCFOd5HzDvx15x1q0GnhlnQDajJuRo2xyPfpjFRPGk8iW+4Sk8jJ3HHUkGlsg8iKfMt1apFE0j+WRsxywP8uv6VNBayW6NHdIQThc5BIJ/l6VYsJJIpm8mIgLBlXPHsD/OorwvaQCSbZcm4BJZGyw4xwfpT8hGZaRTXMp8ssEXGEUgYHr70hUxyRrHI0ci4xkjt1HFTLJA52KkgCsAAuMkkHkn+lJLElvtcSO8b5XLYGPrTvqGwxy9uwUDJxuBAwHBH/wCuq9tCFuZN5KHngHcQMdAPTmnkROFWFSCoJHzc49P50tsCs4mSN/K3biNwBPYChCZbZTuZmliV0BLL2b3Ge/rUcil7be8gI3EhgOSexx68/lTo43N26KS0cfO3Ge/3c/XvVyRB5okVnCueIzgqCOv4e/vSuIVtNE1nA8cqQlEBKgnJI5A+pFFSB7ia3kWPYkqnA+Yktxzj3Az0orWk9GZTQ6/t1F9LKZGjSWT5QHK/OGPTmrFudm23IAdk3DAwuc56+tQyRTrezyEi5glkYCPcf3Thjg4U/nTbcW5YxXBZuBhFbecN6Hr1/KuG10dcJWsS3UskEjGXzI9wJDuPlU+hz61Fp6yhCZ5QpGCFL7gw9BitGWFb3TGQTpdMvCNICW/3XB/nTbHQL+9s1eKyZkiyCd27n/dBGcVPMktSm0ldkUCyyQTxXq2yrL1KsQVHoCfWiNY7f54XYRMpUxfeYH146jApSksR2TWsfnlsNIAQcdzjHB9qdbQx28Anb965bEckRwRn2OMVaJk79DNnnkO07D5Ufzk9cnoPzxTBseEzTowK/dySTuPf6duK0IYYp4yhJOchjFwFx6DHQfzqr5E7hGglL2gyXjdfm45rS5KQxm+zxGFYvNRl3kHhSevbp6jmpDDHPua8JaNuBHuxnjgevH+c0xi3nFrRkaEtgkggoOP6inxT20c7Btsn8LCEZAyepzx1x0pgTKs8yObKPyY3URIcgFQp5/Pmq0NrcXGoBrbmZGyXdPlde6k85PpVfUr0o4gRRHuyjsBlsd/zNLoyXMq3EULmOJXBVv7wPbnii1kM2YRNbLLDKfNkc7lTnYo79OPz6Yq1JJbyzmF5RsxuYMoZX45P6Cs/zXmW7iVAsY+UmP8AdluemT2qprS2rWskMbOskZGFA74+UZH86SV2M07kyvbXbQR70QLgY2hSDgkD2HINZVzakRKUKHfkOHwOM8Y7jPpXU29lLNpsUV6wMjRbWIHQ4xn3zUEWkPsiSacrJuYnauFYdhz07VCmkaOGhX0G4MkZ2wiMKMbSpw2DxjNaC28TY8+FVyPlx9189fr3pthZxWkEUBkEpXAJA+9g8Dg8GkumZpNhea3ii+bLD5SOufzqPibKelkc9qemS2cyy6fEHjOMiMHcGH9KpBgFhVZA5bkyA52nr0P5V17rgws0rRs+Qq8fOfp+vFVr3RoJl82I7JCMM2Mq34dRWiqW3J5L7HLWh25kVIy8YwwY5ySevPT8KW5nZ3EjIiOWxt45+o/z1q1caXJaxqm1FyPvLkgjP51Vggg851WQODkkkE4wMHn8q1TT1RDVie3mWSCWGQLhuOnOOmP/ANdbOmOLyJ7C7Q+ZGoI3cMR2Nc8gUgFERPL43gkl/p/hWro8M73P2sIYwgIBduq9yPfjoaipa1y6d07F66tI4g8G8pDg4JPzZA6D1H86wBJKgeUBZwq7ArDJGeBgdfpXSaxAbqy8uIlCh3iQ9D6A+mc1R05fJs5obqJAjkBsryG5/HPpShK6uKpHlduhlFEijxNFKGCB26jBPfOas/YybmJnbMbqGVlYH3INF3EtvOZEAkikHI2hgCMDGRj0oUXcFjLNC/lb1BbDYwvY4+lWReyL8m+8kktS7IJUL7sf3enPb3po0mMMxlcXBhw23BVcDnBx1PpTX16cSW0a2CXA7uSVJOOQMcYP9aksdYa5lMHkxWkjehyHA6gEjg0tUS72LEsP2pRMsO3zfnZnUhn4wAB696usfLiTz40jESrtAYZbPYEj2p1zcRRRoluz+YrBBExDMhP3uew61ktHJazTC7LuDJuUuMAc/d59BSXvBa2onlNcmZr1XSSLIV3OQFJypJP481izllnlUMd4BJdVJYnpkVqatcJJYTRJCZQHVS7EqQOR+I4rNjnmgkWR4l2suyJXHbHP05xVoFcbbiSKPaPNeFpNrZBy3y/y9auWYl8wJLKGhiIZlGNwGfUelNuM3Dot2JIGUcGMZI/H0pJFht7ZmhO6Lgy5bLOTxtH6802LpY0bNfNM5YPIkf7tBFHuYheWIY9B0yarXFtOHgktHeWzddy7wCQ2Ki/tFUskzbE7f3XlxykApn+L1yarf2n5tzJJO0kCKAEVcbV9B9KlJid7kFzcsiyIY/szM5JdsN8xHYAe1ZtqWMxiUCQkFkdl56cVoau8KPvRmdGGQSOD+NUdPIL+fKjLGh+9nj3+pqkNrQkimuMyNIB8se11lIAI6cAc9av28SzRIbMM1wp+eJOAM/XvVZTJPfYXb5iD70g4Le4+h/StyytrffKoiIRmyJAxJlz1I9B/ShskrJayxCbfE52EDj5ic/xH147e9WpImtljmnZ45GyzQqQecADnHA9av+Q7Fpbh4FXq3OOfb9KjaCOKZJAGluApXzCOAvv2rPmBK5Ess7BTAkYj8sszg5U5U8A49aKmnuVkDLDgJtIXjjGOwH86Kab7ETSuRxxXP2u4WM7Q0rnJXOCD2rO1S2ZGV5EKThwUIYA7QfmI7dDVmKCO6vm/tC7ktIUlJYhgWQbjhh6DpW1qenTWUTyW8MGu2qEEvFhpEU9z2NZKdjR6NK42yu4tT0EW98DDco/+i3Rwu5ScbSw7/WqGoB7YeRewyxXBwVuYLkqGH+8ODVUvaTpErL/ozOQi7cAH6cDIq5cW89sn7yKRNPjRXaSOUFEycAlTzt9cHio5bM1TUN9v6/qxHKg8lpJJJCrAhvMk3AgdMnt9ake6WVY1hjyigFnLbhx0IwKrm+sLa8jhube6hSXahnXEiD3B7g1HFcuJDMZpjbk4RvK6DPHf39KdmWpxZNqDsFeRwuzB3OMlseu3vUj2Uc0haCQ/Ng5Xjn6E8fyqL7atvHDJbyqYX3smYSQCOoIxn8KfHeS3NsZ0htvtCttZYGbYw9cHlT7Gj3lsNcreqLMOnNChQ3R2lmbaDwMjv71TtrF44HkYBY1A/dABjnueOo71pxsF2525I5iLd89ST1ptyxtnjlSYguT+7JG3p0/GmpSHywsUl02xeMJclXLjPln5ST1GO9TTaPutBFBbbFwWAD9/Q856elSxxie4SV7WTziAVAA+T1IzWlFMZWaNmIcAZVhxTcmtiEkZVzpk726xQrEuBlS4+bOKu2FkluhX5HlwoZi2BkDGR6VLOGJuAqF9vChGwWJ4ODnoPepNLuPs1lcJdWqPcFQsMjNwvbJ9fXrSbdgv2RG8htbeWOFd8sYyQeAvGcknr71WeaeQlml8tx8zowBAGBzx9c8VLFBE1yoeWSZwOCSeT/LHPTvipbeH9yjImE3cK6YKtnBwPT/Gnoha3KVvaPI6RXE6lQ28qrYBYjPtz7VdawCvFHBKdkYJPXB9Bz1p8ECeXdGOBTvb5iHIPock9BUsiAW8ZkkWTkbSTkDJ4x60XJa6GRFDfwpK4nLF3L4f+QHH9KnS+WOVzdK8IYqGJDY3Y6gdvwqxdp5N0sjzFlTACIgxg9uDwKgdoLlRAp2gHJ3fPk55Gae+407bFiNEmiYwBFdgB5i8qD6EngGqlzpcMkjKxAIGCrLt3HsSfr7801tO8mQSW7rGV+UAgjPcd+ari4LssF5FGmzcGKgbyMdQPx/HFJR7Mrn7jre3jiLRLHCXiztywB5PzHn6VfZV80CMSROw3bsbgOeVPHFVoLGwNu8UUshUc5GQ455Bz1z3pZornYfIlG9txbIDY9Mf/rpNXHGVtyaaeOItISGzgBXGAPfPpVe9tI7yFRJNL0OJCOF+oHf3qppzXEJMGoQhtw2xs3zFyT3PYVpFAVSEHyXGGKr1wOMDPalZxehpzKSMSfS7qIsluqSR8n/WAA+nBqvNZyW9uxuIZon8vDHBzzwAD0IroiSQUZS6g5AlTkj8BxVttpVTC5XuUbIH5VSqtbkOnHocksSwxp5c8m4qX8tVyoH5jr1pIbdRKrGdXlZs7SNnmcdjyBwfbpW49jaIZC0AkUv5u4ykfNjufT9Kqy6dC8u1bhBFKf8AVeq46D1q1UTI9nLoQ3azwX0269IlL9A3C+xPQ1Dq11PKN0hWRDwJlGV3HGTxzntitQ2UDoGm/eAMBGpJ57c+/vUr2ZSKRLbbAGByFXJB+p60vaIFSMqGRHjMJCO7BSVddzMVPXb6kc1lXexpzsJEGCvHBycfNjt+NPvNEubKF57do3cfMJFbawPfHpWssl4XDxwwSuVTcM4ckAZyfrmtOZbonladmZ0dlfXDQuVzayOglkPBCrwcA/jV/X9Cnghsmgjh8tgZvJEuXTOOXyc/0q1vaaRDIkZlXOzaTlenOB361M9xcGOa6uIxNNjGzcdzL2B9ByTipc2TytO6OMvfOE7NIVUghQoAPTvUUyhhKoDFFwx34AI9RW9c6YbmBv3JSUn5R0C+nPcd6SDR4dpeYltgHAk3b+fTjH61fOkgtczobhEiRSvyEKI4zzzn/CtOOzjmzGkJMcbD95jG49TtycYqWwsY7eYvaILpUb5iRjAPYHtWjuDylYlRS/Xac4OOBUSn2GoMz5beSUhmRRKc/OfmbOe5xVkbLeURoJfMJy0hUZ57bjmmTSNFAVAVsHaSPmz64AqG6cmzYCcIgxkNgnb3P9MUtWFki3LMw+SRSqkHDMpwT178mojPi3Jw6Rty0pXJ/wCAqenoKrQQRNFKyu5kK4jeXhc+/Jz3pVn8yBPNCMVYgAjb5jcEHn+Eev0p8qI5mMlaUhGYRW9oASqhstzk5PbNFGpmSeFgjMQjAv8AXuB6+n4UVa2MptXJ7s6FNqrwajY3aStIxa6hYHDDP8GBlelWra2Gm27S6XLbxXJxKktkxiW4Uj+MN8vHcflTL6+s7q5nhNpK00TfK0KIpDZ4BPU9DUcVuzF545JjHIyhYzEAIyB7dTXHr1OtJWI5L2dYIIpWspZHIniKYkQnncrrn5SDxkdqsw3l3pt5HLazbYZU3fZZJBJH/tKvqCf8KUwGaEuUiRNwZndgMH/PWqTG3nux9mT5IyC8ygbT7A9/pjmqUe4m47WJpraCW8vpo4GtrOVF32yMDEOOpGfXkelVbi/8u2ZYbWQiNyAZeFbA5657DtimKyTTy2tu6T8k7cZXAOBt56c+p6063iQtKt7bESxSDaFGGLKOmM9sE8VrypGXMxH1Fbq5SGcSNJIV82MLhcHHyspHPPcdq0baHzIpB/Zsce0YOwAZ6/N15GMVSguBcSlt8kkpOIpW+UtwecDnd161NbahLIqm5RiUQgGM5+m4dev6UmvIuLHW/nOXVZR9qU5ERBA24447/hVqOBtyXDwhpiuWViSffH+FQR3IaZI5WdQ4LtKq4XcAeM1ftb+4lnjWKFZ4iDtk8xVbGOSAe/HNDuVcq6hI6TOGjjXCZ8yLeDGT6jr+dQ25uluTc+YssDgCQu+OvTGOcCrjSyzofL8widTjL4OQ3TnA/XJFUFeOBYxC9shlkz8xBA55I4+97UK9rDk09TVWd44fLjtxynAySWbscnPFU1uLm2SOf7qynDpggHnA2+n/ANerqvO+8R+W1uWHzjG0D/PWs+2+0STNEJGCL8jNncw7qxH93j2oQm9bFhZJp9hd5UZlBRd3cHnIH862IFihtcb5I44+fmYnj1Gf51m3FlIsaW8TxyuVILtkbRnkKRzg1HMFSJo1njSYFZOpO4bhjt6UviHsaIl3CMWskZZWwzOxO4dcE9jUN/cRLY7FuN8kpOdjfMremSefw7GqF6ZBCUZ4fsrsWbzDncfzyvfn2qjLGJ5EmkJaJ02KM8jbx179/wAqtRIerNewjZoc3Mm+NCVIR2J37c8fkT9alnKINsaYO5Gb5OZMnPTt+NYGkHy9YZEbaAvC8ne2OhHf0/GtYIsSR+eNoZzJ8zMoY5GM8ZwARQ46hdxJ7Z5WupvnSUMwCqgBXA9OepH4UiGCTcCi+Q3MmcHHOMHuCOKlMixQLcgL9kVMStHxjjpkdxmnW7okUn2L97GxVQJCAV9+B645qWg5mVTaRgRmxlCyIMkn5t+c9T1//VSQKbYsEZpEOMkr8v0B6+oqSWcxeXKswIbkYRcjPUEHGaiuS821448vKyhAWI3def8AZx6Hjih32GrWuMaeO9kkjaPy40IIBYfNzj73Hf2qrA7gNPbny4nLI0bk5GCeV57/AFq7eW4zIjCQIiAYUAb8nn6c47VRtC8V3Ik3lsvys0IGN3PXnGDQrW0C7vY24WSeBSg2kDIDj5hxVK5XyHVwoOMZUvggex7D2psr2cWJVLQspIEQGWHPAx271Te5nCsHE2Au/cEyATnqfTkce1JRtqipSTWpK1h58rPvljYcooJBxnOC3Spo7i2jiH2lkYqwAfj5c+/rTIIHkSSYyZ8xducD5emSB1pnkCGVY7cyqeGJc/e9eMc/WjcfNZE7tG8waORPLJGTu6fQVMfKPnGPh+2eAfpWPeSTJtIgdkYnJ2gYHYgHr1NKJP8ARpBNbyEKwO18BunHT+lHKHtOpZiupRcqrB5MLnfknGf8irM+TsLRSbs7dykZHvWfJIsbhRaThnGV+fKj8jxVWaaNcyxhiyruKmQtkZ9vw4zRa4+ZI1ySsoRXlbrk4zioZZUW7+RpThfmDDAP44qkL5OFCSFwcFWyFJ7jr7U1JrQAq4UdNxOcnPp3x2o5QUi7dXf76MuIljXG1ckn8hTlMcm3aP32MhQp479O1Zci2SSNPGyEx87WY7h6jHp0NX2vwI1ljKM+MfJ83Pp7n61ViFImvLt7cLHOVWVl+VQvU/h/WqT3cYRkd3LBA23bwc5yPl4pks3mGaRRHKoQI524bJ7k9OPSopIJJjE8igtxtZTjA6dB1HJqopIiTbGSSSvGH2oqyMQ+zgkcYx/ntVm1hgs1d9xMQBDl84ZvqR+lRQr9muI1iEefuFM9STxya0ZiJLdVmlkSJY9yMRmQkdee5ziruZPsVpoi4SSFhFKpzuQDI/EdRRIFnd5p4Xd4hgyMQfL9Ao7+tPtDsCfPbsgOMoNpHThvfNXplj8tLm3xJF0lj7//AKqGK5Ru2nVXDIHRUxuIz83TJPSio1jY71t4RKAhLFlx25b2orWm4pamc0TXCRwM8iRoqpM2BGDnJJyc9O/eq2ngT2UgnW4K3DeYkbNtb39s8flWfdXPm3t0b+VYYxIyqNvQZ5J/ADHuam82a4XBa5CMTEHC4C4OcgjBz/QVyRjZHU5FqWD7NNGGJ8tQPKhRiXVccknoecVUELmGMQwEx72Mg5Jzzg9cbecetW4Ypri1kSVEiYDbIwPLLnnr2PGPWoJrW28iaWG6aN9qxk4LYxnGf5elUTcsXjgWSW1uyxq+S3kxgmNuOMkAjJA+vaq8FuItVt9QPmF44ykqlsBjjAZiOhX9amjeWezjmmkgAVg0hXI3qOcDuSPwHNTGWaO3mbzW8gKw+T5SSMdCCeDz79aVugaFS3T9zdzlvMkxhpCm8ZOeSR0OOTirOmWs98piilBZRuiGcbuAODj9KgMLSRMsrosMOW8oZYhm5wxxzjp3x+NEcjL9mnA2SYy+xsjIPBB9f8KoavYS7eeF0a4kb5QAsmMgH3XpVtMzW73CfZGGwwquwqck9iDwK1dStk1ayk1CCRWmjTF3AgwR/tY7g9/SuetoRZ3Yfy90cpwY89R7UbrQcZX3NKMtHaFkWFtowflxtxjPfA5qneyJNbRWnzK8eWD9Fc4zgnt+NJZAOpSckqGyiOT+Jx3qfUbxWPlwBXZfvd8EdqOUq/QmsGMtp5D3MSlSw8twS3rnnoc9MVNZMLcSlbczxAjLBirEe/5d6sE208cc7KZIuN6RnII/rzUmnXBsdRki2H7PPgOrDOYyefxHUVO4S0V0VY5jNeWzxXMsKFirLIPm+mR6n0FNWwQ+bHcQys8RLgvghVznC44Pr09RWx4k0SPTooJLWYS28nzo+7JHuD0qhFvulZ3iLqMpOpzwoAww9uh4xSvdXQRaauht3b2ckcEMJMlzI4Ayd4Ck5OfTg9KHhSCxeOO2jigViN7cOSccj2/pSG4ee6lmg5jQFDlDuyTgY7jr9OOac6SCIKR57lAFBONh6cr1pq4Oxlm2eAi9JIuYZAcdgQcjiuo1yC7kv5Huo0lmuAssboPkjU44Udc+/rVKEQyNLHCUk3wgkldvIwccnt9avX10NSs9PdZSksMQjMZzuDdDg+hGKG3cJK9mjI3HTYZ0d43tBhmCZZpHHBBHQDr19KnjvFWAi2Cw71EYaMY37TnaO45496bG4KJ5ThFXoEYtuH9CaohPssrhERgjBmMhGCB1Uc5znng5prUiUXHc0GMLfNMFLEcNxtB/ucn5WOQaqzNJaGKVI1ukZSHjVBuUDkHHAP4U+XWISsMMtuu2R3VWUbGUN1b8AByfwpTK53hII3V2Gx3Ys2cfy46UWsK7HzXFzLcNIsbI6gFxEMqWI6Yzyemaq3M8UlsYYyxlVS68dDnkc5OMDIHrT5BPBbJCZEndJSqPtBAznOT3x044qe98PanZW0V5I3lwkAmUMuFHbp0/ClogVjOmHnEtGoEx5YAk8Ec5P8JzweOafaTG5tZGaZW8l/3QA+abjkfhknFQz7lt3lihhIbJwxHTP3gO9VzcShFLDY3GQoztJ9B+Of8AGrtcRoeYoES2zh5BhCxzlPT6c/nVf7WA6q0XnqrMu5zkhu5GTyAc8e1Vcl7jzSvmqvys/IyeuQD19Paq07IVJRXjVRxnjyxnJ6c0cqHdlnU9QMsny7YwqAKcY2gkcfj0qtZ3gguhvJQLwgIwgGPfnsagUbIYZUjU22/AU8tkDOfpzkjFT3zxm2y4OSMqV5IPbFOy2HfuSnVo2nZxbqwSPGA2B7jpj3qH7S4+eXzMMAoEZ3Y9PYVUhnijErTL5UijJy+NxPA/z9aYqSRKGeLZkfxc+Yc9Ov8AkUcqE2SxySeTJh/vP5YZRx64wO/vzT4Fkkt5iskSvgqoIG7af7oqGWRRKJUkSNN3MYGCp9v1qNmEk5ecooIGdv8ACD04/EUWuS2WJWRJAQcgqSyFQfmwBz68VKrswW5ZD5qhfMRDtAHYH/PSoZ5DI6wlQpjOQWIDdsZPfGRSASqpSJ4jvQ/OXwG9fpmnYm5ctLmForlkdPKdiPIPzZJ/2fr3pl0jWsdt83zIclE5JHXPXgf/AF6ZAihXFxLHI5XKsz438DjI/wAmnSFZY3j8tImOR+9GTknAXPtTsO5prct5bN5DZU7Vb7w9OMfWmABITE0Ss8vzMQWbjsR+nWq3+lBggVY54gF8tsADb2xwB6+p5qVb24liaVJIs87flBI5wevtUW7F301C0jIuPs67DHICpkPylRkkYJPP1NXHSUNMIV8qVCBgdWWqEUzG7w7O285KNEMYI9eo6VdhR4mjlVHRd2S5+YDtx/KqbJtuXWma4s7iGTfHsG75TtGf7pHQiis26vGhVzI7EkkbXUgKfQ+4opKxnJtbFASJHqV0zfIGkfd5jcEbvTHPapLuJ47ktKIxH8snK5G487U9altVLXd1iNniWdnxnqd5HGOnTkd6DFJPKxkWF8ZGd+fm4A3D26VmjYjgupjbJco6u3ILSNggDgZA98/SpluN8wji2E7Bnaw3gDoQCO+elUZ45bbzkZd/mDBCNtYAeuemPbGauLHBDCIx57tCmFaNMNg/7R9BjH1FUxIsFvNuJEdyGjOWZcL83O0Zxx+dGp3UFtJDBcgXckJzuTAJ47kdPbFRSA3ESW/lBUiUlyTtU9sE9yODnNSadZR3F40csi24LbwXwoYHpg9hS03KVih9vhmjZmtJQDkEhiOO314/Pip7K6TrEzB0QqUVQCT3HPTI71vTy6JZyC1SwS6MX35HkbDk54Uj09arXWh2MkP9p2JkNozlwhU+ZFtxuUn0BI/Oi66opNEGmXb2V5HJasyOBu2vyR/st2IIq3r9ploL20Upa3C74wG4VweUP0P6VHbStcR7biQbZB+6QZzgHgj09DVix1B4I5LaWFLu1c5eNzgP23Iw+6aBtO90Zxe3uU23EZ3lsnOQRnsO1XJLG3dVjUGOFQX80HduHcE8c81ow6C13G02kXBuYwQWhZQJIs9iO49xWfJG8chtirpNGwHltkHcTxxRe+zGmnsRqGOXtcog4RX/AIx3z9asRusphVysSgeWuWyM57/0NWdSs/7Mla1MoeRAN+T/ABEZxWbBK0F1tONsn3cjIDdsilurotao1k1BxpkunMqNbwufLyMtnPIHoOtUbJnjkmkUiOIKC7v0PoGB7dKgFxFI8pldhIpCkbAdxGO+RjPPXGOKhmkjmk+ywSCJVVQGfGc+5B5A/GqsZpJbEkly0l4GSCdJCxBKttG7bwFA65J6VbkiRppZHUidWCq7NtVmJGeRyMAY5HJqtK32O3illA3u+XIZX3kEDoORgc++avWrpPIr2dxLDG24FJc/MexUEemCcfzpMViOSctcQvdxq+0GJiqgAqAOMZ9MVamhL2t9MCXjgZEOM5bI64HTP6U0hzawTMTLOWwdxxkAfr/WqiySRySxmQpHJkOSdvHbP0pbmiWmha0wSPdlbcGNojsVmx97HTPfPFLbKDfNILd0uYJB8suApOOuSepz054/OrENykVqpWYFlCn5EyXGRnPPTA6+9M1mS3SCKK6fZE7P8/leY4JXAweCO3HuKSM6mpXJmiukm2D7bNuydgPHT3AGfzqO8DRafIyMqTg4VmO5uvQe3U1F9olEEZUfvAFQy7vlKgfw9gPpUUQa4eOcyFDCwyBjBOPenYFG6KSuGCQeYxCBthxtyQB0J7V3fgtzrfh+/wBLuCCihWjJGQM5OPcAj9a42eMJehuGRfmOHznI4/xxXR/C24Lavdw5yPKPQ8cMOn51NXWN0TONos57VbR7O5eznh2FHLMqDp7/AENU2ikjtmkVyS2EWToApx0HavY/EWhwazasrfJcqpEUw6qff1HtXi0nnQ3Elo7iIxud6k5IIPOfyp0qnOiYSU0bOnWeprZSXmnRvPHFhJUADZ7nK96o3Mml67YXF3oUsZns1ElzCwwFOT8gY9c4OB1r07wHYSWWjtPLkNdMJQh/hXHH59aS+8M6fbwNJY2VtHEJJLqeARjbO5U4J9w2DWbrLmaMpVEpM8eV5JI1aADysb2D98+ufTH61FFA4RmliIlYA4KDIGe3b1q7o1p/bOpra28KkO3mhWbYuSen04OK7vWfAKppzPp7XEs4AP2YTBQx74Yjjv1raVRR0ZpKUYuzZ5oLKUSLI6ttI+4uN2fbtipZbCSNFzEuw8FQQdpz1yK2bnQNQsojPc2U8VqeN0pGQemGwTj69KntdDe+sGuLEGaVDtlgT7yjs2D1H0p863uV7tr3OOWJ4mKBVYZwxbqc+4pRKyMVZWjCjaCFzg8AHjrxWg0TmZhg78bCRxgjIxiomt2JCm3MeMqTnvx69DxVXFyMgYbwHbAaM5PmcE9Onr0FOe5ia3CS+dJIxIyMkcYxg/lVuYxTmUSN5czYDOcnABzj+lV44FeaPyn3R4PygYP19+9UmLlIZpjIVkGZApwCVxx1I44/GnTzztNlNqoSFCHOAe5waJ/3TlpYpAqYXk8cfz+tPmDyyKrl3I4YMSO/b1FArWEhSO5lkZFaNYhzuJ+bnBP9Knghl2Mm6GFkPL4BI568D6fSltlRN0xLLCqYGSdrknAJ61Pa3AhiEqOHh34DuDjJAy2f8/pSfkUiKSSSRA7MHhYbzK5wM/p7c4p6XsjCKRwXSP8AdZIIAJHJI78ZqCaK4RggZPMcKwGBuYZ4GO/TNWIVZQZLkbXbI+Ybj9MdhQFrkdxPCzuShWIncIiSQMjqO/eimrbqXmMpBcrkjPeih1OTRGckat28drcsZI4xukfcW78ng+/eoIY5ZmmjPQFZNyg4IPXGeg6ce1F66XplSdY5BEWYN0I+YjB/DFPiiYMESWPYYuRI4Az2BPesY7GrXUqSRKbmOSVYxE3yGRWI3EcYB5z7/SpgVhuG3QNPg5IVgF3f5/lT54N6wg8MzbiuNu3j0HryfwpllMUVomUOckMpPXngg1RUUOsprS4l/wBILxK7AlXGV9xgY54GM0s0cEm5IxKoXiF3cMW7leOvWnXOlxzBZIw8kIIYnO05649/wpIoJbRS9vgxq+4BuQPzp+hSjfYtyaaYId8tzA7v93DZUEDpnpXXeCkVmfSLmNvKlQzqVIOxujc+hzWBo+k6jq5yluzxOQrHG1F/2gT1/CoWmuNP/wBL0nzFeAsqSBCVbBwQPUVnL3ly31HJcycTX8VaDFpc0ZtZC2DlcjGw9gayIGSaNklYQ4I+RY8kH1/EZ59cV1Wk+LdN8SaXLY6w6Wd+h2ksPlJ7Mvp7isTUtGuIFa7tfnjBZVnXleOMkelKEna0tyYNr3Z7kuiTvY3UEmWyCCCDguM9CB7Z616DcadpurXFvdlUeaBlYOh545Ab/A15bHO7OrzxkSKwIZRkZ9QO1bWg6qumawrAu8Uo/fHbjGemfcGpqQb1W4VKblqtzZ8ReDZtT1J7y3vwhdtxR48gccAEGuP1jSLizuBBfRbDtypH3W9w1exIyugZCCpGQR0NR3dtFd27wXCB43GCDWUK8luYQruOj2PDU8sxvHexOXJAWb+6uc8ke4q9b2NrEokgRJJXEiMTyigggNyeuK6/WPBZiizpbGaMfeglPP8AwFv6H864650t0ldVDQEHbsZSMsP8iumM1PZnXFxqK6GuTYsiEJPbySEqCQeoztFaEkJht281N6ABm2RtwechRngcjPODVR7CYwIIY98sZWR8dlBG5vwrUFrczziJLiSaZuiJ0I/zzQ2XKKsJbrBf20ckcbFY/l8wqVUgdsdcjsat6Xq9lDZHTtUsVZ5Nyi42A4z0Jz7+lZ9qLqBHM9rCx3FpEdPnV/U1am23EccdxG0UaAbmjj3DcT95T29+Md6l2ejI5G9GI9pHDEoaWN9rj5k+6V7f/qrN1WeaUwyW7KxQfvEOVzzw2R1yAM9604LFoB5iM0qEnCyYwOe9VdUtp3ZZLdCVkH70IMHjHA54zimpJPUqVNtDZlhubVZJjHFM2ZEClSVzyB9OaxPN8wKWOVYZKhemO+Pery2i3EAl2pySCDweOx/MVM1m8M++BoWCgJ5ifMucZxz+P9Kd7BbSxy8upyIAsZLtGxUYXHAA498V1vwkaW48QyytFsAieQnGAQSo6dv/AK1J4Y8Lzavqd0Xl8i1UAlgmWLE9Pb1r0fw74ds9CWb7KZHklxueQgnA6AYHArOrVSTj1Ma04xTj1NmuJtPAcH9u3F/qFwLmN5WlSHZgHJzhj3HtXbUVyxm47HEpNbGQtzdtrkECQn7H9ncyuPurIGUKM/TdWpTjTcc+1F7mcjzLxXpmk+Htdt9TudVu7T7XchxFEF428sAeoBz29av+IPGMV5o8h8N6ikGoxtlUngJDjuOf510Xijw1YeI7aKK/Vg8L745E+8h6d6wv+FcacYgkt7fSYPDF1yP0raMotLm3RqpQkk5vVHLeHvHGtTXCWPiWzt7yynGyWaEbTHnuQeCKjgkfS9YdtPuEmg3Zjljccr2z/UGuj1TwPpVlYeZPc6kyKwBaAAsoPBJAHT1NTv4K+yWAisZftTnoZwFOPXcPT6Vqpw3RanTT02ZxmqmfU7/fHEou5+saAAu3rj19alk8KeIJlR72S3tLdRy91cYA/CtybwzeWzF7nUbPT1AOyTzNrjPXkYP61ha5pWm2siy3OrDVY3wsn74lk9wCSDVqSekSue+kWXdI8B/bFkE+rWToh4NuwfI65PTFUp9O07TFvYml8yZMpbvGwKk5GWIGcD69axktVsZ5EsHikjIP7zBG4H1/woxIxZDcoMcH5fzq0n1ZSUt2xGk8pTuTcWbhT0A9veokso7pi8nGDllfGF57evNXLWbyZn/eW8qZBxIAc8dcHuKddmOS2l2OC0q/e4AQZzjHrVFNhaMrytGo2QkggLwpYZOOe3rUMymFJfJRSJOoPQMRzwOAKcsUchWKI/OUQgrwoGO56n/9VPUrDPJHbDCNHsDMclsc59utFhXKEbi2Oxt8sqqVUgkeUP6cUG6ZJzc3bDGeM9/TAro9Fi0AtjVpLlWIHyxrxn3I5rc0OHwy+rGfySDFuMcty42xjsQD3+uTQ526ESmorZnEah4f1zV1OoaZY3EFlGgfLkIXx1wDzjFFd34n8XWbadPZ6RcSzSONrzEkBQeuM96Kwk5vpYzU5yWqOauoGF2V2rsDFgfX5j2/H0qqlnsCstuq7pciPCktjncD7c1clJFxIjEvGXYnaOnJ49azr7KSncqBHULgtwRk87hwPce1EDsasgkjdF3xNOZDkSjgbB3xng96S4WISwzxKNzIPNUZPlt0AzS28QAfzP8ASIgF3yRkfN1zzyeoHaoGWXEIXb5DNyFzww4+b3HHatFuStDoNMntZXsrO/lEMDbiZQDuUHof0rs08OeHba2jnnumeBvmHmSgK/4Y5rzmVwJt0aiVFVU6ZAPeuiXVlvdDW2uYI5FV9yuG2soxWc4N2sxSUn8LLXi7xZcXNnNZaM7WUW3aLiPG8j/ZH8I/zxXltvFremRvb2eoXE9oX3+WzHAb1z6mu0nWM4XywCx+8TnaPpUDrEpjhKxA7vnZsjAz/wDrq4xSVki6aVPRF7wjod/q6zS3EUS3Eajlxjfn3FXJZrqwlaK7kdLiFtgAJHHUexFXLCa/0xwLPb5bn5kfgOKh1CXz5PMuLOIIBtIQ9G7H1/HtUK7fkW5Pm1WhL5S6qtxKGhgnwHxjaoUdfxPtUH9iXd5Yi9jhARGwdjnIHc471XN5sWIOC+5fmGMEehPpn3q/pniK402ZsEPbJgmIkfODjkehp+8thtO3uk+k+JJdDtsXEU8+noOGC5YeuK9Ctp4rq2ingcPDKodGHQg8g1gQeG7K6SaRpZJLO6XekfTZuweDW1ptjBptjDZ2ilYIhhQTk1y1ZRlqtzjrODd47lqqGp6dHe7GKoWDDIflSueePXHQ1forNO2qMU2ndFKz0qxsjKba1jjMow+BncPSrKQxIcpGikdwoFSUUNtg5N7mD4i8PpqSNNaOLa+AyJAPlf2cdx79RXDaddXEd28U8LLdwviS3lGNvoynuPQ16vWVrmg2GtKn2yIiWP7k0Z2uvsD6e1aQqW0Z0Ua/J7stjiiR9lW6yo2ttOTklT/nFY0s8ljIZjI3kSON6FsqVJ7fjXYS+C5jE0S6mzIB8u+IZJB4DYPI6Vy2oeH/ABEbS4tp9LEojz5c0EykSDPUKcEH2xW8ZxfU7I1YPRMzdXvJLI3EcaqYHkEq4XlM9hnqOT+VRWYll83e6+W3IxkMR27/AMq09E8KeJtV8pNUit9Otk43kbpSvoP8iu+0rwhpenTrOI3muBg75WzkjocdM0SqxirEzrwp+Zs6bEsNjAiQiH5BlAOhxzVmiiuM81u7uFFFFAgNNNOpppksQ03mnUlMhnjHxAsPFGufGHQ7LTJ7uw0q2gErXMTFV25zJ9T91cV63cWnmIVjuJ4SRjKN/jVogZzgZHGaQjP0q+ZtJdglNu1uh5h448PLp0Iv31NnDHbtmQMSfYd/fNcSZbZkhktZpJ5fuyEIFXPYBR/U16D8SPCmta9qNk+nTQfYo1KtG7FSrE8t79vyrATwFrmlqsto1nd7R9yNyCR+IAP51005q3vM66dSPKuaWpj3SiIxllUknfJGOgwOmP8AGmRGVgdi4aYhxjBO3H+f8Kt3gHmg3Nr9m8okMSnKt7iqty6wBIo+WYk5XjJHTP4VsmaWuxqRyTzxwhFtzgtulIVenqeTzii2tnFwWMXmZHL7Oc+uTx+VbGsWH2SGyu4pTNaXEQaKTADKf4h9Qarpdzu4eNAsisrIF9R3P49qE77E7q6FtocJcSusTYC7mByFU9VGfSoIreItLskkZnX5wQG/p06flWrcsxtpJFtoUHmqZlwcHcTg47jg+1VrYwlwpVoYpAQ0kS49xwOp7UXGtjP+ziFZAAkx3gszZJQAc/rimQhhMY8pGWycO2VYD9R9avXCrLDGm8Rbhn7mWYMRyQe/9KhS1huIuEYeW20bThXGepyM4/CquLYj/s4mG6uJpoyqcGNATuJHUHpgY65op1zazrZTLMmyYn5tr/eUZwO2eKKxqakts0XgaS5mDSBkDnCkn1PYVTZI0MwkiTYrbSUXJ3/XH+ferly6F5k/i8zdwDz82B+NVb61QSStOyiE4GC+w7hxuzkZ/wDr1ETrUlYatqBcRxxo+Q24bSBuJOQSe/0pIRK8rSIWZ2bliMZ45Xk9c8de1SzRlDGI3IBQKAXDbuPvDntyKmsImtghfezMMlsFlyRwevt9aq+hmyo5kTzxGduMbo93IPU4PpxUEcrJGPJkVQ5wo659cfyq95P7m4VpIkiRyoPIKgnoRjr6etNS1YX7xwl2DfKr7AeOew69vTvV3BMS4aJYJElmDs2U2opwhGCc/hU95LHNvjsj5cU2w3LEAcdjnJ55xjsKgtw9mW8zYJg2C6g7Qfu4Pr34qxZwpFMTEiRlC0jHduQHoQ3XPy54ouFrmrcyIumRR+fI5UMHBXBA3EY9OmOaoWy4XIkL4baNucg9vxqG38x5Ji00aKIydgHIYjoPbjNdX4Gs7RLpZ7iSINGv7tCejHvz3x/Opk+RNlp2jcTTvBt1Is091tRpBwjNyfrW/Y+FLSPyXuj5zJyUIG0+mfpXSUVxyqyZyvETegiqFUKoAA4AHaloorMxCiiigAooooAKKKKACiiigAooooAKKbISsbMq7mAyF6Z9qbbSmaBJDHJEWGdkgww+uKAJKq6nf2+m2clzdyBI0Gfcn0HqayPFPiqz0GHBxcXZ+7AjAH/gR7CvBW8R3njHVruTUGaKeFtott5+U9tvtW1Ok56vY2p0XPV7HaT/ABK1trx5I4oo7YSFQnl7uM+vX610enfEuCWKU3djKrRjkxHIP4HoK85twq25e4cBOFEezGX7c+lNjhO0iHDyO23gYQZ6/Wun2UX0N5UoPoer2PxG0K6XLtPBzj548j8xmtSx8XaFfXf2a21GFpuMK2Vzn0JHNePvp9pdWdzcRssbw4ygO0nqCRWHo1mHuYw3JmmVCV5KgnGfrUexg9jOWGh3PpnFNqC0gj0/TooVZjFbxhdzHJIA6mvItS8f63f3sj6W8drYgnyxsDOR6tn86xhBzehxwpOo/dPYjnkY7VlX+r6Zo0YXUL2GFgMhXb5j+HWud8D+MJtVuTYamsZuedk0fAbHYjsf51y3xT8Pyxas+o5le2uMHcTkI2MbT7elVGn73LIcKF58k9CrrGtJ4h125lgjZbcBVULjdxnBPqT6fSsfUbhvkiQKZR0POAc4rP0tp9OBW4BWIHKMvGD/AFrVbY8cC28bpOASWd8hxzn8P6mutJLY7klGyR0TSB/h5ElyNkkF3iEPwZAckgfmfyrBs2lNzEBjcMx8kEH6j2FXWvvO8NpaSuTPBc7os8gKynIz9aqWZRLWMxw5YrvAXPOG6tnp0NEVa5mlZO/c1p2guLZV/eMQwjdumAOgA/OlljK26yGPAZiiKDuc9fm47cCqsh8vCFJBmMPuPXd2B9+vFWrcJJNAWZgykEb324Hdc9vb3oH00EuRJcWlvAvlRyRMyyOy7d0fBBJPJwc8e9TWKRi1eSd5pbpDtij3ALggEA/j+lX9NsGCfaZ4JRGo3RTPjgg/KT2K9Tkms+VZF2yDchc7iCc5Ydx6fnRe+hno9iLU0GXeKFowkOJS4+8SMNx29qKhnjl8uaKV1LhCc7iSeP8A6/Wis6g2kSTq7SOtsd7B2Ds5wMlu30GfzqFojNG0aMrEg7UY5ZR9OvuarySBbxw2/AdsFUJ9cZ7H0p0ci7pWnMeTlkAJ3dMqMihbG6RXUtFJHHbpGMDCnOAfUetXY5TMDb3rushy0kbHhx2UdMfWobmQPAAhZip4RVztPHX396VFjXbNfTq20BUHBAJODn2HWmNx0JZPK+zwhQgib5iD8wY5659h/Ole4liJkvI0IZBgmQhtv8QGOvGOPbNNjmaO8eSZmIGHRFHBBHXPY9Ks3KSIy+eiTEYIIPLbu546gZ59qBWIxdr5sls1sVJYSrlPus3T8MeveoZjHJbw7pgzK3lF0XOSc5Ix6Z6YqK8uXebzJWYys4O4DO4g8bs/h0qVZ1Q3Ei+TJG3yo6/KQ2eo3elMaQoeW1hilgXzio2negTdt7DHTv1q3btJPa3M0ICqpJcE5BJz0/KseASSxfKGhREJfysDcozyAfxHfr1p6tK0rL5hIEm8bGC5XqAwznj1+tVYpOx6B4e8Rz6ZpUja1KJbWKHzIpc5kPoh9fY/nXUeF9YTXtCtNTiTy0uFLBc5xyRjP4V5XK6XsE0UiyC3lwZIlUkqOuOf6Cs7SpdXsNNGhrez2UKu01tNGxTcD1U+49OnNc86KewpUFU1WjPYdZ8RWGmuIGnR7xyVSFCGbOO47fjXkWp+IfHEurgQX6xw7/l2qgAHYEDOfzqPw54HtFfPmX+q6huMhmSUhITnPUfeOe5P4V6F4U8JyQXQvNSTY6kbY8g5I9faklCmncFGnRWurKHhTxDdI8MGpa1HcXEhJKyRgA/iOldPP4s0q2YC6vIojnBHJxzivOLz4SXmqeN9Uvrq++x6RLLviSE5dgeSAOijOf8ACu68P/D7QNEffBbyTt2+0v5gH4dKmfs9zOo6L1/I09M1uHWJNlpDceWORPsIQ49CetO1iXWrdEfS7ezusEb0kZkYj26itdVCqAoAA4AHalrHmV9Ec7kr6LQbGWMamRQrkDIBzg+madRRUkBXnHjvV9cstSMUMzQ2xP7vy17epPX1r0eqWr6fDqmnT2dyP3cqkZHVT6irpyUXdo1pTUJXaOY8C+J5tUneyvT5kwQukij+EYB3fmOa7SvG9J8K+KbbVy9gPs+wmI3DuVDKDnOO4OBwOOK9ggEqxxrMVZwg3sOMt3wPSqqxSd0XiIxUrxElZId080wjiVfm3kBR75rzfxz49QBrLRbgKMHzLhep9k/x/Kl+LOtsyro9tnHDzEdTxkAfzrzcaBLbW63V6kyQyD5HkUqGPt6itaNJfFIujRVlKQyMS6lKxyfL3Z3E559zU9zpiW6rewQlroKMnac46Z+nH45q1p0a2Vq0c0bEthixOFGf5101/rU9/bYlSERPGkXlFQGHocn35rok30NnJ30OX1QrDPH5Drc2kZRi4UqA23J4POOtWY5TNHPC6lmYDLiM5Tn7wA/U1o/ZrdrYQAvNBD+8yFCrnGDn8R7/AIVGjxy2527gGGTgEE44/LB/Sl0Iv3Mq9gZL5CG8qRgS0bPn5fXp3H86Yzw29wDC37ncGRh0De5rUtrY7pZHjRlwV2kjIyOn4j+dZYtmcFArSxyHOFHynHQAZwPT8DVJiemh1OjeLdSgv2a+mmubVwVdDgkDsVrjFaPz4lt+Q3D54x9fepJreW3J8nzIctjAYMuevGTx0qdYLkW53QkOzeZ5h79AOPTmhRS1RKSjexpJZyQQx3VvcQZ3ZAVsMGHt1/GtGy8Z3ckVxb68q3dpMCjx8Ky+6kDmuf3yiMSuq7QccnOKU2dnJG6hhMsTZDHOeSTzQ4p7i5VL4ilfPFLKixYLBvk6EgVqDETrEgKhST8gwTgDt6c1SAtI2BiiDHcAGbgH0/yKthNtyZRPCrScMS3ygegH5896obH2VlLdrK5ZI0U7ny+ACT/nikhi8hmk3ssURDBwN2R3GP8APWmQtKxUJtG85xjgDuT6fSrKxPLbqEUxxOwbeRyFHPI9c80Nk6llQzeaJwz78fOw6HjJ+nTn61BErzBYI1AbzMqP4SB79hVmVbeaCNEZw0uWIU5Jx3PPWmW0xiLbI2SdQu5hkcY4wenSpTHqbL6lLbXEtrYTpJBKSzsjYjI2gFQGHPOcmqkt1JK8OxHzGhO3HGc4xn86pIqgK0blWUbQp5Bz3IHerLurApGWLrkErn5M9+aWiJ5OhXufONu5DKCm8jIOMEdDz1oqWO322VyqZb5WZiQPT04orKo7sJK25myiYXcrqhPzsoPI43HP+TU8qq8NpbyJ5dxvO1xn7v8AtDPHtjGKi1C2See4eFTCys2Q8hJbnkj+dWrexa3UyW7iYupVcvjtyByOaaRvzK1zOmRbeUiRjHtyUxxgk8/WkSZ98Nv5UTrO38CAMT6+npV5EnmSLzIoH8tz13HjHXn0x2Peo/OV0ZYkjjKoGLxIQHU9uefWquO4q2y2fM7h0ZeBu3MRnlhg+vrxUCyutu0ayO6hsJG6hsKD689uamnuRKkizXLwtgDZGAV9wB1zxSQALJGjqhD8BScZJOB3+g5o9RpW1FullS5VpNrq7gKmAof0HX6GrdvB580vnSRAWsYQhmwWPdFB69PwFRSWbebJLcJIkqqQFMm7HODjOfw9B0pGd3kme2VzHuBdGGNvrj396PQEu5ZewmjleVkjjjEZUurcovB59fy9apW8UcU5eddqhQCcnaoboCPfPar64EjSH57baQBuJwOwHes+8iktsu8YlS4YlkZegwMe/TPenHXQJK2pZ2mGQSifa87AsqgDb9T2PH5VuaGbiK9ZrWP7TMD9x18wMP5KeetY6sLkWuYiuN2cqRj6j1HrXT23ilNK0pYNPsxPcI2XydqsD3FRK9tEVNu1oq53dosUa+XHHFDIQHeOPHBPc4/n7VYrij4pXUdKu0dJbC5Kjy2R8knPY4p/gK7vpbu/hv7qW4ChGRnbOOua5XTaTbOJ0ZJNvodlRTZHWNC0jBVHUk4ApUZXUMjBlPQg5FZmItFFFABRRRQAUUUUAFFFZl9r2m2LtHcXcYkXgovzEflTSb2Gk3seaeO1SHx2TPEUjIilJJyJF6MfbpjHtWl8W5+dNVXX7MULgj6r0/CtbXZLLxJaB0sr5jCT5c6RdfUfSq/ifSrG58J2DefLCLT92nnRkuwIwUI/AH8K6ouzjfodal8N+mh53IkV3cqyTqB1EgXDZx0A7irOn20kd4kmRc4fa5GQjKR0+vXrT5IIDEAW2BR8pPB471NZXTJtxJKPN+dhgKCehIHpgc10PbQtrUnkjNpI7JHDErZ2DcG2jPOT0PQfWoJAkJT7TKS8iliUwVUjP4Zxg5FWNPt/Pu1kYk2nJYcYAxkDHqK1XigRIVQzySckMyhR6/8A1ucVHNYUrJmPvZVGIWdcKgK42gdznOc1SRJGOPL3ShUx8m3Azg5GeuPXrV27ZluSx/dAbuFxktzlvTAPtz61ZYmSBHikURjAZ9hBOep29hnmnexFjMntLQqfLSWWXI5KYyecn05qnqEUJWRI5XkkYq2XBAI6AY6Dg+2a3PKZbeTyXm/dL9yQAZ75FZ4lkMzRyR+YknzgQhW59/TNCZVjMktJ0eeNTGzo2UwduBVuO2eV2UQRxlFALk4DDGev4dKtpYBrkecqRSKgbZu3Y+nfpwaZHGqJPsb5SuSQp3Nj09AP6mjmHy3K1zbwROxmcEgcLCvy5/z2qFY5rmZI4I1R4/mCuvQ+p688e3WtVV3pHGcM+d3yjkDtyaJ0cySCOMq5GC4BBHfg9KOfoP2XW41LBlkhfyYvPRs4Me5mOcjknAHXikt7wM0kJEiiMfdB+QAc4LHtUccYTzGurqVVJwzLyHPGM+/vTbby4N8YXzyG3hjyPqM801qRJaksiRxsJdkjMxyuw5GR2GMcf/WpklqoAlZnhi4CxFtxz6nnA9s+1SS2zW1vFK7bIwd0e9gQCT7c4J9aVVafdujjlYNvK5KB+o7/ANKL9h8pZUxtHEiwuhXbgnJPp19fep4CBH90KTgEHj9ags2a2jwHRpJVwqLjcg789hn6VOSsKbh5YCg8bccDqfxrOTLjEZdN59lKvlsE2naqDAH+PSisq51Oc2Usa26xO3+rZnVm255yAOOtFKSaMZ7jpHWO9kNoAkjzOPMbDg9cjrwOlOGLy3kgJTaoB3LkAevPb+dKWSOWUXSIFZnCg4B++euO1Nijlv7sW8MbFQMCOJeM9yce1CelzZLTUmt5UMzCAReZJxudsM2PTIxzgVUuyyNEZFLLGwBDA8DnrjoO2MUXkcVvceWEXZEMFyMYGevrT443Qyxh3yykls84PQD/AOvVIH5DIWkjZgzKx35dwMgAnhee/wDhV7eZL2GPaN4BcDj5h2/LnrUFmzzLDC6eU5bc24HDD0PvSmZ3keRomiUB1aSE7NxB4+btmiw27F2DbcTbftHkGNtrPNwA3X8RWhpEFne2LRQyPBqUeGRRgxzkA/Kh6jPcdelZEQJiikkCxlJMbnyxGcenU9qnaQxrDJshguFbzA3nYKEAcgdAT1pNdhSdyK5jczyQ7ykcmWdEHRscAEnrgY/rUgKSNmSd9kZwXz8+AePryPxpl46faWdkSMM24K6qMtwC2R6nPtU81vCkTyxRzSR7hlmUK3bIwDmnca21IJZRHbxtJcStExGN8Zyp6kjHXg+lQW4Mks3lTSIqsVJkwBnOAOuef60khCIu6MKmwkROeEOc4H97uOuetWra2hgjt7yd2ZCxl8zZky+innOQSDTeiBMkhijMcM7lnWMkyO2SvXqMcn649M4rN8S3l7DYSR+Hb14Lhp0eKZB8wH+7+PerU7lpfJMsk5j+cxRgABck7eByTmhxHEB9jEsV1hpAso4cdOTz37/Wl6jWu5Yh8TahceEo9O12Fbq5QbZZ3+8xDcMQOPSnWGpXdimLC6aNWAICcgn1xVJJp5beTKhEU7ZfOHzE+uB6D0qG7NvbNA1vgozkh2y3Pp7URilpYaS6I7e98a3GnRaesqQytNbrJI5yMMSew7YFZFz4/vJ3XynFuvX5Yx27c5qPxLe6Vf6DZR+Q39qKqRiRUwR/s57iqy6Wl5N5RicyRx5VxwGOM4z2NKMIJXaIpwi1ex1lr428tFN7AHUkDdFw312n/Gut0+9g1C0S5tJN8T9DjH4GvGjo2yJw8rLK3zImcE54/EA1Dcm9tJFRGkJKr8wJXJGe1TKhGXwsmeHjLbQ90oJCgknAHevGrXxprOnRRo7uY+oM67sj0yef1qbUfHsmrwNp7xBGRVaRozhJQ2QOvIAwc/hWf1edzH6tK+53useIoPslzFpshkutpVHVcqG6Zz0rzSytH+2yxyhnlDAZcE5JOck/nU0V00QLxhsRcKFPAzT7Ke4md7xFil8l1LR9B3B69+a6IQ9mnY3jBQ0Rv3WovYx2yxmQyo2IQMA8+nt7Gse9vdQuMwzAuASVEj5wxPJx271L9l3STXt+wjZfuop3nd2/Ht6VmWzrLasBIYwWB2RHAHrk9aIxXQel7iWmmqJczSPc3OCGRV464zn8M/SomEUIR5oYEhcBgoO4ZHJ7989cVZdAiF/9aigHa5zjBzwaWaP7PFExiAkijWORy2SvzcBTjA68+lUS3caEYhpZ/ICGQAAMEcNgjHHBGPerNo5me4JgIkD/ADbRuyv1PHT0NZ06xvDF5DRL8mYkEhV1JIyCe+c1cguJUZbWQuoztZ/KCqMAY284znNS0LZlmaUJeRBREy7CVUdgM4JPTFV0EsMwRDu8w7su+Wc9/wAP505RayebBbLukLYZyOWyepJ7e/HWqssi/apbdcyJHhSzEEqc9RkjjqKhI1XKi4kbGXzCpDEEsxbGT2GPSoFVWsmW5IYZ27tpwKj23Fw7CeNTboNoKMMnHPpxmpBbRiKXcjLuO1Adu3H06ii1txuTeyK07g2sjJOkbRDJkzghfQgc1mLqeyPEMMoYtlpT2HcfWp7lZ4X81LYxpFkRfJnjpg+uapGG8huZGitpHDpuzjAGedoB75rVJE3dzTt1e7ufKguYYVdTIs8p2qwHX6/SrWq6WltbRhru1lS4X/l0kJwD3Pt/hVazt5IYA9xNHjhtm0MiE9Ppz6e9XobaKLy/I8uOU8Erk5HcUm0tiOWTdyhZwSXF2xdCtueIwRgjH8RPf60v2fzCq3HmzBG4YEIGx/OtNI41QBIy2WOF2cD8T2qv9pgtnkEkwRwTjcQce4X0qeZ9DRRXUja2jllwjyoYlyVwNyrzz7j60N5lwQUSUsq4ViAcn19v61Nca1Zoodb2GVn5XYu8tj6CnRtFOsMxVRubcpRiOe+cY/I0m3bUFbcjgj+WaWZUjlkXG2M9AP5ZqjrbXM9r5VmZFdSrOApJKd8c+1aSwRGR5MfPIdzFW+8fX3H0oBCMjxqyNuwdw+7/AJ4qb2dy90cgLh5CoiiUwKgyQTuOfQdue1FdLqloWtpWiWPeRlgVHzY9D/WitlB1tUc1WPKzLvA9zqVzhGIRjhOT/FyRWgupS2UE9raIttJPxKysQ7D0z/OqN7M0d1cPD5kTSEiUtngZIHzD1xTbdCkUsk7+aEXcQqHt0+nNRukaLXRlxAzwyNllwQuFPJI68eg9TU7SDy1WCTZiXf8AdAPYZz6cdc1W3H9zON3nh0DkAbMEcjr6UXLKFIQ7UzzJgfpz1/OktRsmeOea7iD5wBj5ZNzKAMZJ9OpqOVY7djE0wKEgq77f3jf3to5/Xn0qAFr1f9TIgYksyZCsAeo7e/vRdyLsXy7eNZSpRRKMHgYBJ7YprsS9UXIGVVEscZeSTKrG5LbPb8snPaqpT9y0zkvLEBtRctvB6j146Z96lF2yTBbi2ILDH3gudo6npke4piKjPmGZQiqXPJ+Y843H+HrTQWLheN7dUUPErqRGXGcnGeRxjrTC8p8sws0scbK7LtKAk8ctjPXB+n1qa7YzoUDtsihxteMKC3HC/U8VDDFBLIrXJxIQSBkgMVPC57AYxmkh3b0HXcu7z4mtsgDqhBMYPBGM4PGfpUz3Z+zyafG4hCEDbu3KSoycZ79Fx7nFRACQRwRrHuZmLM0hD5yDyP8AP61ejtMrt8yE3G/bkw84IztH4j6UNoFFsx7iOV4HnMQihTGEkwu0sckDPOTjgmhtRItoXsBFBEhIkXAYcHnnOTn+hp89rdR7VuEVdq8AHjr1POB1H5U8W09pLB5iJBwGYuVCl8HC5Jzk5p6BqRsS0jzxozoT83y4x39T14/PipAbNoFVNzIq4cSqTt4GSD/npVi4spER3KQwuGG+NSCuRyScnjjHNDm2UHfG7SyjEgikyDluC3T0HXjnrRcpJoV7KG3hWSGS4unwCnPC8Yz09/c1chvJpLxWtJFkCf6uWRhg9jjoB071FB9mE82dlzaRbUZEGCSckuFPOPp71dnltLrDRsSsR+bzMRyONx+XBHrRfuO5narcyJtEyKIYdxEcXJI645/mOaqW9zBeW8HmvIjRbv8AXNjvkDcBz1FWWsXv7B5F8iC0T5mV5T5jDsOefyplxcwT2EVla20dvGoBaT+KQnjOTyTjtVpCvroN13y76wUFlLQuC6oD8oJI5/Cs+5tbb7ZDFbZPm+Wq4PUAn/GuoYL9pVXSOXKBm2A/MuOOemcdfpUEqaXa6kbqGOMxsyiNQpAAI5P/ANYVKlpYd7blCxsphbTQTSsWaQGIgjfn1x371NbPa6TJLHL5/wBqY8yGPKqeq8ZycHv/ADqV/sbRuqhZ4GHl5IIVXzuC57d+p6detVELm4MkaPLHIwVGjQEEjggY4PTtTWu5L1Nd5Iprh7iNoZEmURKU5dm7kAfh19agt4IWEzSWriPI3qIQWUDJIHpxjnvT9L00pPNPfqIFKj9wCAxBOCzdunArWWFbaGHe8e44AMhGVUDgFuM1DklohcrMeFdyp5sG+1O4KSQTJ8wO0AAdxgE+hqW5sVlZGcFBIQJIgx2se2e5PAzU11PFKix22ZkGMquflbPGMdu+DUKwTBma4uIyzDC7FKhRnjPPP5VDkzRQXUqS2Vr5ix5gjG3fgYyCPfuKi8q8J2QoZYWZSwfCnpxj0HrgVrW8UJgKxoXVf4iNvP4c1JPNmMrBnPoFwT270czQ3CL6GDa6XPbXLO7rtmk+fBJVQTkAZ/nU7W8aXDENM3zhgo+6O3Lf/rqcx+W0K7lebOQuSwB5wetWLdpfJwdkeDu4Xlj3zz2/CqcrmdrEEcSGZw0Ee4/MRwcZ9Mmm3ccLOv2u2VcD5S7BgP8APtTdSu4rcXJu03sF3p5ZxjJxzj34rDn8QXZWSOC1W3GPvA7go9ScdaFFsd0dCkQtkdoTlSMkjPX8OKrTT2tssTMRbF+WwwJ9T/MViXMVxcGIXE5wuFLq5TOed2B36g1SjklGsMG3+WXw7BBx0C9e/HWqVO+7E5nV27QXUUhtJRJDjGQSQp9ME1hHXNkfk2ieUuSv2l1zj1wv+NZTvvnnMMkqqhAH7zB47nHBzTmijNmJ7UNOX+Zg45wOOfoapU0txOTGTXks+Wu72a4iIHyFgF/75BH5VUuFFuyxhPmJ3B1XBA6Y9+KsyqzpLOkGF+XduUY6YHH/AOuqo2NDKSoKK6ttYZL+ox26VqQSWYj3pIwlCkbkKAMyjuCO1Tzi1nuWZ2kjQjAkQY2kdTjtn1plipN61w5BdgY/JBxkYHf9abexiIOQHdHwyqoO3nORk88HNJ7gjXgum05nRrhplRM+WzAkdxgEZ5/Grmm6ul/vaQCKRf8AllKcE1zt0RPHaRDAkMWX3HPGeBmrdhazfZFnFtEbmJiN82VLjnHfnjHWolBPcpTsdPcb2Ew3fIUJ4HP0orlje/aZvKnuZrSUjDRnOMjt68+9FVRVk76fIVa2lizPeoJpoyJWcSyAeWM78sePaks5EDbWlljKAloickH0I796fd27z3zK7rHGsjkuhyc56H0+lPeJYWIHnTOw2ozjlc9PmNYXVi13Ir2aO3tma1bAP3QjY59uT/hUCSi4t4kG2IRgEopHT3P4VOIWjhAv/LFxGuAWbcxGeCADjNTWZEVuJLfy9iHBKDk5Geh7/Sne2wNN7kdwYfsQWFrh4UXhFYgg9un+c1Z0i0vGtZ/tDyneCsfmn5gO3P496njubm1to5pQ8qocFUIJbPr7is2OGSS9mUvK0vmbxIkuCo7cHn8KndFo1fs6yQxRTCBvJJI3MckYwOOKz4g32ppGeSBlGCyDcDgYOCPXPpzirUsiXGsR291GPMUZEoyoPoAB1FL9pLBreSGLIZljYn7zDkZ9KaYuW5Wgv/IcAKSgZliVSTjn72Pfjr07VaiD3cVzdM0MEW0BoxHjcdw2jn1ySfpzSMWiZZgER1PPmSD5s4JwT39PxpyPCk08xYu75IZwGKA5HCHgjjFO/YhxZcb7K83kbWDJkptfnkc9eh6Ac1bnmuVcZlQW54BQ5YY7E9+fSore5juMGKIROw2spUfr2Bq5CsDxERojIowFXjn1/wDr1m33OiOxG0JS0uCEy8x/ebX5+ucZ/Cqvkv5rQJNujjCsqtgnPbZnODnsfWtSdXWJWRZJJPUYBT15oS7d3MUeR8uWVQCMnjr69c0KTQmk2V1LYEt4G8nndGz7+c8Anp+mBim3QGwRrdCFWUkEyBi/oAw4xx61eeJbWN22A7+Su4Afjk9KhSCGV4zc29uCBmNMfd9QO2KE76j2IbFFjRzHDjzyrNJ92RwB0GM4/QmpLm3Uzx3ElvEqxRkYDBGf8OpxjpmrtsqMpkIlWPhfLbCFRn2qVSfNbaiqikoBvLZ9x3zRd9Be7szGtdPnXzwLfeh+YEyBVY55XHfrV2LyYb9/Ot90DEKx24x05X8e9aSyxwxRCMCItxtJIyT6+31qCNWTyC7zxwKCHQLlPzxkD3p876kuMXoZFrGZCTaP+8RyEcnKiP0IPX8KiWJ2/fPZCWSQbFYORxjqSPXHP1q3a2XnXUj2yLFFgAzAnLjJOME8duTVqPTiolEMrgFiU3O7c+uR1qnLUSWmxUW0MCmG4SIRGQ7Yk3Oy8YAAJ/H2zUsMsIgiikCq4nPVhyPc568+verT6eZFwZbhRnhWduP16Yp8dhAlwjK3VTg5AwOh2noP51PNfcLJbIY1tcy3YBjEYUj5VcvkDue305+tJNCzo0U8UBUbSGZCQze46n1zx2q04LuQkriNVC78YA9sgc1WjeCBpiZBMSBgZIxk8Db1qLlct9xk8kaLGI4zMd+AmeA3uD2pGhje4EzOp8r93tGcA/4/57VFHDcee6LIBtA3LFnKH/Z7DPerhmItmMbBQPubgSrf5FNvsCWo2dvLj/dwmTdzhXx+dUt6JmcOzZO3IUqAuc/lx17+tWsStKZF8sb/AJW3A7iaiEa/LIo29s849Oh7VOxpbUz7mVlmSWJDJ1xtIIHHPBxxWNrV3J5tituxg81C0jxMW3c9s/Wt6QkIZISrDBBGzJznnI7iqGo2RntxJGhM6qPLB4A/3c9DWsGuplOD6HGzwz+ZhZXdNu5kOd/6/wAqvFljge0ucSMcRYRtuw+m7v6mr9jZymZJLqR13ZizKNrP/n1HXFX00yASSCJAtvKrLu5JR/Vc+nP51u5Iw1MQEIjFCxWMuzAjnoAOvt/OqPntJG0xO6IEAocgdMDJ71LfWUyOI5ZMCMllizt3A98ep6k068Tyora2NxG4TI+bA4PXPFUCXcr7GhVnGxdnDoDyoz1wckjnr3qbiFAyN85B/eKMZHftTLYbHzvWQlDEJFGWxjgD1P8ASnLdNDarbvGZSBy0udqjPC4xnPvwaGCGrvnt3AkdhFhiCMhPf179qZgz2pQspUHZnGWUYzkZ6fhU/nxhSsMUEbuu2V3y2SD0A/WpLK3N/C2JIIEg3AeY+0HHJbB60XsJ+ZWNh9quGSP98HQhWVNqNjHOa1YIIkzZ3skfmbwoQEhgD0+o+lUo7PZcQiOSNw7FRKj7uMdwDwPrVqO1nGoCd/8AUq+AW5d16bRnr9aGyWY13Apu2ELQYSXCfNxtHIwf51b1C6huLqS48uR2gk2oocqMA596saYtszTSGEQTCTafL/g9Qe5/Gp4NO+1XIQR7EkfdI2/DD3x3+tK49tyPU4bWeEToSoIUrvABB78nnmiqurSvb3It34+zuNzqBz2x+vNFaUpcq0MavS5a1GWJDKqkfek3FBljhjkenQ1V/tI+Ugs7baN2CQTu69PYVKlys99cx/uoZVeRse24gk59hnFNtx5cjOkqgA5XcACep5x61xpaHamaMRuJo/kKtIAQyyMSPrjHSqyKs6GZn+fIHlpnKdjkVoT6pLFpey2tpgrDcM5ZRkctxz/jVE3Nu1si2skkaA4LsNpIPLcDnjBFArltGaW3FujRxRqSCrKVDD/PeoA8sAIaVgvOCgBAIPAyBkjGOtQSXsqSh/LnjXb94Ljd9c9B+FX7GSN5Cp+cbcrIi4dS3pjH6UbDI7u9lhjik3mTziVQRrtOCOePXvVowWj2GbcCWMruZWfLhT1Iz/KljWC6MguB55DBWDKNyHtkD69aSe3jSSHauRHym0gnbjj5e4zilpsF5bkMVhp/2a2SO4EhiJZVf5i4xkrz+FDXDSkxgRiFdyPG/YcH5TyO/tVK9U28aS2aFsPhlxnk55B5wc549BVnTm+1OsU0pE0BLHCbc88YB4PoTTae5SaL1k4WcRLHHHbOiyW5XIUkHHOe+O1bLBYjE21mPIyOQF7/AI1l2cVhMDZ2pdd6eZmeM/K2Rke2alspswxLIshE52bXG0InQNj04qXqrhzJOxeiZUlRm3SS4xu2jcAeQD0/SpXTzpAzq4xkKQMEY9+30qITKkn7q4y2/YgGCd3cDtggdu2akKTXLgXV15KA/IIyE3cd2zyM5qdUVzXEDwogkkuGdASRxkqfp+PFT2tzNcsrwwbY1fBecABh3xgnmoEeONf3bxorjLhTuDYHoe3vU67njhTYI44zkK4zjjt+tO4mnccJZRIRGmI1yZCn3mP+yT1B/CnhPMlfLsY3THlnAwfWk6EuGCwhgrEA5Y/4VMGhiZt/mghtowvNJvsVGKW5GYRcqjbgzbc4I5I9DjtUkVuSQ5TCA7lU5yvqevNPBZJgEhXnByBxj+dPVXMRwdr5OQzDJP60X0C2pG6JLh2id9mcDAUt/wDW+tSxGJ1AdGUA8hTk/TiiJwpESuNyEcnkk+vc47UpwY2YxyLj72w459D/APqqR7boTZvBbzGUJ6cZ9qFtY7cF4RLuPYggfjxmmkOvlJkI5x8rsCSPSohv4MsZBLcbTuB9/pRqU0rWuM2sZ9zQRbQPkYqARx0wD69zmozFMzPMUVGI27AvQe+KtMP3jkMyuVwFzkgfSoYiJPmcPE6n/VqRwf5/0ouFugzzdysCsaJIQp25O4dwf6fWljaOV2YTOpU8oz/dJHQDt9KeCjBUeTeqZ3ErjHHXIqKW1hlhVEV4/wB5uLIeGI75p6bENO90PDsBiMKMHJGe9QSCVWHmA7N304xwfapcKZAjMBnoAcc8dR+PWmrKzpy6oFGOnTB65p2GYmtl4ghXzRb7sSqM5A45BHT8KqWlzsLwm4nlkLZSF0OQowRk9f51u3MaXFjK0D+Xg5QZxj/EVitZ3ksVxdxlla1ISSVV+Yfrnbjv71tCzVmYTdncfcapZTuIiyIrLyJ14II7Hp+eKsvHviV4hGxIwSRk4PBIbPHH1rFRAzGaSRWMnTaPXg5XuQec1W864tJo0tJcAHlAnysSfT8Krk7BzdxLyQPCsGojyXRiysCcpycDH8S4rPks2VTLLAXibhZHfjJHbHUEDNb1xqNuIoTNE58wEkLg7QDjGOp+lLcRWzWozblImHRwQRnpwf0+tPn5d9AUL/Dqc79kAMMbSMqFgwLfw8deO3vS3FsbaVZDNlo1GCB98e3tVjyFS9NvODHBuAjkZdwI7Ant+FQztFdAbsCDnIXCkv6bfr3rS9yHdDrVBLa5leMoq7nBJBz2+bsO1I1tFO+/OIJEx1Ixx0ye+c896Se6ST5HQfIuwMj849Txio0KeUY2IWEggYGd5A6H/GgTG3ELxxnyIpFkAwMrjb65NNuQ73v7xDH8o2M7Hpjsc/ypN8giZyofeOHx2NaVmsc1jMkpZI5H2/IcENjjBzj8KNkK7vdkXhyOa61Py95cOp3s74IUd8+ma0p9TsrPI/ezXJGRcQkYVT2AzzioLOzslhmR7hjlyHYHYfu9vzqOLTY3geFnZkjfOcZIHfgVLsTu7h4ggtoWgvLK5MwugpdWTkHGM9fSirWow28xd0jcyIq75EABIx1I7dOlFa0qnKjObehQs4/tepalIZWXbI0e0DGcscEn8KSUrGVfLSxs20gfwkd//r1WsXP9uXwYnZ5z5UHrhzVouss7K68ICQMehJ/niuK9mdmnKmTebO4cmUyFlzsjTkDsc54NZ9tI97dQ28SukCfLtA+Z+en50XGqywSGGNRgklmzy2eTmuh+H2qpF4ge9uotyrbuAFAJUjB4zTb5Y3Jct2ix4qRNK0xInC/bXUSSM3LKx+6g9MD+dZEFwsSwymTbLHGMquDjrxn1qje3763q9zJcswiLtIB1PJ6fka1bjwrGLAXiTK0BXO0oVb0HQkU1ZKzZPMlv1Ktw8o3SBXLTNuV0BXP1A/rWxE7SWsPnpm72/KARwB2Hf8a5uzu1tVLTbjJu2HbyCB9TVq11kgh0j3RxnkMACQfp3zmk10NFJG5czC6laBFGxV5Yj5mPt6nNHmLas0UbMZNqkofnZeMbvTtVA6qt0ufJAR/lAJ+6R0P5/wAhTLBxfTCaSRxOrby4XGSOCMZ71NtC1JXLKySx3No0aNkOwCqeeTnJ7HIGBW6pO1mULmPKlnbIGO//ANeshtRgeaKJ7bccg8nhSQeR+VSteRQ2x86FnVl2vtkI5Hp7VLd0VomXw1xFcRsEghWUMdpBO455Yceh/WrUTJPPJGqQRumMK0eEcY6jI4/Ss20e2NrOlus7jA3ee+SOMgKR06+lMtrtYmjbDSFGxmTkjnpkYyPrRfS4klex0agCMDakkir1xgBfyFQSyoCNrMGl+TgkKuT61SjuraRwGjdWRsnYMA5/H3q0b8JcSwnIXaSdqDoOMDmpTKdloXGZLiFSMq2TsMg5+oUmgEh5ZVlyqfdiPCj39SfpWY12JnnEhkVdwVCh5AAz6+tWvtFtuUhCSBgFkB49OtD0BWL0VwsjtCCwYAE5X1pdmJlAVF7ktjJ/HoKqNepkAlyOpBUde2Oelc/r2rzT6h5FmzW/2YbpCAPnzjpxxVRjfYHVV7HVu6RoXuXjXr8ysSMe54qsLy0mneKGeLzUOGUPgg9xz1+lcQl6l358dyrzlR+8kfAY9eOOOD04q4NS+wTW5MQxKdy7Tkqe+SevStFSIdTXQ62G+05oWdZbcFeD5pIA59ajhu7IXPlJeIh2h/KwdyjtjjpXLJfI9tjYxL7VPJUNz3AP61ZutRiuJpk2tH5R2BVUYPbk9enaj2aE6nU60vDuKmSNmIz8xAOP50yTbtA5YOc7guVx9a5CK4s2WSKS38yaNCPNK4bjvkHk4PWl0vxDJAZEaSaUQtt2OBgDrgEYP51Lp9mUqp01x5jvhMocjJXkkd8U1LhJWYLHlDxtB24I9ulVhqUN3YiYpJG55BABI49aZHqEckhJV9w+Qg4we+aiw+dblsSAF1ZW4AGQR9DipVVlAR/mUKcMepb1/HFZbXdvbQFYUkKxuMbu2fTn3qaDUVeVYTvAHoB349afmK6LSEEtshVlI5/2hj09vWqV1BHe26LGZvkJx5RwCPUHOR6EdKS01JJQ7FHWVTtBznGDjNSS3UWxyDKF5IUAYHv16007MiRkwQxRS7rqSSeOEctCF3qB2Gff09Kz7jZHcEW8Rl8t8CWJg7c5PfAxWytzazSmQ+cSFCsrKCDxn14PPWqPkWcpuDEkqlTnbvKhvrg1sprqZNGTB5jXsy28xj81jnuT7k54PX8qS08i1N4VuHa4L7dzR/d49CTkY71q3VvayhRDbJBsGdycFj7+ves+5eFpHMw3vCQhIjUEg5HJ79hVcyYk7FKSR0nMr3cE1rIuFwCCw+nTH61BFZyzJ9pt1Kbzgo/8WAOQQOn4VOliJIIrgTyIRGG8tVAUZ9Mc025s7cWI8suB5eehG1s9Rz7HmqukHNdiXdhOqJETbxrK25cZJA4HBxzVqbTxHEHE+ASQGZe3Tjp696icm4jtZLt2lZY9wjxhSO341mCO2cvvWQ/daME52jGcfrRcVye6jXy0jmuIxGMlCMEjHsT3rQ0yS3gSON3iZGYzZIznt17GqHlxxWjMQwLuAoQ7dq56VLFttBvhB2z5XJ64B649aLqwN3NqTyBcGZ/KKMvSNgDx1HIPPHWqbTlSxumMSS8qgY547cDHSk01nljQOIjNJk+bsGcZ6f571HcWFqxnRPNM+c7nP3s+pqLpbkpiPcKzyPE8m08tgfLjbgUVBbW8dzFJvZ8LhSueCR0/Ciri0jOpLU//2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Low power (40X) view of a pancreas biopsy in a patient with autoimmune pancreatitis showing a large pancreatic duct surrounded by a dense lymphoplasmacytic infiltrate.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Russell Dorer, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Autoimmune pancreatitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 270px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    High power (200x) view of a pancreas biopsy in a patients with autoimmune pancreatitis showing an infiltrate composed primarily of plasma cells admixed with lymphocytes.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Russell Dorer, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Autoimmune pancreatitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 270px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Low power view of a pancreas biopsy in a patient with autoimmune pancreatitis. Obliterative phlebitis is present focally (arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Russell Dorer, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Autoimmune pancreatitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 270px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    High power view of a pancreas biopsy in a patient with autoimmune pancreatitis. Obliterative phlebitis is present focally (arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Russell Dorer, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Autoimmune pancreatitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 270px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    High power (200x) view of a pancreas biopsy in a patient with autoimmune pancreatitis showing a small pancreatic duct with a lymphoplasmacytic infiltrate.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Russell Dorer, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_45_44762=[""].join("\n");
var outline_f43_45_44762=null;
var title_f43_45_44763="Recommendations for diagnostic criteria for Proteus syndrome";
var content_f43_45_44763=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F52150&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F52150&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Recommendations for diagnostic criteria for Proteus syndrome*",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Manifestations",
"       </td>",
"       <td class=\"subtitle1\">",
"        Category",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Connective tissue nevus",
"       </td>",
"       <td>",
"        A",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Epidermal nevus",
"       </td>",
"       <td>",
"        B",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Disproportionate overgrowth of one or more of the following:",
"        <ul>",
"         <li>",
"          Limbs (arms, legs, hands, feet, digits)",
"         </li>",
"         <li>",
"          Skull (hyperostoses)",
"         </li>",
"         <li>",
"          External auditory meatus (hyperostosis)",
"         </li>",
"         <li>",
"          Vertebrae (megaspondylodysplasia)",
"         </li>",
"         <li>",
"          Viscera (spleen, thymus)",
"         </li>",
"        </ul>",
"       </td>",
"       <td>",
"        B",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bilateral ovarian cystadenomas or parotid monomorphic adenoma&nbsp;before end of second decade",
"       </td>",
"       <td>",
"        B",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Dysregulated adipose tissue (either lipomas or regional absence of fat)",
"       </td>",
"       <td>",
"        C",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vascular malformations (capillary, venous, and/or lymphatic)",
"       </td>",
"       <td>",
"        C",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Characteristic facial phenotype (dolichocephaly, long face, minor downslanting of palpebral fissures and/or minor ptosis, low nasal bridge, wide or anteverted nares, open mouth at rest)",
"       </td>",
"       <td>",
"        C",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Diagnostic criteria: sporadic occurrence, mosaic distribution, and progressive course, plus one category A, two B, or three C signs.",
"    <div class=\"footnotes\">",
"     * Consensus opinion derived from the 1st National Conference on Proteus Syndrome for Parents and Families, National Institutes of Health, March 18th through 20th, 1998 (Biesecker L, et al. Am J Med Genet 1999; 84:389).",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_45_44763=[""].join("\n");
var outline_f43_45_44763=null;
var title_f43_45_44764="Infrequently isolated spp";
var content_f43_45_44764=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F82263&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F82263&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Methods to determine antibiotic susceptibility of infrequently isolated bacteria",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Organism",
"      </td>",
"      <td class=\"subtitle1\">",
"       Method",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <em>",
"        Abiotrophia",
"       </em>",
"       species and",
"       <em>",
"        Granulicatella",
"       </em>",
"       species (Formerly known as nutritionally deficient or nutritionally variant streptococci)",
"      </td>",
"      <td>",
"       Broth microdilution",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <em>",
"        Aeromonas hydrophila",
"       </em>",
"       complex (includes",
"       <em>",
"        A. caviae",
"       </em>",
"       ,",
"       <em>",
"        A. hydrophila",
"       </em>",
"       ,",
"       <em>",
"        A. jandaei",
"       </em>",
"       ,",
"       <em>",
"        A. schubertii",
"       </em>",
"       , and",
"       <em>",
"        A. veronii",
"       </em>",
"       , two biotypes) and",
"       <em>",
"        Plesiomonas shigelloides",
"       </em>",
"      </td>",
"      <td>",
"       Broth microdilution and disk diffusion",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <em>",
"        Bacillus",
"       </em>",
"       species (not",
"       <em>",
"        B. anthracis",
"       </em>",
"       )",
"      </td>",
"      <td>",
"       Broth microdilution",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <em>",
"        Campylobacter jejuni/coli",
"       </em>",
"      </td>",
"      <td>",
"       Broth microdilution and disk diffusion",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <em>",
"        Corynebacterium",
"       </em>",
"       species (including",
"       <em>",
"        C. diphtheriae",
"       </em>",
"       )",
"      </td>",
"      <td>",
"       Broth microdilution",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <em>",
"        Erysipelothrix rhusiopathiae",
"       </em>",
"      </td>",
"      <td>",
"       Broth microdilution",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       HACEK group: the Aphrophilus cluster of the genus",
"       <em>",
"        Haemophilus",
"       </em>",
"       (ie,",
"       <em>",
"        H. aphrophilus",
"       </em>",
"       ,",
"       <em>",
"        H. paraphrophilus",
"       </em>",
"       ,",
"       <em>",
"        H. segnis",
"       </em>",
"       ),",
"       <em>",
"        Actinobacillus actinomycetemcomitans",
"       </em>",
"       ,",
"       <em>",
"        Cardiobacterium",
"       </em>",
"       species,",
"       <em>",
"        Eikenella corrodens",
"       </em>",
"       , and",
"       <em>",
"        Kingella",
"       </em>",
"       species",
"      </td>",
"      <td>",
"       Broth microdilution",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <em>",
"        Lactobacillus",
"       </em>",
"       species",
"      </td>",
"      <td>",
"       Broth microdilution",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <em>",
"        Leuconostoc",
"       </em>",
"       species",
"      </td>",
"      <td>",
"       Broth microdilution",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <em>",
"        Listeria monocytogenes",
"       </em>",
"      </td>",
"      <td>",
"       Broth microdilution",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <em>",
"        Moraxella catarrhalis",
"       </em>",
"      </td>",
"      <td>",
"       Broth microdilution",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <em>",
"        Pasteurella",
"       </em>",
"       species",
"      </td>",
"      <td>",
"       Broth microdilution and disk diffusion",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <em>",
"        Pediococcus",
"       </em>",
"       species",
"      </td>",
"      <td>",
"       Broth microdilution",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <em>",
"        Vibrio",
"       </em>",
"       species (not",
"       <em>",
"        V. cholerae",
"       </em>",
"       )",
"      </td>",
"      <td>",
"       Broth microdilution and disk diffusion",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Clinical and Laboratory Standards Institute. Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria; Approved guideline. 2nd edition. CLSA document M45-A2, Clinical and Laboratory Standards Institute, Wayne, PA, 2010.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_45_44764=[""].join("\n");
var outline_f43_45_44764=null;
var title_f43_45_44765="Sarcomere function";
var content_f43_45_44765=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F63547&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F63547&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 582px\">",
"   <div class=\"ttl\">",
"    Relationship between myocardial sarcomere length and tension",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 562px; height: 296px; background-image: url(data:image/gif;base64,R0lGODlhMgIoAeYAAP///wAAAIgAAAAARO7u7gAz/4iIiDMzM6qqqhEREVVVVSIiIkRERHd3d8zMzNDQ0BAQEN3d3bVgYGZmZpmZmeDm/7u7uxBA/4CZ//jw8CBN//Dz/0BAc8DA0cDN/4CAgEBAQEBm/2CA/zBZ/6Cz/+Dg4PDw8LDA/yAgIFBz/5CQkHCN/7CwsKCgoJCm/8DAwKZAQHBwcMSAgJ4wMLxwcI8QEFBQUGBgYK1QUPHg4AAZf+nQ0AADD9DZ/wAMPwAjrwAv7wApzwAJLwAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACH5BAAAAAAALAAAAAAyAigBAAf/gACCg4SFhoeIiYqLjI2Oj5CRkpOUlZaXmJmam5ydnp+goaKjpKWmp6ipqqusra6vsLGys7S1tre4ubq7vL2+v8DBwsPExcbHyMnKy8zNzs/Q0dLT1NXW19jZ2tvc3d7f4OHi4+Tl5ufo6err7O3u7/Dx8vP09fb3+Pn6+/z9/v8AAwocSLCgQXoBEipcyPCgw4cQAQRoNDGixYv+Ki7SiLGjx3kcASQIkKBQyI8oU6LjSEEhBUInVcqc6Y0jA5IBGMCkybPnNo0RElpIGGFQTJ9Iky7TaCAngAMBDBhVSrVqMo0LGC6YarWr118VhwYoGjSABUFHv6pd+6riBKeC/25OQFutQQAFbPNmpFj3rt6/+tLupGYXL+DD9QRznWb3wM0FDhBLdsew8sK+BwA01Tm5s+dOhQE4IPm5tOlKoYeWPM269aLQbw27nk0bgN2ROQnU3s27t2+eD24F/03cnokWKGzcsoGihYni0N2ViAEh4YtbLxJCiFEiundzLEAsRJELxUIQLL6r/ybesvv38OPLnw9ivf1t4ceXP5/+vv9s01UXwHW2ZBfAdt39p2A2xyW3XHPPLSihNsPVUuGEGGao4YYcdujhhyCGKOKIJJaYSgYSCKDiiiy26OKLMMYo44wCSJBBKSjSqOOOPOpoo4ldpdjjkEQOKUEpQhap5P+SLx4JZFVMRimlipAMYKWVkEyppZJPQrnllzxWeeUAWYJp5oxdUpXkmWyu6KQjY5L5yJptsvlmmj7lWKedNz4SJyR67mnmj3jK9ICA88EHwYWUHJroo5BGKumimTgqaWWUForRB5e69wEmnHYq6qiSfgoqqQuZqqlFlpKaqSWtoirrrNox2iiio766qkeBCvoloXCOCSidvk4J7K4yEVussWJeCYmyy0Z5J7IpRXtms1g+Yq2Z1M60LZjYyunIt192myy5zPop7JzoSjmtuR312q6RfQbr7CPyzsvjsfA+FKuout5K68CyBiwwqgb3C1CosqpaCcMER9ypww/TSrH/wgD922nCkWgs8cfxcdwxrgDbijFB+errY72N/IkvtCrLyO/JEMEcs8zhPnszke/S7NDOReasLdBD+nwR0UWre++4SIdpdEQ2N+2m0I5ELXWNT0eU8tUqzqyIy45szbXXWffj8aQmjwzy2vOJDMnZkbpd9jwQk3qxJHWzrXdld+Nt8dz8wA2p3I0IvjfIhBdO8sZpA56P2FeTjQjYjUAuteSO92P15VQ3snnTPWfuD9c0ds4I6WiKPhDqMpq+COsxqj7Q50iHPvm6VcPuou2yP077zpgbQjkjloPOcu/3GJ5o4osof3jEzDe/+KXRI19O3qL2DQn2z+ut/fZ/Wy+P//PyVY8I+d3Pav7506Mt/oTDvy//KPHPb78n9d+vfyb57+///wAMoAAJYYIEfaIEEZJGAQ+BwAFS5QE3CEDjMPGAANxggsYIUH8KwQIEObAnLWhPfUQhwhYwIz8BIA8izBMA9HwwJSX4AK5MKIoWLAQCHzDgMEygAhYmRAWJUMF4VJDAF0bEQOlzD4GEgcRRLdGIEInhDEdhQ4XgUIfC4KEPAwBERAhRISggIhQ9EsKEjDAUJTxhe1R4CBa6cIwpgaAEQ1HBC0JDg4foIHfgSJMFgqKB0/BjIQDJx0IaUi8IWEgDzhGBmyREKofUCwGy8hJyTDIACIikJO2iEEiOI/+RW9FkXm6CF6h4UhygFGVeTHnJU4bjkplUpVoQMJIFZMWV4XCAI6Miy1760j+cVIhsfgnAlgyTmPtLZAIig0z/JdIszXRmQmIZzfs9k5rVtB9UsJnN+UFlIavppjjHSc5ymvOc6EynOtfJzna6853wjKc850nPetrznvjMpz73yc9++vOfAA2oQAcqiUfJ0qBZUwxdVKlQiZStoQ19IUQfOohvJoQBRVmoKDVigQlkJQCQWYzRNLJNACggAIvUqCY18hZIGoAzDk1oRTFp0gBUMqYbHcRImGkSigrCojnhaUQ/WJHRhLOnMv0pTVOp0kgWlTSHGOquSEpTAhClqYf/1MhOo+rTp9C0JaHE6UoHsRndUACmUl0VVRWCUZE6lRAG+GhIsXqyiTKUL0ndyEHx+jS75pQRadUUQjeaqDES4LC6IeiTDICbaeoTdxCBbDQa61hZNqWTnJCsQzT7jAQoALGJ7aVVAxBaTXDWIKdtRgM+i9hfjra0/FtaZGUbjcsqhJuafG0nUksQ3i6DsjQVbUJgiwnfCsS4yfAsaF073N3S9hMZwIHuVFQDGtDvuc9Y7XLHYduodNcA3yXrQsA73qToNrPY7cQMpssiGYgCucgAanDFcd76NpcQ9iWtNcL7C/6aNr2b2AF7WQSD9wKYGfLFrTfym9jzDoLB13Aw/zjgW4kcDHhFBQ4FhY8BWuJ+A8IAkHCI7ytiaZS4GxumxHov7F4NH3gZCbYkiWesX/zS2MPQODE3UjyJDMCAvdW9bramEeNxgFjEIK6Gjm2BviS6CoOtaI+T9dbFVyDWAQnIKH1vLAgkc9kaS64F96Ycse+1oolkBtkZXYHYoeCyG9+Nc3kFIWfMKvm+vGhymt13CynvWWJVboV836wh/36Dx/tAtDCAygAcy1PR+YB0MLb72Bcf19LLoHQjEgnXhBwgo5f9tC8lfQ9S+4KxC1HwIT46iNFERgF4cbVJj6lJU9fD1rwArqoPMRSycsYCJXmpIICtWN8ot7WP6LUgJv8wFwAEhQDMFsSzi80b7SLbEcoGQLSdTdptT1siluFFBURQgHKb+9zoPrcINkBtb3R3vozItrABQEvNcKbehkhrYBMx1A1gIN0AD3gBRsBubey7nrpOtkZkDWvRBODVtBYrXzERUQxcoNwh6IFUKxCEgVfA4O0+9mEf8VG4hBrUntbyYB5xcK4uggQaKLcGPEBXRfBgBOXGQMGt0fJ5WnvkqND3JgTjAZwXQAMkWLkjArCBEMj8BNfouTyLbAqha+IoFXB6AS6gc6SyXBAniHkBQvBxakg9nlQvhdUzcZJxm3sFO1c6X/1d7gvQfBpnP+euO5yKtVOcEP6+eAFEUHb/l3+dEBUwugvw/s8DLOCUDda02iORd426QPAhuDu/KW+IDZB78HFvRuXL+RaQFiWRCEg7Kfx+iYnA/OkTj/0gXFDuERRe9AAlAAImcBbUq94RBHCkqAHgSJjmm/Oa8IHWL5D0pSP/EB64OPOfMXpxSj7y147EBDLzFLzE9bCPRwTrKbGBFNS964dP/yESX+4UhB4Z1a8mqm9riAlo2QC7VsQEDNOAuSjApREncYCVCeYHegX1fInwb0eneVexTwlXCAeQABRAACeVf4lAABE4AY0GAAtQSRTAfccHCWfnAeUmBJQwftAndhiwFA7IWkBXCKiWFRsoCcIWV1LRgYLw/4EwEW6yJwlOJwIHh4KHUH61d3vFEH/R9HM4dlkLoHKQkABnAQAUsBX/JwirJX4IOAkkeAEVEIRZ+HLS13zGgITN9Htv4Vkk4YSO4BhxoRPfN0mEJoSPEHMr6IUiGAnsVwDuN4b79HsHIGpNYYGI4ADfNHzFt3l3WAkksHXsZofq9wgKOHNHOBC4tguViAx8ZwinZAFRWHVfCAl0WHMDmIiS4AEqSAxk2At19kibcIm54IrFAG0jcQCCqApyyAj/pgFu9YijOAlE6HHCkIq9kGSxNWTSAIvEcFIKkWWGQAAG0ADQ2ABqKAq3qAgbcHFi6IjOZwkkIH1QBwzCyAvEWP9cmIYMyDgMCWB/upcAuKSM9HcK1ZiARyd3vKhXl5CHKwCO3TCOl3COteCPwGBVN3UAKUUICeB4DNAAyxR0n8gIFXBxDKiNPTgJK1CEvhCOu8CPlgCQs8CRv5CBDXATN9VlmMQApVSLh0CIQhEXF4WI9cgI5BYCXteQLokJJ+CNvYCRuqCRlaBZ0QVk1nU7xugNtMRWzWhTCpmUkxABCVCQmrEA4BeHNJkIFVBuDCiA2/iSlICPvKCTucCTlKBZKzZgLSY85VgNEfCMI0kIB6AAo1FZkXCFhFCFmhGA8WgI5pcCIXiApLgJFQmMueCVt7CKvPRfQylgFyYAGWaWQ7n/Ddj3gs24eyhpCI6XECGFg1IIgjM5kYlAggVghFjJmVjoCTeZc4FJibRlYYm5mIXgkbvgewyBW/MHl5CwACm1fRzogZrpHlnpCD9oeFMJnJyQdTJ3lbIgmCj2XGPJXmXZmmcJDbCZaobwgJHAAJDUa3Qpl3vZm4ywhaAZmr3InZ3QjeW2brWAnDv2XD4GlIngmhnZZZInCCLnaIsQV0WhAG4IlXA4mlp5CKEonP0JoJ3geXUnhrGAnrGgZ3/2KG7jZws6MIFWC7qhe4ighJWgjIbYkvwpnomwiBfwfqJojwGqCaaIcd+5CggKC2P2oHaTCGjGorOyZrTAABg1i4fw/26TyXbBSQj/KaCi6aOfoIAXsHiwkKKvoKAwqigT5KBJSioRKgtWRV5QsZYiEZsM2ZeKkIuKIJHhSQrEOXYnCo+o2ZjP4J4ZiUlvYQEEOZ0uSJ+fcJfXWAAGup1Y2qWlcHlbR6SsYKTYYKau4Ke6sAAMkBUY6JRW2KZ9t6MAoKVbeoKK6glfSnZ7OqbicozPKQ2cpABBQaW/R407+pAFYJybOaKjegp4OqQoSqnVAKi6AF66NwHE1amhEI8xaacc2qitEKlhCgp8eg2sugq/OpiUpWCZKKZ1WghVGaq2+qN0ugqn+o2eqE/UeZzBmZfMuqHX6qVGl4/Rmk/zeZw8uP+sguCZu7qLt1qTr/CXtjd5+mSh5zmVv5mtzSqisVCaFwCts9qHVkoLcuid50qv8moKXOmp+mSGnsQAVEqwWtmj4gqwDdsK6lqultCrfFSsD0aQiLWmxvqSHgqi2Eqq9CgLpVkAK/imxRZMc9att8qwD4uuLZurWieJnUCxcGQABzABH6hyKHtRbjqzn8ioIDuvuJoL5GmAQ7dPpZcZ7FgI0GYA2aeyshenc/qyQPqxtkCgWze1lUCzRmRV+5cZGtuMT7t6Xwi0QVuqQ7sLJQqmOppPVoUADZAZtqmJw3qljwiqouqw/1q1tiCkWvuo7YSQggpNhTCtZIultcqXirv/t7aQh3u4tfuEZQrRbIWLqHbbm8mat3obsOCpC5GouVS7TpzobGpZoZa7sb1prZPApZvLC2tbsotbT3/YCLLKCbzJV+TqqKsLuFdbgOvKu+k0u4xQuyZLivG6u8h7trdQtHB3rFN3kH8YvZ2IX/E5Clbnr7obu6GbC1+KqowbuJahYDaLs8MHtaPIssBrrmlrDGsrs60LT3+IAPI7v8SVtCJBaLzKeR07sdn7vb+Ap2y7vvQkvIrgtQoAtoZqvZyHvukbonwrDBvwlyTrsZ37TttWwJgUtxyYwAq7dGbbv87rssnwpRqAryH7Dx1wJRzQDClsJSscD4J7E9N7uI/A/wPY+HfJ67/DEHYmKrT+0MID8MLLAMRC/A6SmxCUa76LoAPziMPa+77IQHfleXtcCwvu+HBX7ABZTAlEzMIqPA9p2QAJawmHaLVUCQTK6sTAW8Wj4Hbl+Y1s/AqJBIJzPAh1XAldzAx5DA8RgAC60ceb8Ibh98CEkLiiGYRSFVHhSIYc4cZbJwI6gAGSjAEnQME+LAx3TG8BQMebbAl7rAyf7A6OpxuJNMaSQJcGYJePkLn9icghjLZXV7yIJwKCB3AjsAKTrLlxjAmZ3MudjMdfrMfB/A5WlVLFrAmYqYOELAjk9gOv7Mogu8iybAgngAGRLMkrYHTnBruXHAy+zP/JmikJoYwM47wOVmUYo8HBk5DMu9mk7vzO3bMM32zHv8zFwfyT0xVkhFDO60BKDZAVM3yhkKSdsNy2nsDIHXy0+asM8ywImTwJebyc09Wc/KwORxwASXwJgiyV+TrNCr3QPgvSx5DFJL0QPBUJXYyYF8aaFZ0OFkABpcsJZbzMIPzRtpvQsSzS7NDFqrnS+zzM78AA4Xy5B63TOW3UBl3U7xDRiUnRQO0OqVe97dYIebye+RyUg9DS6EC86PRF8DwqIICkX21FUPaR+wpPTDrWkZLWav0oZjZpUr1OXt3Way3War0+rXqzOXsKTBnQX6mMEugLpVeYvTAUplwOWi3/DIltDva7tKVQen6NCxFwAJFhF75A2VJYY7vAlIHdDosNDJ9tZBh9wE+hzrwa2btgAWF1akN9C3CImTv91OQs2+acwXJr2m+K2rpgf7/QEg/XCwmZm+4Q2r5A3OIQw4RbdbqNCwZw0r5AAQnQs68QkoIA2+100Rm9esttCwyQo/y63a+wS0gMT2F82Kf9C5ONv7dgAW3FWNItC9btTvI7jaEw2LusCGLhErzQSJYJ3rMQ3+s0m9k91R4yi9/k3QR+H+k4bCiV4CHyczb13g5+H/KVELg94f9R4Q2O4RzSYZDJ4SAe4iI+4iRe4iZ+4ig+Cyel3pKgTCmuDhGgjLbp/9y6sOKXMFqR4eIvjg5ZkUkUyOK0YOOWgOOafFQ7Pg5G5dwWhdlQ4VGZkXoK4QAUmBCBbVQnlQAIcOU+7o5SoUxv4cdcXgg2rkuWmUlQccCbTMpZgRsXTYskUXr42xR4oeNHHg0lZ50wCFJe5WlD0YQzJRXbZFQE0BLRvRnEB00A/UzTJMMcmNw15bS2RABG5VWLxEojYQE4TuTKpHtQdaN+Qed1/gwE8M+YdVbL6FUDjdGDUBZFYRcTMOkurkxlMV46Put2Jggr7tsmbUo11QCplOkJkeOk8ZZL+OmdHurSEBuq4QAuzuu2oerSdlWuDuukIetXRc+rweqIkOt6zs+WvHRSvq7nwP7bLk7siCDnRY7sz6BLsXQT+EcaTVESzt7nWsbrgV7t+C7vfmFS8tvpZ47r2LTiBDASUtFIGPjtKBUUWfaWkXHp6W7uWyVemUHo6u4Mo+5Igyx8pOHsmRnlU04SL0HtJeHi0MZWfdzpJX9RKjfmu1RKCL9I0L3JVxVq5T5cQ3FM8Y4TRl7xawFWjtAUzo3uPP8X7sgANI4IJqmJ+z70TN/0Tv/0UB/1Uj/1VF/1Vn/1WJ/1Wr/1XN/1Xv/1YB/2Yj/2ZE8QgQAAOw==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Top panel (A) is a schematic of a sarcomere. The thin filaments (actin, shown in black) are attached at the Z band. The length of two actin filaments as they extend from the Z band is indicated by \"b\". The length of a thick filament (myosin, shown in maroon) is denoted by \"a\". Panels B and C show the correlation between sarcomere stretch and tension. Position number 1 shows extreme sarcomere stretch (as occurs in the volume-overloaded ventricle) where neither actin filament can interact with the myosin filament; as a result, tension development is zero. Points 2 and 3 demonstrate situations of maximum actin myosin overlap with maximal tension production.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Braunwald E, Ross J Jr, Sonnenblick EH, Mechanisms of Contraction of the Normal and Failing Heart, 2d ed, Little, Brown, Boston, 1972. Copyright &copy; 1972 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_45_44765=[""].join("\n");
var outline_f43_45_44765=null;
var title_f43_45_44766="RAI in thyroid cancer";
var content_f43_45_44766=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F58786&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F58786&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 578px\">",
"   <div class=\"ttl\">",
"    Radioiodine ablation reduces recurrence and mortality in stage II and stage III thyroid cancer",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 558px; height: 288px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Long-term development of recurrent disease (left panel) or death (right panel) from thyroid cancer in patients without distant metastases at presentation, who received either 131-I ablation (red dashed lines) or no ablation (blue solid lines).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Mazzaferri, EL, Jhiang, SM, Am J Med 1994; 97:418.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_45_44766=[""].join("\n");
var outline_f43_45_44766=null;
var title_f43_45_44767="RVOT nine site mapping";
var content_f43_45_44767=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F72301&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F72301&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Nine site mapping schema for RVOT tachycardia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 394px; height: 351px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The septal aspect of the right ventricular outflow tract (RVOT) is depicted as seen in the 30&deg; RAO view, divided into posterior (sites 1, 4, and 7), intermediate (2,5, and 8), and anterior (3, 6, and 9) sites. Pacing from posterior sites (1 and 7) results in a dominant R wave in lead I, and frequently in a small R wave before a dominant S wave in lead aVL. Pacing from anterior sites (3 and 9) always produces an initial Q wave (QS, Qr, or qR) in lead I, and a QS complex in a VL. Early precordial R wave transition (R/S &gt;1 in V1, V2, or V3) is observed during pacing from posterior and superior sites. Moving diagonally from superior-posterior to inferior-anterior results in progressive delay in the precordial R wave transition.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Redrawn with permission from: Callans DJ. J Cardiovasc Electrophysiol 1994; 5:880. Futura Publishing Company.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_45_44767=[""].join("\n");
var outline_f43_45_44767=null;
